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Abstract 
The ovarian follicle is an individual functional unit that provides the optimal environment for the oocyte 
within to develop. This thesis outlines the research in the field of ovarian follicular dynamics that has 
already been established, and further develops these findings to explore in greater detail the relationship 
between the oocyte and its environment, both in an in vitro and in vivo setting, using a variety of species.  
The first major research area involved studying the role of oocyte-secreted factors, which was examined 
using a series of dose response experiments. These were performed using an ovine granulosa cell 
culture model, and elucidated a possible role for a collaborative action of BMP15 and GDF9 in the 
promotion of oestradiol synthesis, while inhibiting production of progesterone in this species. This finding 
was then further investigated using an ovine in vivo immune-neutralisation study, the endocrine and 
histological results of which confirmed these findings in a proportion of these animals, although this study 
was limited by the animals appearing to have been in seasonal anoestrus. 
The second major topic that was investigated was based around the ovarian microenvironment, in terms 
of angiogenesis and hypoxia. Again, ovine granulosa cell cultures were used, in this instance to examine 
the effect of hypoxic conditions on steroid hormone production. These experiments indicated that somatic 
cell steroid hormone production is likely to be compromised by a hypoxic environment, and therefore that 
the provision of oxygen through a local blood supply may be a vital requirement for these cells. 
To investigate the relevance of studying ovarian blood supply and physiology in a clinical setting, 
perfusion studies were carried out based on a series of bovine phantom experiments, which were used to 
study the effect of varying flow rate on the parameters routinely measured using this technology. The 
routine clinical ultrasonographic methods of ovarian assessment such as 4D Viewª, SonoAVCª and 
VOCAL were also examined, based on bovine phantom experiments, revealing possible weaknesses in 
the data provided by ultrasound that are increasingly relied upon in the clinical setting. 
Finally, a clinical trial was carried out to try and encompass all of the findings of the in vitro and in vivo 
work, in order to place these theories into context in a human IVF setting. This work was unfortunately 
limited severely by a lack of patient numbers, but some interesting results were observed with regard to 
oocyte developmental potential relationships with follicular fluid and somatic cell factors, as well as 
ultrasound measures of peri-follicular blood supply.  
 iv 
 
Acknowledgements 
The past three years have been enjoyable but testing at times, and there are certain people who have 
helped me through the tough times and kept me going! 
Firstly I wish to thank Professor Bruce Campbell and Mr Nick Raine-Fenning, for giving me the 
opportunity to undertake this PhD, and for offering guidance and support throughout the entirety, while 
allowing me to find my own way along the path. I also wish to acknowledge Dr Peter Marsters, for all his 
help and advice about all things molecular, and for helping me to see the bright side when things arenÕt 
always going my way. He has always been a friendly ear to talk to. 
I donÕt think I would have enjoyed this PhD as much as I have without the company of a certain doctor. Dr 
Shyamaly Sur has been an excellent colleague to work with and also a friend from very early on, and for 
that I am very grateful. 
To Catherine Pincott-Allen I owe a huge debt of gratitude, for her tireless assistance in the lab with 
ELISA, RIA and histology. Her help has been a huge contributing factor to the success of my research. 
Thanks to Dr Juan Hernandez Medrano, for his help with the infusion study statistics, all his assistance 
with the animal surgeries for the infusion study, and for blood sampling sheep at some very unsociable 
hours of the night! Finally I wish to thank Jeanette Clewes for recruiting and scanning patients for the 
POEM study. Without her input the trial simply would not have been possible. 
 
I want to thank Mum and Dad and the rest of my family, who have always supported me in whatever I 
have chosen to do. Lastly, I want to thank Jen, for believing in me and being by my side through thick and 
thin! 
 
Adam Marsh 
December 2011  
 
  
 v 
Table of Contents 
Declaration .................................................................................................................................................... ii 
Abstract ........................................................................................................................................................ iii 
Acknowledgements ...................................................................................................................................... iv 
Table of Contents ......................................................................................................................................... v 
List of Figures .............................................................................................................................................. ix 
List of Tables .............................................................................................................................................. xiv 
Abbreviations .............................................................................................................................................. xv 
Chapter 1 Ð Literature Review ..................................................................................................................... 1 
1.1. Introduction ..................................................................................................................................... 1 
1.2. The Reproductive Cycle ................................................................................................................. 2 
1.2.1. Reproductive hormones ........................................................................................................... 2 
1.2.2. The oestrous cycle ................................................................................................................... 3 
1.2.3. The menstrual cycle ................................................................................................................. 5 
1.3. Follicular Development ................................................................................................................... 6 
1.3.1. Preantral follicle development .................................................................................................. 7 
1.3.2. Antrum formation ...................................................................................................................... 8 
1.3.3. Cumulus expansion ................................................................................................................ 11 
1.3.4. Follicle selection and dominance ........................................................................................... 12 
1.4. Oocyte-follicle interactions ............................................................................................................ 14 
1.5. Oocyte-secreted factors ............................................................................................................... 16 
1.5.1. Growth Differentiation Factor 9 and Bone Morphogenetic Protein 15 .................................... 17 
1.5.2. GDF9 and BMP15 signalling .................................................................................................. 20 
1.5.3. Bone morphogenetic protein 6 ............................................................................................... 23 
1.5.4. Insulin-like growth factor ........................................................................................................ 24 
1.6. Follicular cell expressed markers ................................................................................................. 25 
1.7. Angiogenesis ................................................................................................................................ 26 
1.7.1. Vascular endothelial growth factor ......................................................................................... 28 
1.7.2. Hypoxia-inducible factor-1 ...................................................................................................... 29 
1.7.3. Follicular blood flow ................................................................................................................ 32 
1.8. Experimental models .................................................................................................................... 33 
1.8.1. Native OSF bioassays ............................................................................................................ 34 
1.8.2. Cell culture systems ............................................................................................................... 36 
1.9. Ultrasonography ........................................................................................................................... 37 
1.9.1. Power Doppler ....................................................................................................................... 37 
1.9.2. Antral Follicle Count ............................................................................................................... 39 
Thesis rationale, objectives and hypotheses ............................................................................................. 40 
Chapter 2 Ð Materials and Methods ........................................................................................................... 42 
2.1. Cell Culture ...................................................................................................................................... 42 
2.1.1. Follicle dissection and granulosa cell isolation ......................................................................... 42 
2.1.2. Granulosa cell culture ............................................................................................................... 42 
2.1.3. Estimation of viable cell count .................................................................................................. 43 
2.2. Sample analysis .............................................................................................................................. 44 
2.2.1. Steroid Hormone ELISA ........................................................................................................... 44 
2.2.2. AMH, BMP15 and GDF9 ELISA ............................................................................................... 45 
2.2.3. Radioimmunoassay .................................................................................................................. 46 
2.2.4. Reverse Transcriptase PCR ..................................................................................................... 48 
 vi 
2.2.4.1. mRNA extraction from somatic cells ................................................................................. 48 
2.2.4.2. cDNA synthesis ................................................................................................................. 49 
2.2.4.3. Reverse-transcriptase PCR .............................................................................................. 50 
2.3. Tissue processing and staining ....................................................................................................... 50 
2.3.1. Hemotoxylin & eosin staining .................................................................................................... 51 
2.3.2. Aromatase immunohistochemistry ............................................................................................ 51 
2.4. Ultrasound ....................................................................................................................................... 52 
2.4.1. SonoAVCª .............................................................................................................................. 52 
2.4.2. VOCAL power Doppler analysis ............................................................................................... 55 
Chapter 3 Ð The Oocyte Effect on Granulosa Cells ................................................................................... 62 
3.1. Introduction ...................................................................................................................................... 62 
3.2. Materials and Methods .................................................................................................................... 63 
3.2.1. Experiment 1 ............................................................................................................................. 63 
3.2.2. Experiment 2 ............................................................................................................................. 63 
3.2.3. Experiment 3 ............................................................................................................................. 64 
3.3. Results ............................................................................................................................................ 66 
3.3.1. Experiment 1 ............................................................................................................................. 66 
3.3.2. Experiment 2 ............................................................................................................................. 66 
3.3.3. Experiment 3 ............................................................................................................................. 70 
3.4. Discussion ....................................................................................................................................... 77 
Chapter 4 Ð Hypoxia and Angiogenesis in the Ovarian Follicle ................................................................. 84 
4.1. Introduction ................................................................................................................................... 84 
4.2. Materials and Methods ................................................................................................................. 85 
4.2.1. Experiment 1 .......................................................................................................................... 85 
4.2.2. Experiment 2 .......................................................................................................................... 86 
4.2.3. Experiment 3 .......................................................................................................................... 87 
4.3. Results .......................................................................................................................................... 87 
4.3.1. Experiment 1 .......................................................................................................................... 87 
4.3.2. Experiment 2 .......................................................................................................................... 88 
4.3.3. Experiment 3 .......................................................................................................................... 93 
4.4. Discussion .................................................................................................................................... 96 
Chapter 5 Ð In vivo immuno-neutralisation study ....................................................................................... 99 
5.1. Introduction ................................................................................................................................... 99 
5.2. Aim ............................................................................................................................................... 99 
5.3. Method .......................................................................................................................................... 99 
5.3.1. Active Immunisation ............................................................................................................. 100 
5.3.2. Oestrous synchronisation ..................................................................................................... 100 
5.3.3. Ovarian vascular cannulation ............................................................................................... 100 
5.3.4. Ovarian stimulation .............................................................................................................. 103 
5.3.5. Ovarian infusion ................................................................................................................... 103 
5.3.6. Blood sampling ..................................................................................................................... 104 
5.3.6. Tissue collection ................................................................................................................... 104 
5.4. Results ........................................................................................................................................ 105 
5.4.6. Follicle counting ................................................................................................................... 106 
5.4.7. Aromatase immunohistochemistry ....................................................................................... 107 
5.4.8. Ewe 1 ................................................................................................................................... 110 
5.4.9. Ewe 2 ................................................................................................................................... 111 
 vii 
5.4.10. Ewe 3 ................................................................................................................................. 113 
5.4.11. Ewe 4 ................................................................................................................................. 114 
5.4.12. Ewe 5 ................................................................................................................................. 116 
5.4.13. Ewe 6 ................................................................................................................................. 117 
5.5. Discussion .................................................................................................................................. 120 
5.5.6. Follicle count ........................................................................................................................ 122 
5.5.7. Aromatase and oestradiol .................................................................................................... 123 
5.5.8. Limitations of the study ........................................................................................................ 124 
Chapter 6 Ð Ultrasound phantom studies ................................................................................................ 126 
6.1. Introduction .................................................................................................................................... 126 
6.2. Blood flow phantom models .......................................................................................................... 126 
6.2.1. Aim .......................................................................................................................................... 127 
6.2.2. Method .................................................................................................................................... 127 
6.2.3. Results .................................................................................................................................... 130 
6.2.4. Discussion .............................................................................................................................. 133 
6.3. SonoAVCª ................................................................................................................................... 137 
6.3.1. SonoAVC measurement of follicular size ............................................................................... 138 
6.3.1.1. Aim .................................................................................................................................. 139 
6.3.1.2. Method ............................................................................................................................ 139 
6.3.1.3. Results ............................................................................................................................ 141 
6.3.1.4. Discussion ....................................................................................................................... 146 
6.3.2. SonoAVC measurement of ovarian reserve ........................................................................... 147 
6.3.2.1. Aim .................................................................................................................................. 147 
6.3.2.2. Method ............................................................................................................................ 147 
6.3.2.3. Results ............................................................................................................................ 149 
6.3.2.4. Discussion ....................................................................................................................... 153 
Chapter 7 - Clinical Trial: Peri-follicular blood flow, molecular markers and follicular fluid constituents as 
predictors of oocyte and embryo quality .................................................................................................. 156 
7.1. Introduction .................................................................................................................................... 156 
7.2. Aim ................................................................................................................................................ 158 
7.3. Study outline .................................................................................................................................. 158 
Screening (Visit 1) ........................................................................................................................ 159 
Trial period ................................................................................................................................... 159 
7.4. Data Collection .............................................................................................................................. 162 
7.4.1. Transvaginal ultrasonography ............................................................................................ 162 
7.4.2. Blood sampling ................................................................................................................... 162 
7.4.3. Ovarian cells and follicular fluid .......................................................................................... 162 
7.4.4. Granulosa cell and follicular fluid collection ....................................................................... 163 
7.4.5. Cumulus cell collection ....................................................................................................... 163 
7.4.6. Molecular analysis .............................................................................................................. 164 
7.5. Results .......................................................................................................................................... 165 
7.5.1. Case Report ............................................................................................................................ 166 
7.5.2. Power Doppler Ultrasound ...................................................................................................... 169 
 viii 
7.5.3. Oocyte Retrieval ..................................................................................................................... 170 
7.5.4. Oocyte Fertilisation ................................................................................................................. 172 
7.5.5. Embryo Transfer ..................................................................................................................... 175 
7.5.6. Follicular Growth ..................................................................................................................... 178 
7.5.7. Patient Age ............................................................................................................................. 180 
7.5.7.1. Follicular size and vascular indices ................................................................................. 181 
7.5.7.2. Follicular Fluid Constituents ............................................................................................ 183 
7.5.8. Follicular Aspiration ................................................................................................................ 184 
7.5.9. Follicular Fluid Steroid Hormones ........................................................................................... 184 
7.5.10. Follicular Fluid TGF! members ............................................................................................ 190 
7.5.10.1. AMH in Follicular Fluid .................................................................................................. 190 
7.5.10.2. BMP15 in Follicular Fluid .............................................................................................. 195 
7.5.10.3. GDF9 in Follicular Fluid ................................................................................................. 197 
7.5.10.4. Intrafollicular hormone and growth factor interactions .................................................. 197 
7.5.11. Ovarian Stimulation Drugs .................................................................................................... 198 
7.6. Discussion ..................................................................................................................................... 198 
7.6.1. Follicular Size ......................................................................................................................... 198 
7.6.2. Vascular Indices ..................................................................................................................... 199 
7.6.3. Patient Age ............................................................................................................................. 201 
7.6.4. Follicular Fluid Steroid Hormones ........................................................................................... 202 
7.6.5. Follicular Fluid TGF-! Factors ................................................................................................ 204 
7.6.5.1. AMH in Follicular Fluid .................................................................................................... 204 
7.6.5.2. BMP15 and GDF9 in Follicular Fluid ............................................................................... 205 
7.7. Conclusion ..................................................................................................................................... 207 
Chapter 8 Ð General Discussion .............................................................................................................. 208 
8.1. Summary of research findings ....................................................................................................... 209 
8.2. Limitations of the research ............................................................................................................ 211 
8.3. Future work ................................................................................................................................... 213 
8.3.1. In vitro culture ......................................................................................................................... 213 
8.3.2. In vivo experiments ................................................................................................................. 214 
8.3.3. Clinical research ..................................................................................................................... 214 
8.4. Conclusion ..................................................................................................................................... 215 
References ............................................................................................................................................... 216 
Appendix .................................................................................................................................................. 243 
1. Cell Culture Media ......................................................................................................................... 243 
2. Assay Buffers ................................................................................................................................ 244 
3. Tissue Processing ......................................................................................................................... 245 
  
 ix 
List of Figures 
Figure 1.1. The hypothalamic-pituitary-ovarian axis .................................................................................... 2 
Figure 1.2. Dynamics of bovine ovarian follicular development and gonadotrophin secretion during two- 
and three- wave oestrous cycles (Adams et al., 2008) ................................................................................ 4 
Figure 1.3. The menstrual cycle (Petroff et al., 2001) .................................................................................. 5 
Figure 1.4. Schematic diagram of follicular development in the mammalian ovary ..................................... 6 
Figure 1.5. Scanning electron microscopy image of a human secondary oocyte after zona pellucida 
removal (x10,000) (Makabe et al., 2006). .................................................................................................... 9 
Figure 1.6. Molecular basis of oocyte-cumulus cell signalling pathway. .................................................... 20 
Figure 1.7. KitL, BMP15 and GDF9 interactions in oocyte follicular development ..................................... 22 
Figure 1.8. Summary of the IGF and BMP systems .................................................................................. 25 
Figure 1.9. The HIF angiogenic pathway ................................................................................................... 30 
Figure 1.10. Bioassays of native oocyte-secreted factors (Redrawn from Gilchrist et al., 2008) ............... 35 
Figure 2.1. H&E stained ovine (a) primordial and transitional follicles, (b) primary follicles, (c) small antral 
follicle and (d) large antral follicle wall. ...................................................................................................... 51 
Figure 2.2. 3D ultrasound scan image of bovine ovary with follicles visible as dark circular appearance . 53 
Figure 2.3. Semi-automated SonoAVCª measurement of bovine ovarian follicles .................................. 54 
Figure 2.4. A 3D ultrasound scan of a perfused bovine ovary in the VOCAL image analysis tool ............ 55 
Figure 2.5. VOCAL analysis of Power Doppler blood flow in perfused bovine ovary ................................ 56 
Figure 2.6. The first stage of highlighting a follicular volume of interest in the human ovary, involving a 
series of 15¡ rotations around a central line of reference .......................................................................... 57 
Figure 2.7. VOCAL contour selection adjustment in human ovarian assessment to achieve an accurate 
line trace around the interior follicle wall .................................................................................................... 58 
Figure 2.8. VOCAL shell application to human ovary for power Doppler analysis of peri-follicular blood 
flow ............................................................................................................................................................. 59 
Figure 2.9. VOCAL selection of power Doppler peri-follicular blood flow in a human ovary ...................... 60 
Figure 2.10. Human ovary mean follicular diameter measurement in 4D View ......................................... 61 
Figure 3.1. Total cell number estimation of ovine granulosa, granulosa with COC, and COC alone, after 
192 hours in culture ................................................................................................................................... 66 
Figure 3.2. Mean total cell numbers after 192 hours in culture for granulosa cells from different sized 
follicles, with and without FSH ................................................................................................................... 67 
Figure 3.3. Oestradiol production by granulosa cells originating from different follicle sizes after 192 hours 
in culture with or without FSH .................................................................................................................... 68 
Figure 3.4. Oestradiol production per 10,000 granulosa cells, originating from different sized follicles, after 
192 hours in culture with or without FSH ................................................................................................... 69 
Figure 3.5. Ovine granulosa cell oestradiol production in media after 48 hours in culture ........................ 70 
Figure 3.6. Ovine granulosa cell oestradiol production in media after 96 hours in culture ........................ 70 
 x 
Figure 3.7. Ovine granulosa cell oestradiol production in media after 144 hours in culture ...................... 71 
Figure 3.8. Ovine granulosa cell oestradiol production in media after 192 hours in culture ...................... 71 
Figure 3.9. Ovine granulosa cell progesterone production in media after 48 hours in culture ................... 72 
Figure 3.10. Ovine granulosa cell progesterone production in media after 96 hours in culture ................. 73 
Figure 3.11. Ovine granulosa cell progesterone production in media after 144 hours in culture ............... 73 
Figure 3.12. Ovine granulosa cell progesterone production in media after 192 hours in culture ............... 74 
Figure 3.13. Ovine granulosa cell neutral red cell number estimation after 192 hours in culture .............. 75 
Figure 3.14. Ovine granulosa cell oestradiol production per 10,000 cells after 192h in culture ................. 75 
Figure 3.15. Ovine granulosa cell progesterone production per 10,000 cells after 192h in culture ........... 76 
Figure 3.16. Ovine granulosa cell aromatase expression at 144 hours in culture ..................................... 77 
Figure 4.1. Oestradiol production per 48 hours by ovine granulosa cells over a course of 4 timepoints, in 
the presence of normal or high levels of media, with or without FSH ........................................................ 88 
Figure 4.2. Culture 1 ovine granulosa cell (a) HIF-1! expression and (b) VEGF expression relative to low 
density control ............................................................................................................................................ 89 
Figure 4.3. Culture 2 ovine granulosa cell (a) oestradiol and (b) progesterone production by cells seeded 
at different densities and cultures with or without cobalt chloride .............................................................. 90 
Figure 4.4. Culture 3 rate of ovine granulosa cell (a) oestradiol and (b) progesterone production in 
transfected and untransfected cells with or without cobalt chloride. .......................................................... 92 
Figure 4.5. Ovine granulosa cell HIF-1! expression against follicular size ................................................ 94 
Figure 4.6. Ovine follicular fluid oestradiol concentration against follicle size ........................................... 94 
Figure 4.7. Ovine follicular fluid oestradiol concentration against granulosa cell HIF-1! expression ........ 95 
Figure 4.8. Ovine granulosa cell HIF-1α expression for follicles with low and high levels of 
oestradiol in the follicular fluid ............................................................................................................. 96 
Figure 5.1. Immuno-neutralisation in vivo study summary diagram ......................................................... 100 
Figure 5.2. Photograph of exteriorised ovine reproductive tract with vasculature. .................................. 101 
Figure 5.3. Diagram illustrating ovarian arterial cannulation in the ewe .................................................. 102 
Figure 5.4. Ovine in vivo ovarian infusion study set-up ........................................................................... 104 
Figure 5.5. Infusion study mean ovarian FSH and LH across all animals ............................................... 105 
Figure 5.6. Ewe 2 positive aromatase staining of the granulosa cell layer in a large antral follicle on the 
treatment ovary at (a) x50 and (b) x200 ................................................................................................... 108 
Figure 5.7. Ewe 3 treatment ovary weak positive aromatase staining of granulosa cells (x200) ............. 109 
Figure 5.8. Ewe 4 control ovary positive aromatase staining of granulosa cell layer (x200) ................... 109 
Figure 5.9. Ewe 1 oestradiol profile over 36 hours .................................................................................. 110 
Figure 5.10. Ewe 1 androstenedione profile over 36 hours ..................................................................... 110 
Figure 5.11. Ewe 2 oestradiol profile over 36 hours ................................................................................ 111 
Figure 5.12. Ewe 2 androstenedione profile over 36 hours ..................................................................... 112 
Figure 5.13. Ewe 3 oestradiol profile over 36 hours ................................................................................ 113 
 xi 
Figure 5.14. Ewe 3 androstenedione profile over 36 hours ..................................................................... 113 
Figure 5.15. Ewe 4 oestradiol profile over 36 hours ................................................................................ 114 
Figure 5.16. Ewe 4 androstenedione profile over 36 hours ..................................................................... 114 
Figure 5.17. Major peri-follicular blood vessel on large antral follicle of ewe 4 treated ovary (x50) ......... 115 
Figure 5.18. Ewe 5 oestradiol profile over 36 hours ................................................................................ 116 
Figure 5.19. Ewe 5 androstenedione profile over 36 hours ..................................................................... 116 
Figure 5.20. Ewe 6 oestradiol profile over 36 hours ................................................................................ 117 
Figure 5.21. Ewe 6 androstenedione profile over 36 hours ..................................................................... 117 
Figure 5.22. Mean ovarian oestradiol plasma concentration across all timepoints for ewes 3 to 6 ......... 119 
Figure 5.23. Mean percentage change in ovine serum oestradiol concentration from baseline against time 
in animals passively immune-neutralised against BMP15 and GDF9 ..................................................... 120 
Figure 6.1. Ultrasound set-up for the measurement of blood flow in a bovine ovary at different flow rates
 ................................................................................................................................................................. 129 
Figure 6.1. Mean vascular index against flow rate using human blood ................................................... 130 
Figure 6.2. Mean flow index against flow rate using human blood .......................................................... 131 
Figure 6.3. Mean vascular flow index against flow rate using human blood ............................................ 131 
Figure 6.4. Mean vascular index against flow rate using bovine blood .................................................... 132 
Figure 6.5. Mean flow index against flow rate using bovine blood ........................................................... 132 
Figure 6.6. Mean vascular flow index against flow rate using bovine blood ............................................ 133 
Figure 6.7. Visible artefact on the ultrasound scan image ....................................................................... 136 
Figure 6.8. Manual dissection of a bovine ovary ...................................................................................... 140 
Figure 6.10. SonoAVCª d(V) measurement of follicular diameter against the dissection diameter 
measured manually following dissection .................................................................................................. 142 
Figure 6.11. SonoAVCª m-d measurement of follicular diameter against the dissection diameter 
measured manually following dissection .................................................................................................. 143 
Figure 6.12. Bland-Altman plots of dissection diameter minus the measured SonoAVCª diameter by 
volume d(V) as (a) absolute difference and (b) percentage difference. ................................................... 144 
Figure 6.13. Bland-Altman plots of dissection diameter minus the measured SonoAVCª mean diameter 
m-d as (a) absolute difference and (b) percentage difference ................................................................. 145 
Figure 6.14. SonoAVC antral follicle count against follicle count at dissection. ....................................... 150 
Figure 6.15. Average number of follicles missed by SonoAVC compared to the count at dissection, 
grouped into 3 groups of low (<25), medium (25-50) and high (>50) follicle numbers ............................ 151 
Figure 6.16.  Overall SonoAVC percentage follicle visibility in three major follicle size classes .............. 152 
Figure 7.1. Schematic diagram of POEM study design ........................................................................... 161 
Figure 7.2. POEM study patient outcome flow diagram ........................................................................... 165 
Figure 7.3. 3D power Doppler ultrasound scan of the ovarian follicle at hCG scan, later selected for 
aspiration ................................................................................................................................................. 167 
 xii 
Figure 7.4. 3D power Doppler ultrasound scan of the ovarian follicle selected for aspiration at egg 
collection .................................................................................................................................................. 168 
Figure 7.5. Mean follicular diameter against oocyte retrieval ................................................................... 170 
Figure 7.6. Follicular volume against oocyte retrieval .............................................................................. 170 
Figure 7.7. Vascular index against oocyte retrieval ................................................................................. 171 
Figure 7.8. Flow index against oocyte retrieval ........................................................................................ 171 
Figure 7.9. Vascular flow index against oocyte retrieval .......................................................................... 172 
Figure 7.10. Mean follicular diameter against ooyte fertilisation .............................................................. 172 
Figure 7.11. Follicular volume against oocyte fertilisation ....................................................................... 173 
Figure 7.12. Vascular Index against oocyte fertilisation ........................................................................... 173 
Figure 7.13. Flow Index against oocyte fertilisation ................................................................................. 174 
Figure 7.14. Vascular flow index against oocyte fertilisation ................................................................... 174 
Figure 7.15. Mean follicular diameter against embryo transfer ................................................................ 175 
Figure 7.16. Follicular volume against embryo transfer ........................................................................... 175 
Figure 7.17. Vascular index against embryo transfer .............................................................................. 176 
Figure 7.18. Flow index against embryo transfer ..................................................................................... 176 
Figure 7.19. Vascular flow index against embryo transfer ....................................................................... 177 
Figure 7.20. Follicular mean diameter growth against oocyte retrieval, fertilisation and embryo transfer 178 
Figure 7.21. Follicular volume growth against oocyte retrieval, fertilisation and embryo transfer ............ 179 
Figure 7.22. Mean follicular diameter against follicular volume ............................................................... 179 
Figure 7.23. Patient age against oocyte development stage ................................................................... 181 
Figure 7.24. PrehCG vascular indices against patient age ...................................................................... 182 
Figure 7.25. Follicular fluid (a) oestradiol, (b) progesterone, (c) AMH and (d) BMP15 concentrations 
against grouped patient age .................................................................................................................... 183 
Figure 7.26. Developmental stage outcome against number of aspirations required to obtain an oocyte
 ................................................................................................................................................................. 184 
Figure 7.27. Follicular fluid (a) oestradiol and (b) progesterone against oocyte fertilisation .................... 185 
Figure 7.28. Follicular fluid (a) oestradiol and (b) progesterone against embryo transfer ....................... 186 
Figure 7.29. E2:P4 ratio against (a) oocyte fertilisation and (b) embryo transfer ..................................... 187 
Figure 7.30. Follicular fluid oestradiol against prehCG follicular (a) mean diameter and (b) volume ...... 188 
Figure 7.31. Follicular fluid oestradiol against (a) follicular mean diameter growth and (b) volume growth
 ................................................................................................................................................................. 189 
Figure 7.32. Follicular AMH against oocyte fertilisation and embryo transfer .......................................... 190 
Figure 7.33. Follicular AMH against prehCG follicular mean diameter .................................................... 191 
Figure 7.34. Follicular AMH against grouped prehCG (a) follicular mean diameter and (b) volume ....... 192 
Figure 7.35. Follicular AMH against grouped egg collection (a) follicular mean diameter and (b) volume
 ................................................................................................................................................................. 193 
 xiii 
Figure 7.36. Follicular BMP15 against grouped prehCG (a) follicular mean diameter and (b) volume .... 195 
Figure 7.37. Follicular BMP15 against grouped egg collection (a) follicular mean diameter and (b) volume
 ................................................................................................................................................................. 196 
Figure 7.38. Follicular BMP15 against follicular AMH .............................................................................. 197 
Figure 8.1. Oocyte interactions with intrafollicular and extrafollicular factors .......................................... 211 
  
 xiv 
List of Tables 
Table 1.1 
Expression of GDF9, BMP15, BMP6 and their receptors in ovine oocytes, granulosa and 
theca cells 
21 
Table 3.1 96 well plate format for TGFb dose response culture 64 
Table 4.1 HIF-1! expression and follicular oestradiol concentration for a range of follicle sizes 93 
Table 5.1 Mean follicle counts following H&E staining on ovarian sections 106 
Table 5.2 Aromatase immunohistological staining results of ovarian sections 107 
Table 5.3 Summary of aromatase staining and encrocrine profiles in relation to initial hypothesis 121 
Table 6.1 
Flow index, vascular index and vascular flow index for 8 defined infusion rates using 
human and bovine blood 
130 
Table 6.2 Follicle measurements taken at dissection and by SonoAVC software 141 
Table 6.3 
Antral follicle counts performed following ovarian dissection and using SonoAVC 
software 
149 
Table 6.4 
Antral follicle counts at dissection and by SonoAVC with percentage visibility for follicles 
in different size groups 
151 
Table 6.5 
Overall visibility of antral follicles detected by SonoAVC software in major AFC size 
classes used in the literature, and mean percentage follicle visibility per scan  
152 
Table 7.1 
Power Doppler ultrasound and follicular size parameters measured at prehCG scan and 
egg collection, grouped according to oocyte retrieval, fertilisation and embryo transfer  
169 
Table 7.2 Mean patient age of oocyte retrieval, fertilisation and embryo transfer  180 
Table 7.3 Summary of numbered developmental stages according to the final follicle outcome 180 
  
 xv 
Abbreviations 
2D Two Dimensional 
3D Three Dimensional 
AFC Antral Follicle Counting 
ALK Activin-like Kinase 
AMH Anti-Mllerian Hormone 
ART Assisted Reproductive Technology 
BMP Bone Morphogenetic Factor 
BTC Betacellulin 
cDNA Complementary Deoxyribonucleic Acid 
CEEF Cumulus Expansion Enabling Factor 
COC Cumulus-oocyte Complex 
COX Cylcooxygenase 
CV Coefficient of Variation 
d(V) Diameter by Volume 
DAB Diaminobenzidine 
DARS Donkey Anti-rabbit Serum 
DNA Deoxyribonucleic Acid 
dNTP Deoxyribonucleotide Triphosphate 
DO Denuded Oocyte 
DOB Date of Birth 
DON 6-diaxo-5-oxo-L-norleucine 
DTT Dithiothreitol 
E2 Oestradiol 
EDTA Ethylenediaminetetraacetic Acid 
EGF Epidermal Growth Factor 
EGFR Epidermal Growth Factor Receptor 
ELISA Enzyme-linked Immunosorbent Assay 
FDX Ferredoxin 
FGF Fibroblast Growth Factor 
FI Flow Index 
FSH Follicle-stimulating Hormone 
GAST Gondaotrophin-releasing Hormone Against Stimulation Test 
GC Granulosa Cell 
GDF Growth Differentiation Factor 
Grat. Graticule 
GREM Gremlin 
h Hours 
H&E Hematoxylin & Eosin 
HAS Hyaluronan Synthase 
hCG Human Chorionic Gonadotrophin 
HD High Density 
 xvi 
HIF Hypoxia-inducible Factor 
HRE Hypoxia-responsive Element 
HRP Horseradish Peroxidase 
ICSI Intracytoplasmic Sperm Injection 
IGF Insulin-like Growth Factor 
IGFBP Insulin-like Growth Factor Binding Protein 
IMS Industrial Methylated Spirit 
INHBA Inhibin A 
IRAS Integrated Research Application System 
IU International Units 
IV Intravenous  
IVF In Vitro Fertilisation 
k Thousand 
KitL Kit Ligand 
KLH Keyhole Limpet Hemocyanin 
L&R Left & Right 
LD Low Density 
LDCC Low Density Cobalt Chloride 
LDSA Low Density Sodium Azide 
LH Luteinizing Hormone 
LIF Leukaemia Inhibitory Factor 
LO & RO Left & Right Ovaries 
m-d Mean Diameter 
M-MLV Moloney Murine Leukaemia Virus 
MII Metaphase II 
min Minutes 
mRNA Messenger Ribonucleic Acid 
n Number 
NIDDK National Institute of Diabetes + Digestive + Kidney Diseases 
NRS Normal Rabbit Serum 
NSB Non-specific Binding 
NT No Treatment 
OCM Oocyte-conditioned Medium 
OOX Oocytectomized Complex 
OSF Oocyte-secreted Factor 
P4 Progesterone 
PAPP Pregnancy-associated Plasma Protein 
PBS Phosphate Buffered Saline 
PCR Polymerase Chain Reaction 
PCV Packed Cell Volume 
PI Pulsatility Index 
POEM Pre-implantation Oocyte and Embryo Markers 
POI Primary Ovarian Insufficiency 
 xvii 
PTGS Prostaglandin-endoperoxidase Synthase 
QC Quality Control 
RCF Relative Centrifugal Force 
RI Resistance Index 
ROS Reactive Oxygen Species 
rpm Revolutons Per Minute 
S-D Systolic-diastolic Ratio 
SAPU Scottish Antibody Production Unit 
SD Standard Deviation 
SEM Standard Error of Means 
SET Single Embryo Transfer 
TC Total Count 
TGF Transforming Growth Factor 
TMB Tetramethylbenzidine 
TNFAIP Tumour Necrosis Fector Alpha-induced Protein 
Tx Treatment 
UMP Uridine Monophosphate 
UOP Utero-ovarian Plexus 
V Volume 
v/v Volume by Volume 
VEGF Vascular Endothelial Growth Factor 
VFI Vascular Flow Index 
VI Vascular Index 
VOCAL Virtual Organ Computer-Aided Analysis 
VOI Volume of Interest 
w/v Weight by Volume 
"-ME Beta-mercaptoethanol 
  
 xviii 
 
 
 
 
 
 
 
 
There are in fact two things, science and opinion; the 
former begets knowledge, the latter ignorance.  
Hippocrates (460 BC - 377 BC) 
 
 
 
 
 
 
 
  
  
1 
Chapter 1 Ð Literature Review 
1.1. Introduction 
In the field of reproductive medicine there is increasing awareness that oocyte quality is a major limiting 
factor in female fertility, probably as a result of the increasing age of first conception for mothers, resulting 
in poorer conception rates. The current lack of understanding of the physiological mechanisms controlling 
ovarian follicle development is an obstacle that needs to be overcome if the techniques associated with 
assisted reproduction are to improve in efficacy (Campbell et al., 2003). Two of the major hurdles that 
need to be overcome in the near future are solving the problems of the lack of objective and reliable 
oocyte developmental competence predictors, and the poor success of in vitro maturation (Li et al., 
2008a; Gilchrist et al., 2008). The oocyte developmental potential, and hence the chance of later 
obtaining a pregnancy, is determined by the quality of the oocyte. Oocytes gain developmental 
competence [defined as ability to mature, become fertilised, and give rise to normal fertile offspring 
(Duranthon and Renard, 2001)] gradually through the process of folliculogenesis, as the oocyte increases 
in size and its surrounding somatic cells differentiate (Eppig et al., 2004). Morphological parameters are 
routinely used for oocyte selection during in vitro fertilisation, based on the visual appearance of the 
cytoplasm, polar body and cumulus cells according to the opinion of the embryologist. The basis this 
selection method is highly subjective and therefore inaccurate (Balaban et al., 1998; Nicholas et al., 2005; 
Wang and Sun, 2007). Only a third of IVF cycles lead to a pregnancy, and around 8 out of 10 transferred 
embryos fail to implant (Bromer and Seli, 2008). As a result, the discovery of objective and non-invasive 
molecular markers capable of predicting oocyte developmental potential is a key area of research (Li et 
al., 2008a). 
There is an extremely diverse range of factors that affect oocyte competence during folliculogenesis, 
doubtlessly not all of which are known or fully understood. For example, the size of the follicle of origin 
(Lonergan et al., 1994; Rosen et al., 2008), the health status of the follicle (Hagemann, 1999), the extent 
of hormonal stimulation (Sirard et al., 2006) and also the bi-directional communication between the 
oocyte and cumulus cells (Krishner, 2004; Gilchrist et al., 2008) have all been studied as potential 
candidate targets in research. All of these factors contributing to oocyte competence need to be further 
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researched and understood so that they may be used in the drive to improve efficacy of clinical in vitro 
fertilisation. By examining the molecular and cellular pathways involved in the follicular setting, it is hoped 
that the underlying mechanisms can be revealed and the knowledge integrated in order to develop a 
model of the processes determining oocyte quality. 
 
 
1.2. The Reproductive Cycle 
In order to fully comprehend the complex process of folliculogenesis, it is necessary to understand the 
basis for the reproductive cycle. This topic could, in itself, fill an entire thesis, however for the purposes of 
this research, the reproductive cycle and the endocrinology are summarised. 
 
1.2.1. Reproductive hormones 
Gonadal function in the female is primarily under the control of the hypothalamic-pituitary axis, forming a 
dynamic relationship between the ovary and the brain (figure 1.1). The sequence of interrelated endocrine 
events involves the hypothalamus producing gonadotrophin-releasing hormone (GnRH), the pituitary 
gland secreting follicle-stimulating hormone (FSH) and luteinising hormone (LH), antral follicles of the 
ovary producing oestradiol and inhibin and the corpus luteum secreting progesterone (Bartlewski et al., 
2011). 
 
Figure 1.1. The hypothalamic-pituitary-ovarian axis 
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Development of the follicle, maturation of the oocyte, follicular steroidogenesis, ovulation and formation of 
the corpus luteum are all under the regulation of pituitary gonadotrophins, and the regulation of 
gonadotrophins is controlled by a range of internal factors such as ovarian steroid hormones, 
neuromodulators and uterine products, and external factors such as photoperiod and nutrition. 
Oestradiol, a steroid hormone produced by granulosa cells in the ovary, inhibits FSH and LH secretion 
when at low circulatory levels. At higher levels this negative feedback switches to positive feedback, and 
this results in a surge in both FSH and LH production. In addition to oestradiol, when at high levels, for 
example in the luteal phase of the cycle, progesterone also acts to suppress FSH and LH. Progesterone 
is also able to block the positive feedback effects of high oestradiol levels, thereby preventing the surge of 
FSH and LH (Adams et al., 2008). 
 
1.2.2. The oestrous cycle  
In the bovine and ovine species, which are at the core of research models for human reproductive 
physiology, the reproductive cycle is called the oestrous cycle. During the oestrous cycle, which lasts for 
an average of 21 days in cattle (Grunert et al., 1973), and 17 days in sheep (Mellin and Busch, 1976), 
follicular development can be observed to occur in a wave-like pattern, under the control of hormonal 
regulation. Following ovulation, a new follicular wave commences. This begins with a number of follicles 
being recruited from the pool of quiescent follicles within the ovary, the mechanism of which is not yet 
understood. Once this follicular growth is initiated, development continues until the follicle reaches one of 
two fates; ovulation or atresia. In a monovulatory species such as the cow, only a tiny fraction, less than 
0.1%, of these follicles will ovulate (Webb et al., 2003). The rest will become atretic and regress. 
In cattle, the cycle is characterised by two or three follicular waves, each with around three to five 
developing follicles, growing to more than 4mm in diameter (figure 1.2). These follicles then continue to 
grow to reach 6-8mm, whereby a mechanism of dominance is employed, which allows for the selection of 
just one follicle to become dominant over its subordinates and inhibiting their development (Webb et al., 
2003).  
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Figure 1.2. Dynamics of bovine ovarian follicular development and gonadotrophin secretion during two- and 
three- wave oestrous cycles (Adams et al., 2008)  
Dominant and subordinate follicles are open (viable) and shaded (atretric) circles. Each new wave of follicles is 
preceded by an FSH surge (thick line) and an ovulation is preceded by an LH surge (thin line). The LH surge is 
caused by high LH pulse frequency due to decreased progesterone concentrations (Adams et al., 2008). 
 
Only when progesterone concentrations are low enough, will this dominant follicle ovulate, however if a 
corpus luteum is present, the level of progesterone will prevent the process of ovulation, and this 
dominant follicle undergoes atresia. A new follicular wave will then commence. 
Formation of the corpus luteum (CL) occurs as a result of a series of morphological and biochemical 
changes in the theca and granulosa cells of the preovulatory follicle during luteinisation, after the LH 
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surge. The CL becomes highly vascularised, and blood flow in the tissue increases with volume and with 
the production of progesterone (Berisha and Schams, 2005). 
 
1.2.3. The menstrual cycle 
 
Figure 1.3. The menstrual cycle (Petroff et al., 2001) 
Higher primates do not present with ÔoestrusÕ as such, and therefore their reproductive cycle is not called 
an oestrous cycle. The characteristic periodic shedding of the endometrial lining of the uterus 
distinguishes these species from others, in the process of menstruation, hence the cycle is called the 
menstrual cycle (figure 1.3). Although both the oestrous cycle and the menstrual cycle reflect cyclical 
changes in the ovary and reproductive organs, the days at which these cycles begin differs; day 1 of the 
oestrous cycle is considered to be the first day of oestrus, and in humans the first day of the cycle 
coincides with the initiation of menstrual flow. 
Another difference between the oestrous and menstrual cycles is the follicular to luteal phase ratio. The 
menstrual cycle usually consists of a follicular phase length equal to that of the luteal phase, whereby 
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luteolysis is followed by menstruation and then the initiation of a new cycle. The follicular phase of the 
oestrous cycle is considerably shorter than that of the menstrual cycle, as follicular growth takes place in 
the luteal phase of the previous cycle. No menstruation takes place following, however there are usually 
changes in reproductive behaviour around this time. 
 
1.3. Follicular Development 
 
 
 
Figure 1.4. Schematic diagram of follicular development in the mammalian ovary 
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1.3.1. Preantral follicle development 
Primordial follicles in the ovary consist of a single oocyte, which is surrounded by a flattened or cuboidal 
granulosa cells (McNatty et al., 1999). The pool of around 100,000-250,000 ovarian primordial follicles is 
established during foetal development (Gougeon, 1996; Juengel et al., 2002b), and once selected for 
development they leave the resting pool to become part of the growing population, by a mechanism that 
is not yet fully understood (Webb et al., 2003). Once growth has commenced, follicular growth continues 
until the follicle reaches its final fate of either atresia or ovulation (figure 1.4). 
It is thought that anti-Mllerian hormone (AMH) is one of the growth factors responsible for maintaining 
the primordial follicles in the dormant state (Durlinger et al., 2002), and that the granulosa cell-produced 
kit ligand is likely to be the main factor involved with primordial follicle activation (Parrott and Skinner, 
1999), the effects of which may be enhanced by leukemia inhibitory factor (LIF) (Nilsson and Skinner, 
2002).  
Bone morphogenetic protein 7 (BMP7) is also believed to be a requirement for the transition in the rat 
(Lee et al., 2001), and in other species additional members of the transforming growth factor " (TGF") 
superfamily such as growth differentiation factor 9 (GDF9), activins and inhibins, as well as other growth 
factors including basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF) may also be 
needed (McNatty et al., 1999; Knight and Glister, 2001; Smitz and Corvindt, 2002; reviewed in Webb at 
al., 2003). It is believed that gonadotrophins are unlikely to be involved in follicular growth initiation 
(Campbell et al., 2000; Fortune et al., 2000). 
As well as the growth factors associated with the primordial to primary follicle transition, a number of gene 
studies have revealed three oocyte-specific genes that are also thought to be needed; the newborn ovary 
homeobox-encoding gene (Nobox) (Pangas et al., 2004b), Sohlhl I and Lhx8 (Pangas et al., 2006) 
(reviewed in Rodigues et al., 2008). However, almost all of the studies concerning oocyte specific genes 
have been based on polyovulatory rodents, and so further study is needed to examine the roles of these 
genes in different species. 
The mechanism behind activation of primordial follicles has not yet been fully elucidated, however 
follicular growth itself can be divided into two distinct stages (Braw-Tal and Yossefi, 1997). The first 
begins with granulosa cell differentiation to alter their shape from squamous to cuboidal, and the second 
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consists of granulosa cell proliferation, as well as oocyte growth. The stimulus for this process is not 
known, however it seems that the oocyte is the major driving force, producing factors that act by both 
autocrine and paracrine mechanisms (Eppig, 2001). In addition, follicle-stimulating hormone (FSH) can 
accelerate preantral follicle development (Campbell et al., 2000; Gutierrez et al., 2000), indicating a 
gonadotrophic role at an early stage of folliculogenesis. 
Following the formation of a complete layer of cuboidal granulosa cells around the enlarging oocyte, the 
primordial follicle becomes a primary follicle (Hirshfield, 1991). Although small preantral follicles are 
responsive to FSH, the hormone is not an absolute requirement for granulosa cell proliferation and 
follicular growth to occur (McGee et al., 1997). However, as the follicle progresses to the next stage of 
development, the granulosa cells become responsive to FSH, as they acquire receptors; a process 
regulated by a range of locally produced growth factors including insulin-like growth factor-I (IGF-I) (Zhou 
et al., 1997; Gutierrez et al., 2000). IGF-I promotes granulosa cell proliferation and stimulates the 
luteinising hormone (LH) receptors of granulosa and theca cells, marking the timepoint at which these 
cells become receptive to LH (Magoffin and Weitsman, 1994; Richards, 2001).  
 
1.3.2. Antrum formation 
In the very early stages of development, follicles of 250#m become responsive, but not dependant on 
gonadotrophin stimulation. As folliculogenesis proceeds the follicles enter a critical phase in which they 
become completely dependant on FSH for survival, from around 2-4mm in diameter in cattle, and 1-2mm 
in sheep (Campbell et al., 1995; Webb et al., 1999a; Markstrom et al., 2002). In addition, locally-produced 
factors such as IGFs are believed to play a role by enhancing the effect of FSH (Webb et al., 1999b; 
2003). IGF-II mRNA expression has been found in thecal cells of follicles at the time of antrum formation, 
as well as type 1 IGF receptor and some IGF binding proteins (Armstrong et al., 2000). Several other 
growth factors, such as members of the TGF" superfamily, are also believed to be present in the early 
antral stage. The roles of these factors are not fully understood, however they are probably involved in 
follicular differentiation by enhancing gonadotrophin action (Campbell and Baird, 2001; Souza et al., 
2002). 
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Formation of the follicular antrum occurs in cattle and sheep when the follicle reaches a diameter of 
around 200-400#m (Turnbull et al., 1977). Antrum formation is accompanied by a divide in the granulosa 
cell population into two primary groups, with a switch from proliferation to differentiation (Webb and 
Campbell, 2007). One group become the cumulus cells, closely associated with the oocyte to form the 
cumulus-oocyte complex. Their cytoplasmic projections penetrate through the oocyte zona pellucida, 
forming the gap junctions required for oocyte-cumulus cell communication (Albertini et al., 2001) (figure 
1.5). The second group is composed of the steroidogenic ÔmuralÕ granulosa cells which line the follicular 
wall, with the cells nearest to the antrum being termed periantral granulosa cells (Eppig, 2001). These two 
cell types become not only phenotypically distinct from one another, but also functionally different. The 
cumulus cells, unlike mural granulosa cells, have a high rate of proliferation, a low rate of steroidogenesis 
and barely any LH receptor expression. They also have the ability to secrete hyaluronic acid, and 
consequently undergo expansion (Salustri et al., 1990; Li et al., 2000). mRNA expression changes 
significantly in the two cell groups, most notably that of the steroidogenic enzymes such as P450scc, 
P450c17 and P450arom (Bao et al., 1997). 
Figure 1.5. Scanning electron microscopy image of a human 
secondary oocyte after zona pellucida removal (x10,000) 
(Makabe et al., 2006). 
 
 
 
 
 
 
 
The oolemma surface is covered with microvilli, to which the cumulus cell projections become associated, 
through the zona pellucida. The gap junctions, which span from the oocyte to its surrounding granulosa 
cells, are intercellular membrane channels, through which small molecules such as pyruvate, amino acids 
and signalling molecules can pass (Kidder and Mhawi, 2002; Yeo et al., 2009). These molecules are a 
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means of communication between the oocyte and cumulus cells, and include ions, metabolites and amino 
acids needed for oocyte growth, along with the small regulatory molecules that are key for oocyte 
development (Simon et al., 1997). The junctions themselves consists of groups of 6 connexins; protein 
subunits that join together to form a channel called a connexon. The connexons of adjacent cells then 
connect to form the gap junction (Bruzzone et al., 1996). 
If the oocyte-cumulus cell communication axis is disrupted, cumulus cell proliferation is reduced, and 
apoptosis increases considerably (Luciano et al., 2000).  Furthermore, the attachment of the cumulus 
cells to the oocyte has been shown to be crucial for meiotic maturation and fertilisation, using bovine and 
porcine models (Zhang et al., 1995; Luciano et al., 2005; Amano et al., 2005). 
 
Along with the cellular differentiation during antrum formation, there is also a major step in oocyte 
development, as the oocyte gains the molecular and cytoplasmic apparatus needed to fully support the 
process of embryo development (Sirard et al., 2006). Prior to antrum formation the oocyte is arrested at 
diplotene stage of meiosis I, controlled by an intricate balance between intracellular factors including 
cAMP, purines and calmodulin (Lanuza et al., 1998), and is meiotically incompetent, probably due to a 
lack of regulatory signal molecules required to resume meiosis (Eppig, 2001). However, the vast majority 
of oocytes in antral follicles are in fact meiotically competent, and have been shown to spontaneously 
resume meiosis if they are removed from follicles and cultured (Handel and Eppig, 1997).  
Oocytes that are capable of resuming meiosis are, however, not necessarily able to complete nuclear 
maturation and hence progress to metaphase II. Because oocytes from small antral follicles resume 
meiosis but arrest at metaphase I, it seems that further development of antral follicle oocytes is needed to 
attain competence to continue to metaphase II (Handel and Eppig, 1997). The oocyte normally acquires 
the ability to resume meiosis after antrum formation is complete (Mehlmann, 2005), following a number of 
changes in the oocyte cytoplasm and nucleus. 
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1.3.3. Cumulus expansion 
The oocyte is surrounded by a number of layers of cumulus cells, in the majority of mammals, which form 
a ÔcloudÕ around the oocyte; the cumulus-oocyte complex (COC) (Yokoo et al., 2008; Gosden and Lee, 
2010). The structure of the cumulus-oocyte complex (COC) is such that it promotes separation from the 
follicle wall, as well as oocyte expulsion in ovulation (Yokoo et al., 2008). The primary functions of the 
cumulus cells are fundamentally to support the development of the oocyte, in addition to production of a 
number of hormones and growth factors (Gosden and Lee, 2010). It therefore seems obvious why 
ovulation rate and overall fertility falls significantly if this process of cumulus expansion is prevented 
(Chen et al., 1993; Fulop et al., 2003), as the cumulus plays a vital role in the process of folliculogenesis.  
In response to the preovulatory LH surge, the oocyte undergoes the maturation process, and the 
surrounding cumulus cells begin to secrete hyaluronic acid, which is bound to the cell surfaces by linker 
proteins (Chen et al., 1996). When this becomes hydrated, spaces form between the cumulus cells and a 
sticky cell matrix is formed (Eppig, 2001).  Hyaluronic acid, also known as hyaluronan, is synthesized by 
the hyaluronan synthase (HAS) enzyme, which exists in three isoforms (HAS1, HAS2 and HAS3) (Spicer 
and McDonald, 1998). HAS2 mRNA is expressed strongly in cumulus cells after an LH surge, and it 
appears to play a key role in regulation of cumulus expansion (Yokoo et al., 2008). Hyaluronic acid is 
synthesized from glucose in the hexosamine biosynthesis pathway, a process regulated by uridine 
monophosphate (UMP), which inactivates hyaluronan synthase (Gutnisky et al., 2007). 6-diazo-5-oxo-L-
norleucine (DON) also has a major role in inhibition of hyaluronic acid synthesis (Prehm, 1983). 
Cumulus expansion is not only due to synthesis of hyaluronic acid, but also its accumulation in the 
spaces between the cumulus cells. It remains in the extracellular matrix, stabilized by hyaluronan-binding 
proteins, and as a result there is a close relationship between the extent of cumulus expansion and 
hyaluronic acid accumulation. This relationship has been explored in pigs, where a link has been found to 
the oocyte maturation process (Yokoo et al., 2008). 
Cumulus expansion can be induced in vitro using various hormones, growth factors and serum 
supplements, depending on the species, which implicates distinct mechanistic differences by which 
expansion occurs in different species (Gutnisky et al., 2008). For example, cumulus expansion in mice, in 
contrast to pigs, rats and cattle (Vanderhyden, 1993; Ralph et al., 1995), requires the presence of the 
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oocyte (Sutton et al., 2003), which is due to oocyte expression of the cyclooxygenase-2 (COX2) gene 
(Joyce et al., 2001). However in cattle, BMP15, secreted by the oocyte, is needed for cumulus cell 
survival during oocyte maturation and cumulus expansion (Hussein et al., 2005). In addition, cumulus 
expansion enabling factor (CEEF), secreted from the oocyte, is another factor required for FSH-induced 
cumulus expansion (Salustri et al., 1990). Therefore, it seems that there are a number of secretory growth 
factors that are involved in the process, the requirements of which are markedly different between 
species. 
Cumulus gene expression has been investigated to attempt to find a correlation to oocyte quality and 
developmental capacity, although the extent of cumulus expansion is a morphological criterion for oocyte 
selection in IVF that has been used now for a number of years (Russell and Robker, 2007). Gene 
expression studies of COX2 and HAS2 for example, have been significantly correlated with blastocyst 
quality (McKenzie et al., 2004), indicating a possible role in the future for gene profiling as an additional 
oocyte competence indicator. 
Research using rodents suggests that cumulus expansion may be in some way functionally related to 
oocyte maturation (Wert and Larsen, 1989) and fertilisation (Chen et al., 1993). However, in cattle the 
relationship between expansion and oocyte developmental capacity has not yet been elucidated 
(Gutnisky et al., 2007). 
 
1.3.4. Follicle selection and dominance 
In monovulatory species, just one dominant follicle from the developing cohort is able to continue all the 
way to ovulation, while the others regress by a process called atresia. While this system has been studied 
extensively, and the involvement of gonadotrophins as well as locally produced factors is now widely 
accepted, the underlying mechanisms of follicular dominance are not yet fully understood (Webb et al., 
2003; Webb and Campbell, 2007). 
It is widely believed that the primary mechanism by which only one follicle survives from the growing 
cohort is the decline in circulating FSH, as first suggested by Baird (1983). The largest follicle plays a key 
role in decreasing FSH to the point where the other smaller follicles are unable to continue growth (Webb 
at al., 1999a), although it has been shown that the larger follicles of this cohort also play a small part in 
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this in the initial stages (Gibbons et al., 1997). The growing and selected follicles suppress FSH 
production by secreting oestradiol and inhibin, although it has been shown in cattle that the effects of 
these hormones can change depending on the follicular wave (Webb et al., 1999a). FSH has been shown 
to induce oestradiol production by bovine (Gutierrez et al., 1997) and ovine (Campbell et al., 1996) 
granulosa cells in vitro, further demonstrating the key role of gonadotrophins in the regulation of steroid 
hormone production, and the paracrine mechanisms by which they are subject to. The dominant follicle 
has a much higher concentration of oestradiol in its follicular fluid than the subordinate follicles, and it 
seems that a rapid increase in oestradiol is in fact a key characteristic of dominant follicles (Fortune et al., 
2004). Follicular fluid levels of oestradiol in cattle preovulatory follicles reach more than 1#g/ml before 
they ovulate (Bridges and Fortune, 2003).  
It is likely that the dominant follicle develops mechanisms which allow it to survive the fall in FSH, before 
its subordinate follicles are able to acquire the same ability (Baird, 1983), however this selected follicle 
still requires basal amounts of FSH to continue growth (Webb et al., 2003). It seems that during its 
development the dominant follicle is uniquely able to switch its FSH dependence over to LH (Campbell et 
al., 1999; Webb et al., 2003), as LH receptor mRNA begins to be expressed in the granulosa cells (Bao 
and Garverick, 1998; Zelenik, 2001). This becomes important as the circulatory LH increases while FSH 
declines (Kulick et al., 1999), with subordinate follicles gradually becoming atretic under the constantly 
changing peripheral environment.  
Instead of LH receptor being the follicular dominance ÔswitchÕ, it is thought that the IGF system may have 
a much stronger involvement in dominant follicle selection. Fortune et al. (2004) hypothesised that 
follicular dominance arises because one follicle first acquires proteolytic activity against the IGF binding 
proteins -4 and -5, and an increase in free IGF and oestradiol, before its subordinate follicles. Free IGF is 
then able to amplifiy the effects of FSH on the follicle, allowing it to increase oestradiol production and 
hence decrease circulatory FSH. This then prevents the follicles in the cohort from acquiring the PAPP-A 
protein needed to decrease IGFBPs and hence increase free IGF. However, this is just one theory, and it 
is thought that the BMP system is also likely to be involved (Campbell et al., 2009), further illustrating that 
the process of folliculogenesis relies on complex interactions between gonadotrophins and locally 
produced growth factors. 
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Whether or not the granulosa cell LH receptor theory of dominance is true, LH has been shown to be an 
essential requirement for normal follicular development to ovulation, as well as subsequent luteal 
function, however it appears that it is not of importance whether the release is pulsatile or continuous 
(Campbell et al., 2007). In addition to the effects of LH on the dominant follicle itself, LH indirectly 
modulates the release of FSH from the pituitary, by controlling oestradiol and inhibin A secretion from the 
ovulatory follicle, and hence the fate of the subordinate follicles which are dependent on FSH (Webb and 
Campbell, 2007). 
 
The process of folliculogenesis is one that is still only partially understood. It is known that the relationship 
between cellular proliferation, differentiation and apoptosis is the primary underlying mechanism, but this 
still requires further exploration. Gonadotrophins are well established as the survival signalling hormones 
for the follicle, however their action is indirect, through an extremely diverse range of growth factors that 
result in an ever-changing follicular environment optimal for development at that particular timepoint 
(Webb et al., 2003). Described by Campbell et al. (2009) as an Òintrafollicular cascadeÓ, it appears that 
the interactions between hormones and locally produced growth factors are highly temporally organised, 
and in order for follicular development to progress to the successful ovulation of an oocyte with 
developmental competence to become fertilised, the timing and extent of these interactions is vital. 
 
1.4. Oocyte-follicle interactions 
It is well established that oocytes and their surrounding cumulus cells maintain a very close association 
from the beginning of folliculogenesis, and that this is a relationship that is vital to maintain normal 
development (Buccione et al., 1990). The oocyte and follicle grow and develop in a mutually dependant 
manner, in unison (Gilchrist et al., 2004). The first physiological evidence of this was presented by Pincus 
and Enzmann in 1935, who believed that the follicular somatic cells maintain the oocyte in meiotic arrest. 
They reached this conclusion after it was found that oocytes removed from antral follicles would 
spontaneously resume meiosis in culture, independent of any gonadotrophin stimulus. Subsequent 
research found that the follicular somatic cells promote the resumption of meiosis and the advance to 
metaphase II, and hence nuclear maturation. They also enable the oocyte to become fertilised, and 
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undergo cytoplasmic maturation (Eppig, 2001). Nutrients and regulatory chemical signals are sent to the 
oocyte by these cells, which ultimately enable the oocyte to acquire developmental competence (Ka et 
al., 1997). If cumulus cells are removed at the beginning of in vitro oocyte maturation for example, 
maturation, fertilisation and subsequent development are compromised significantly. This effect has been 
investigated in depth, particularly in cattle (Zhang et al., 1995; Fatehi et al., 2002), and it is widely 
accepted that follicular granulosa cells supply the oocyte with the nutrients and stimuli needed for growth 
and development (Buccione et al., 1990). Perhaps of greatest importance is that the oocyte is unable to 
metabolise glucose efficiently (Leese and Barton, 1984), and so are dependent on the surrounding 
cumulus cells for pyruvate and other products of glycolysis, as well as amino acids that all are critical to 
the development of the oocyte (Yeo et al., 2009). 
The new perspective that has emerged over the last 15 years is that communication between the oocyte 
and its surrounding somatic cells is a bi-directional process. Granulosa cell-to-oocyte communication is a 
fairly well documented research area, however oocyte-to-granulosa cell communication is a much more 
novel topic (Eppig, 2001). This two-way communication is essential for follicular development and 
production of mature oocytes capable of undergoing fertilisation and producing a pregnancy to term (Su 
et al., 2008). In the past, the oocyte was considered to be a passive recipient of granulosa cell-produced 
developmental signals, however research has indicated that this is not the case (Eppig, 2001). 
In fact, it is now well-established that the transition from primary to secondary stage of follicle 
development, in particular, is a process induced by an autocrine/paracrine regulatory mechanism which 
involves growth factors that are produced both by the oocyte and the granulosa cells (Sadeu et al., 2008). 
In addition it is now widely accepted that the oocyte itself acts as an active regulator of follicular 
development (Su et al., 2008). The ability of the oocyte to regulate most somatic cell functions is lowest in 
preantral follicles as the oocyte is undergoing its growth stage, then highest during the antral phase of 
folliculogenesis, followed by a decline after the LH surge and the resumption of meiosis (Gilchrist et al., 
2001; 2004). For example, it has been shown that in mice, the capacity of the oocyte to regulate 
granulosa cell steroidogenesis throughout follicular development varies (Vanderhyden and Macdonald, 
1998).  
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In the murine species, the major benefit of this ability to alter the effect of the oocyte on the somatic cells 
is that the oocyte can direct its surrounding granulosa cells to first promote its own growth until fully 
grown, and then actively prevent the cells from causing further growth in order to prevent overgrowth 
(Carabatsos et al., 1998). The growing oocyte stimulates kit-ligand production by the granulosa cells of 
preantral follicles, which in turn stimulates further oocyte growth (Packer et al., 1994). Once at full size, 
the signal switches from stimulation to inhibition, ceasing kit-ligand production and hence preventing 
further growth (Joyce et al., 1999). Furthermore, it seems that in the mouse it is ultimately the oocyte that 
dictates the rate of follicular growth, not the granulosa cells (Eppig et al., 2002).  
There is still relatively limited knowledge and understanding of the mechanisms by which the oocyte and 
cumulus cells communicate, and the effect that dynamic changes in this communication may ultimately 
have on oocyte developmental competence (Gilchrist et al., 2008). However, it is clear that in all species 
the oocyte plays a vital role in folliculogenesis, secreting paracrine factors that ensure an appropriate 
microenvironment optimised for the acquisition of its developmental competence (Li et al., 2008a). 
 
1.5. Oocyte-secreted factors 
The oocyte plays a major role in the regulation of development and function of follicles of all stages, from 
as early as the primordial stage (Soyal et al., 2000). It does this by secreting soluble growth factors; 
oocyte-secreted factors (OSFs), which act on the surrounding cells, regulating a number of granulosa and 
cumulus cell functions. These functions include promoting the transition from primary to secondary stage 
(Juengel et al., 2002a; Latham et al., 2004), proliferation and differentiation of granulosa cells before the 
LH surge (Gilchrist et al., 2003; Otsuka et al., 2005), the transition from preantral to antral stage (Diaz et 
al., 2007; Orisaka et al., 2006), cumulus expansion and finally ovulation following the LH surge (Diaz et 
al., 2006; Dragovic et al., 2007). 
While oocytes actively promote cumulus cell growth, they also prevent cellular apoptosis. If the oocyte is 
oocytectomised from a COC, there is a significant increase in cumulus cell apoptosis, an effect that can 
be reversed using OSF exposure (Hussein et al., 2005). Furthermore, cumulus cell phenotype is 
maintained by oocyte-secreted paracrine growth factors, as well as regulation of inhibin synthesis and 
luteinizing hormone receptor expression (Gilchrist et al., 2004).  
 17 
The extent to which the oocyte has the capacity to deliver, and the granulosa cells to receive, paracrine 
cell signals, changes throughout the course of follicular development, due to extensive progression in 
oocyte development and granulosa cell differentiation (Gilchrist et al., 2004).  
It is thought that an oocyte-granulosa cell regulatory loop exists, in which there are complementary cell 
signalling and metabolic pathways. These pathways control the development and the function of the 
oocyte and the follicular components (Su et al., 2008). Two growth factors that are thought to play major 
roles in this regulatory loop are growth differentiation factor 9 (GDF9) and growth differentiation factor 9b 
(GDF9b), better known as bone morphogenetic protein 15 (BMP15). These are two members of the 
transforming growth factor " (TGF") superfamily, which are oocyte-derived key regulators of follicle 
growth and ovulation in a number of species (Yan et al., 2001; Juengel et al., 2002a; Chand et al., 2006). 
 
1.5.1. Growth Differentiation Factor 9 and Bone Morphogenetic Protein 15 
Growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) are members of the 
transforming growth factor " (TGF") superfamily, shown to be secreted by oocytes of humans, rodents 
and sheep, as well as a number of other species (Aaltonen et al., 1999; Fitzpatrick et al., 1998; 
Bodensteiner et al., 1999). This superfamily of extracellular signalling molecules consists of over 30 
different proteins which include activins A, B and AB, anti-Mllerian hormone (AMH), inhibins A and B, 3 
TGF" isoforms 1, 2 and 3, at least 9 GDFs and around 20 BMPs (Massague and Wotton, 2000). The 
mature forms of these proteins form disulphide links to form dimers. Most form homodimers, but some are 
also able to form heterodimers (Knight and Glister, 2003). 
They are oocyte-specific proteins (though some non-ovarian expression has been observed), expressed 
and translated in the growing oocyte as inactive pre-proteins, consisting of a signal peptide, a prodomain 
and a biologically active mature region at the C-terminal part of the protein (Shimasaki et al., 2004; Veitia 
and Caburet, 2009). GDF9 mRNA is expressed in primordial follicles of a number of species including 
sheep, cattle and humans (Galloway et al., 2000; Bodensteiner et al., 1999; Aaltonen et al., 1999), 
whereas BMP15 expression commences in primary follicles (Dube et al., 1998; Otsuka et al., 2000, 
McNatty et al., 2001). Unlike other members of the TGF" superfamily, these growth factors can form 
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homodimers as well as GDF9/BMP15 heterodimers through non-covalent interactions (Liao et al., 2003; 
2004), and as a result their biological action has been suggested as being united (Gilchrist et al., 2008). 
The growth factors play critical roles in a wide range of developmental and physiological processes, in 
particular the control of granulosa cell differentiation (Gilchrist et al., 2004; Juengel and McNatty, 2005a; 
Li et al., 2008b) and in fact, the absence, deletion or mutation of GDF9 and BMP15 has been shown to 
result in infertility (Dong et al., 1996; Galloway et al., 2000). Interestingly there are considerable species 
differences involved in the functions of the growth factors, suggested by gene knockout models. For 
example in the sheep, it has been found that heterozygous mutations in expression of the growth factors 
increases ovulation rate, but homozygous mutations result in sterility, as both are required for 
folliculogenesis (Hanrahan et al., 2004). In contrast, it has been shown that the mouse does not have an 
absolute requirement for BMP15 as BMP15-null mice are fertile, although they do suffer from subfertility 
due to decreased ovulation and fertilisation rates (Yan et al., 2001). Yan et al. (2001) also found that mice 
lacking two copies of the BMP15 gene and one copy of the GDF9 gene had an increased prevalence of 
oocyte loss, and a decreased number of later stage follicles. In mice lacking both copies of the GDF9 and 
BMP15 genes, there was arrest of follicle growth at the primary stage, similar to that seen in GDF9 
knockout mice (Sadeu et al., 2008), indicating that GDF9 is vital for murine fertility, but not BMP15. 
Sheep in particular have proven to be an extremely valuable model for the use in studying GDF9 and 
BMP15, as there are a number of breeds that have been discovered to possess naturally occurring 
genetic mutations of the expression of these factors and their receptors. These alterations in expression 
primarily affect ovulation rate, as well as elements of folliculogenesis. Several breeds of sheep including 
Cambridge, Belclare, Inverdale, Thoka, Hanna and Lacaune possess different polymorphic sequence 
variations in both GDF9 and BMP15. In addition the Booroola breed is of particular interest due to its 
genetic mutation of the activin-like kinase receptor ALK6, which is a TGF!-related receptor. These 
animals with the FecB
B
 allele have decreased ALK6 receptor function, which causes ovarian follicles to 
ovulate much earlier than the non-carrier animals. The homozygous carriersÕ follicles ovulate at 3-4mm 
rather than 7mm, at more than 5 ovulations per cycle as opposed to one or two (Davis et al., 1982), and 
their granulosa cells differentiate earlier so that follicular maturity is not compromised as a result of 
shortened folliculogenesis (Baird and Campbell, 1998). 
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In the human, it seems that GDF9 and BMP15 play a crucial role in the regulation of fertility. Abnormal 
expression of GDF9 is linked to polycystic ovarian syndrome and polycystic ovaries (Teixeira Filho et al., 
2002), BMP15 mutations are associated with premature ovarian failure (Di Pasquale et al., 2004; Dixit et 
al., 2006), and GDF9 mutations are associated with increased incidence of dizygotic twinning (Palmer et 
al., 2006) and primary ovarian insufficiency (POI) (Welt, 2008).  
The substantial difference between species growth factor expression patterns and responses is likely to 
reflect the considerable differences between local signalling requirements in monovulatory and 
polyovulatory species (Rodrigues et al., 2008). 
 
There has been extensive research into the functions of GDF9 and BMP15 in vitro, however conclusions 
of such studies have often proved contradictory. This is likely to be due to discrepancies between culture 
method, as well as differences between species of origin of growth factor and cells (Juengel and McNatty, 
2005). Some studies have concluded that GDF9 and BMP15 have a mitogenic effect on granulosa and 
thecal cells (McNatty et al., 2005a), and also may inhibit granulosa and theca cell progesterone 
production under stimulation from gonadotrophins (Yamamoto et al., 2002). More specifically, it is thought 
that the growth factors regulate cholesterol biosynthesis within cumulus cells (Su et al., 2008). 
Through investigation using different doses of recombinant BMP15, GDF9 and fibroblast growth factor 8B 
(FGF8B) on cumulus cells in vitro, it was found that adding BMP15 and FGF8B to the culture promotes 
glycolysis by increased expression of glycolytic enzymes (Sugiura et al., 2007). This indicates additional 
importance of the oocyte-cumulus cell symbiotic relationship, as the oocyte is deficient in the glycolysis 
pathway and hence relies on cumulus cells to provide the glycolytic products it needs to develop normally 
(Li et al., 2008a). 
Using an ovine model, BMPs 2, 4 and 6 have been shown to be ineffective in stimulating the 
differentiation of granulosa cells in the absence of FSH, however there does appear to be a role for these 
BMPs in regulating cellular differentiation when FSH is present, as aromatase activity is closely related to 
BMP and IGF exposure in culture (Campbell et al., 2006).  
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1.5.2. GDF9 and BMP15 signalling 
GDF9 and BMP15 utilise two distinct signalling pathways, both through the SMAD intracellular cascade. 
The growth factors can be in the form of homo or heterodimers, binding to either type-I receptors; activin 
receptor-like kinase (ALK), or to BMP type-II receptors (Edwards et al., 2008) on the cell surface. Both of 
these pathways lead to receptor phosphorylation and then phosphorylation of signal transducers called 
SMADs (Shimasaki et al., 2004). There have been 7 type I, and 5 type II receptors identified in mammals, 
and because there is a substantial amount of interaction between TGF" superfamily ligands and 
receptors, the system underpinning the process is extremely complex (Knight and Glister, 2003). 
BMP15 uses the BMP pathway, which activates the SMAD 1/5/8 messengers, and GDF9 uses a 
combination of this and the TGF"/activin pathway, which activates the SMAD 2 and 3 messengers 
(Hussein et al., 2006). After phosphorylation, these SMADs combine with SMAD 4, and are then 
translocated to the nucleus, where they interact with transcriptional regulation elements (Juengel and 
McNatty, 2005a). Figure 1.6 below illustrates this process. 
 
 
Figure 1.6. Molecular basis of oocyte-cumulus cell signalling pathway. 
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The TGF" superfamily members BMP15 and GDF9 are two key oocyte-secreted factors that regulate 
folliculogenesis.  Their paracrine signalling pathway is illustrated in figure 1.7. BMP15 binds to the BMP 
type-II receptor (BMPR-II) and activin receptor-like kinase 6 (ALK6), which becomes phosphorylated. 
Receptor-regulated signal transducers called SMADs then become phosphorylated, which activates the 
receptor-independent SMAD4, leading to target gene expression in the cell nucleus. GDF9 binds BMPR-II 
and ALK5, which leads to a slightly different SMAD intracellular cascade. 
 
Table 1.1 below summarises the expression patterns of the TGF! ligands and their receptors mentioned 
in this chapter. Notably, all of the receptors are expressed from the start of folliculogenesis, and are 
expressed by granulosa cells at different stages. This allows the oocyte to act in an autocrine and 
paracrine fashion (McNatty et al., 2006). 
Ligand/Receptor Stage of follicular development 
 Primordial Primary Preantral Antral 
GDF9 Oocyte Oocyte Oocyte Oocyte 
BMP15 - Oocyte Oocyte Oocyte 
BMP6 Oocyte Oocyte Oocyte Oocyte, GC?, TC? 
ALK5 Oocyte Oocyte Oocyte, GC, TC Oocyte, GC, TC 
ALK6 Oocyte Oocyte, GC Oocyte, GC, TC Oocyte, GC, TC 
BMPRII Oocyte, GC Oocyte, GC Oocyte, GC, TC Oocyte, GC, TC 
Table 1.1. Expression of GDF9, BMP15, BMP6 and their receptors in ovine oocytes, granulosa and theca 
cells. Redrawn from McNatty et al. (2006), data from Juengel and McNatty (2005). 
 
Despite the knowledge of the BMP15 and GDF9 pathways, much of their cellular biology remains to be 
understood, in particular the ways in which the growth factors interact with each other, other OSFs, and 
the established hormones associated with folliculogenesis (Gilchrist et al., 2008). It has been shown, 
however, that GDF9 and BMP15 interact with a factor called kit ligand (KitL) (Rodrigues et al., 2008). 
Although KitL, GDF9 and BMP15 each have distinct roles during folliculogenesis, research has revealed 
that there are considerable interactions between them (Otsuka and Shimasaki, 2002), forming a 
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regulatory loop (figure 1.7). GDF9 is thought to inhibit KitL expression (Joyce et al., 2000; Wu et al., 
2004), in contrast to BMP15 which is thought to act as a promoter of KitL expression (Otsuka and 
Shimasaki, 2002). KitL then acts to inhibit BMP expression, in a negative feeback loop (Hutt et al., 2006). 
In addition, Thomas et al. (2005) have shown that FSH regulates BMP15 expression indirectly through Kit 
signalling, indicating a role for FSH in controlling oocyte- and granulosa cell- secreted factor expression, a 
theory supported by Yang et al. (2003). 
 
 
Figure 1.7. KitL, BMP15 and GDF9 interactions in oocyte follicular development  
(Redrawn from Thomas and Vanderhyden, 2006) 
 
FSH regulates the oocyte- and granulosa cell-secreted factors needed for oocyte growth and 
development. GDF9 and BMP15 stimulate granulosa cell proliferation. BMP15 inhibits luteinisation and 
promotes KitL-1 and KitL-2 expression, regulated by KitL. In contrast, GDF9 inhibits KitL-1 and KitL-2 
expression. Red arrows depict actions, black arrows depict effect on mRNA expression. 
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1.5.3. Bone morphogenetic protein 6 
Bone morphogenetic protein 6 (BMP6) is expressed in both oocytes and granulosa cells of follicles at 
secondary stage onwards (Vanderhyden and Macdonald, 1998; Glister et al., 2004; Knight and Glister, 
2006). The complete range of functions is yet to be uncovered (Gilchrist et al., 2006), however recent 
research has revealed a number of roles in the dynamics within the follicle, in particular concerning 
steroidogenesis.  
In the mouse, BMP6 seems to act in the promotion of follicle survival, by preventing premature 
luteinisation. It does this by regulating the biological effects of FSH on the granulosa cells, through 
inhibition of FSH-induced progesterone production by the mural granulosa cells and inhibiting cAMP 
synthesis, which occurs without affecting oestrogen production (Otsuka et al., 2001; Miyoshi et al., 2007). 
In contrast to the mouse, an in vitro study by Campbell et al. (2006) illustrated that in sheep granulosa 
cells, BMP6 (as well as BMP2 and 4) is a powerful promoter of FSH-stimulated oestradiol production. In 
addition, the study demonstrated that the BMP system has a significant interaction with IGF-I, as FSH-
induced oestradiol production increased only when both BMP6 and IGF-I are present. The study also 
revealed that BMPs promote theca cell differentiation at very low doses, but inhibit differentiation at higher 
doses, suggesting a higher sensitivity to these growth factors. 
BMP6 is thought to acts alongside BMP15 to prevent cumulus cell apoptosis, through the intricate 
network of paracrine-secreted BMP growth factors and a number of binding proteins such as follistatin 
and gremlin (Hussein et al., 2005). As a result it has a similar physiological role to BMP15, but acts 
through differing functional mechanisms. However, unlike some of the other oocyte-secreted factors such 
as BMP15 and GDF9, in most species BMP6 is not a promoter of granulosa cell proliferation, or involved 
in oestradiol synthesis regulation, although in the mouse BMP6 does weakly induce granulosa cell 
proliferation (Otsuka et al., 2001). This suggests that there are probably species-specific functional roles. 
There are, in fact, some fairly major differences in functional roles between species, for example in 
chickens it has been shown that BMP6, originating from the theca cells, actually enhances 
gonadotrophin-dependant progesterone secretion (Al-Musawi et al., 2007).  
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The BMP system is not the only group of growth factors thought to be heavily involved in the process of 
folliculogenesis. The insulin-like growth factor (IGF) family is another system of local growth factors that is 
relatively well characterized (Webb et al., 2007) and is believed to interact with both the BMPs and 
gonadotrophin hormones in the complex mechanisms that underlie follicular development. 
 
1.5.4. Insulin-like growth factor 
The insulin-like growth factor (IGF) family is believed to play a primary role in regulating gonadotrophin 
action on follicular somatic cells. In particular, IGF-I is thought to be involved with the control of preantral 
follicle growth, with IGF binding proteins (IGFBPs) regulating extra-ovarian IGF bioavailability (Webb et 
al., 2004; Webb and Campbell, 2007). Furthermore, IGF-I stimulates growth of bovine preantral follicles in 
vitro (Gutierrez et al., 2000). IGF-II, which stimulates steroidogenesis, is not expressed in theca cells until 
early antral stage (Armstrong et al., 2000; Spicer et al., 2004), when it seems the whole IGF system 
becomes functional. There are several species differences regarding the IGF system, however it seems 
that in all species the interaction between gonadotrophins and IGFs is important in regulating the 
development of follicles to the point of ovulation (Webb et al., 2007). Furthermore, Campbell et al. (2006) 
demonstrated a clear interaction between BMPs and IGFs in the stimulation of granulosa cell 
differentiation, indicating that the inter-relationships between locally produced growth factors have a key 
role in the mechanisms underlying folliculogenesis (figure 1.8). 
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Figure 1.8. Summary of the IGF and BMP systems  
(Redrawn and adapted from Webb et al., 2003 and 2007)  
 
1.6. Follicular cell expressed markers 
During clinical in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI), the cumulus cells, 
follicular fluid and granulosa cells are discarded, because currently they serve no further purpose in the 
process. However, the cells are easily accessible and plentiful, making them ideal candidates for analysis 
for the assessment of oocyte quality and embryo developmental potential (Li et al., 2008a). 
In order to establish additional measures of oocyte and embryo quality to be used for selection, a 
significant amount of research has been directed towards evaluating follicular cell signatures to be used 
as molecular predictors of oocyte developmental competence (McKenzie et al., 2004; Zhang et al., 2005; 
Feuerstein et al., 2007; Bettegowda et al., 2008). 
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Following the development of high throughput gene analysis technologies such as microarray, it has 
become relatively easy to identify the transcriptome of granulosa cells. As a result, several research 
groups have found a number of potential markers of oocyte developmental competence in cattle. These 
consist of GDF9 target genes such as HAS2, tumour necrosis factor alpha-induced protein 6 (TNFAIP6), 
prostaglandin-endoperoxidase synthase 2 (PTGS2) and gremlin 1 (GREM1) (Elvin et al., 1999a; Pangas 
et al., 2004a; Varani et al., 2002), as well as inhibin "A (INHBA), epidermal growth factor receptor 
(EFGR), betacellulin (BTC) and CD44 (Assidi et al., 2008; reviewed in Li et al., 2008a). Expression of 
HAS2 and GREM1 in particular, is thought to correlate to oocyte developmental competence (Cillo et al., 
2007), and this has encouraged the search for other molecular markers with the same relationships to 
oocyte quality. Other identified cumulus cell markers associated with oocyte competence include 
steroidogenesis genes such as ferredoxin 1 (FDX1) and cytochrome P450 (CYP19A1), as well as a 
number of genes involved in apoptosis (Hamel et al., 2008). 
Recently, there has been research on bovine cumulus cell markers of poor oocyte competence, in 
particular the cathepsin family of cysteine proteinases, which have been proposed as apoptosis-inducing 
genes. Inhibitors of these proteases could be used to reduce cumulus cell apoptosis and therefore 
improve oocyte developmental potential (Bettegowda et al., 2008). 
There have been a number of discrepancies between the conclusions of the studies concerning cumulus 
cell gene profiling, probably as a result of experimental differences, such as different endpoint measures 
(e.g. early cleavage, blastocyst rate, etc.), cell sources (pooled cumulus cells or cells from individual 
COCs) and analysis methodology and equipment (Li et al., 2008a). As a result, more research is needed 
in order to clarify which markers are capable of being used as predictors of oocyte competence, embryo 
development and pregnancy outcome. 
 
1.7. Angiogenesis 
In order for cells to survive, a continuous supply of oxygen and nutrients must be provided, as well as a 
removal system for metabolic waste products. In addition, a transport system is needed to transfer 
endocrine hormones from glands to target cells (Stouffer et al., 2001; Tamanini and De Ambrogi, 2004). 
Sufficient transfer of small, soluble molecules such as oxygen and glucose can only occur through 
 27 
diffusion for short distances of a few hundred micrometers, beyond which vascularisation is needed 
(Neeman et al., 2007). The process by which vascularisation is established is angiogenesis.  
In the adult, the vascular system is generally quiescent, apart from in the female ovary, where there is 
substantial angiogenesis. Angiogenesis in the ovary is critical for the processes of follicular development, 
ovulation and corpus luteum formation (Reynolds and Redmer, 1999; Tamanini and De Ambrogi, 2004; 
Fraser, 2006). Vasculature in the ovary is not evenly distributed around the follicle population, as blood 
flow requirement is dependent on the developmental stage of the follicle. It is thought that the dormant 
primordial and preantral follicles rely on blood vessels in the stromal tissue and acquire their oxygen and 
nutrients through simple diffusion, as they do not possess their own vascular network (Robinson et al., 
2009). As the follicles develop further, blood vessels spread from the surrounding ovarian stromal tissue 
to vascularise the follicle, between the theca cell layers. As the antral cavity develops, one layer of the 
vascular sheath forms below the basement membrane, and the other forms in the theca externa (Martelli 
et al., 2006). The vessels do not penetrate to the granulosa cell layer as they are separated by the 
basement membrane (Fraser and Wulff, 2001), and yet despite this, in the corpus luteum each luteinized 
granulosa cell is, in fact, adjacent to an endothelial cell (Duncan et al., 2008). 
It is often observed that the dominant follicle has a more vascularised theca layer than that of the 
subordinates (McNatty et al., 1981; Zeleznik et al., 1981), which suggests that the development of 
increased vasculature may be one of the determining factors in acquiring follicular dominance (Redmer 
and Reynolds, 1996; Aerts and Bols, 2010). Studies by Acosta et al. (2004; 2005) demonstrated that the 
dominant follicle in mares had increased blood flow prior to achieving dominance, and in cattle the 
subordinate follicles had decreased blood flow than the dominant follicle. There is evidence to suggest 
that the acquisition of vasculature around the developing antral follicle is a rate-limiting factor in terms of 
follicle selection and maturation prior to ovulation (Stouffer et al., 2001), as there would be differing 
accessibility to oxygen, nutrients and hormones for individual follicles at this stage, resulting in the 
promotion of dominance in one follicle, and limited development and atresia in another. 
Research on angiogenesis began in cancer tissue, with the first angiogenic factor to be discovered in the 
ovary being basic fibroblast growth factor (bFGF) by Gospsodarowicz et al. (1985), which is expressed in 
the mature follicle and corpus luteum. The FGF family is thought to play an important role in 
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folliculogenesis (Buratini et al., 2005), although the extent to which these growth factors are a 
requirement has yet to be elucidated. It is thought that there are a wide range of functions, including 
stimulation of endothelial cell proliferation and inhibition of granulosa cell apoptosis, thereby favouring 
angiogenic factor production (Bikfalvi et al., 1998). However, unlike other angiogenic factors, FGFs do not 
appear to have a critical role in angiogenesis (Stouffer et al., 2001). 
Feedback on a microenvironmental scale is required for the balance of angiogenesis with the 
requirements of the tissue and this is primarily under control of vascular endothelial growth factor-A 
(hereafter VEGF) expression by the hypoxic cells (Shweiki et al., 1995). The key microenvironmental 
factor affecting angiogenesis is oxygen. Under low oxygen (hypoxic) conditions, the transcription factor 
hypoxia inducible factor-1 (HIF-1) is stable, inducing VEGF expression. When oxygen supply is adequate, 
the oxygen causes destabilisation of the !-subunit of HIF-1, which suppresses its activity (Neeman et al., 
2007). 
 
1.7.1. Vascular endothelial growth factor 
VEGF has an established central role as the primary angiogenic growth factor. Its immediate effects are 
vasodilation and an increase in vessel permeability, and after a longer duration, endothelial cell 
proliferation, migration and differentiation, which results in the formation of new capillaries (Neeman et al., 
2007). Angiogenesis is then further supported by VEGF by means of signalling to endothelial cells of the 
newly formed capillaries to enable them to survive (Benjamin et al., 1999). VEGF is produced in a number 
of different isoforms, VEGF165 playing the most important role in the ovary (Tesone et al., 2005). In 
addition, two other soluble isoforms are produced as a result of gene splicing; VEGF121 and VEGF145, as 
well as two larger, membrane-bound forms; VEGF189 and VEGF206 (Stouffer et al., 2001). In the primate, 
VEGF mRNA is completely absent in primordial, primary and early secondary follicles, until the vascular 
network forms in the secondary follicle stage, although in cattle it seems that VEGF may be involved in 
primary to secondary follicle transition, indicating species-specific roles (Yand and Fortune, 2007). It is 
expressed more weakly in the theca cells of antral follicles, and the granulosa cells next to the oocytes of 
preovulatory follicles (Stouffer et al., 2001; Taylor et al., 2004). In cattle and pigs, VEGF expression 
occurs during early folliculogenesis, becoming stronger in the granulosa and theca cells of the dominant 
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follicle (Kaczmarek et al., 2005), hence expression increases with follicular size (Barboni et al., 2000; 
Ferrara et al., 2003).  
The importance of VEGF during folliculogenesis has been demonstrated by a number of research groups, 
who showed that VEGF inhibition during the follicular phase, using VEGF Trap, significantly reduces 
follicle growth, and results in antral follicles that are small and poorly vascularised. As a result no 
dominant follicles emerge (Wulff et al., 2002; Fraser and Duncan, 2005). 
mRNA/protein expression of VEGF has been found to be stimulated significantly by the LH surge in 
granulosa cells (Koos, 1995; Christenson and Stouffer, 1997). LH is thought to act indirectly to induce 
follicular angiogenesis, by modulating VEGF expression (Gutman et al., 2008). In addition, treatment 
using GnRH antagonists results in the same outcome as that of VEGF inhibition, which indicates 
gonadotrophins as regulators of VEGF expression in preovulatory follicles (Kaczmarek et al., 2005; Lam 
and Haines, 2005; Duncan et al., 2008). In addition to the interaction with LH, it seems that IGF-I may 
also have a role in VEGF production, at least in bovine and primate granulosa cells (Schams et al., 2001; 
Martinez-Chequer et al., 2003). However, the mechanisms underlying the regulation of VEGF in the 
mammalian ovary have still not become apparent. 
It has been suggested that hypoxia is one of the primary regulators of ovarian VEGF expression, using 
culture of luteal cells (Tropea et al., 2006). In the situation where VEGF expression is mediated by 
hypoxia, there is significant up-regulation of a number of specific transcription factors in the ovary. The 
most notable of these transcription factors is hypoxia-inducible factor-1 (Forsythe et al., 1996). 
 
1.7.2. Hypoxia-inducible factor-1 
Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric transcription factor that is of particular importance in 
angiogenesis, as it regulates and maintains expression of a number of factors involved in the process. It 
is of primary importance in the induction of gene expression for factors that allow cellular adaption and 
survival in an environment that is continuously shifting from normoxia to hypoxia (Semenza, 1998). 
HIF-1 was first identified following the discovery of a hypoxia-responsive element (HRE) in the 
erythropoietin gene enhancer, which stimulates red blood cell proliferation under hypoxic conditions 
(Goldberg et al., 1988). Later studies identified the protein that binds to the HRE during hypoxia as HIF-1. 
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HIF-1 is composed of a HIF-1! and a HIF-1" subunit (Wang and Semenza, 1995), which form a 
heterodimeric complex to allow DNA binding and the transactivation of HIF-1 (Jiang et al., 1996; Kallio et 
al., 1997). It is up-regulated under hypoxic conditions, during which its proteosomal degradation is 
prevented, resulting in an accumulation which allows for binding of HIF-1! to HIF-1". This process is 
summarised in figure 1.9. 
 
 
 
Figure 1.9. The HIF angiogenic pathway 
 
O2 concentration decreases as the metabolic demands of the developing follicle increases, leading to an 
increase in HIF-1! expression. Cells that normally produce HIF then quickly degrade the protein in non-
hypoxic conditions, cease protein degradation, resulting in accumulation of HIF-1!. This then dimerizes 
with HIF-1", and binds to hypoxia response elements within target genes, and activates transcription of 
angiogenic growth factors (Hirota and Semenza, 2006). 
 
O2 concentration falls 
HIF-1! expression 
HIF-1! degradation inhibited 
Dimerization with HIF-1" 
Binding to hypoxia response elements in target genes 
Transcription of genes associated with increased vasculature 
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HIF-1 is a critical transcription factor regulating angiogenic gene expression, controlling the expression of 
over 40 genes (Hirota and Semenza, 2006), which encode a wide range of proteins including glycolytic 
enzymes, glucose transporters and erythropoietin, as well as target genes which promote vascularity 
such as VEGF (increasing vessel permeability) and leptin (inducing endothelial cell proliferation), as a 
more long term solution (Semenza, 1998; Alam et al., 2009; Fong, 2009). Its primary role involves the 
activation of the multiple physiological responses to hypoxic conditions in order to counteract the 
deficiency of oxygen. 
Besides the role of HIF-1 in hypoxic conditions, under normoxic conditions, it has been shown that HIF-1 
upregulates inhibin-!, LH receptor and VEGF in granulosa cells stimulated with FSH (Alam et al., 2004). 
Expression of HIF-1 is rarely seen in somatic cell nuclei in growing follicles, and even in the dominant pre-
ovulatory follicle, but then expression increases dramatically in the short time before, and during the 
process of ovulation (Fraser and Duncan, 2009; Duncan et al., 2008). However, its patterns of expression 
and the mechanisms underlying expression during hypoxia are still not fully understood, and will require 
further exploration. For example, HIF-1 expression in follicular somatic cells has not yet been examined in 
a study relating to IVF outcome, but would be an ideal candidate to compare expression levels to 
ultrasound-derived indices of follicular vascularity, as well as oocyte and embryo quality. 
 
HIF-1" is expressed constitutively, with its mRNA and protein levels continuously maintained, 
independent of oxygen availability within the cell (Kallio et al., 1997), whereas the HIF-1! has a very short 
half-life, and is completely dependent on oxygen conditions (Salceda and Caro, 1997). Although HIF-1! 
transcription and synthesis are continuous, and unaffected by oxygen, the proteins rapidly degrade under 
normoxic conditions (Wang et al., 1995). In hypoxic conditions, HIF-1! stabilises and is able to 
translocate from the cytoplasm to the nucleus. Here it binds to HIF-1" to form the transcriptionally active 
HIF complex (Huang et al., 1996). Gene expression is then induced by the HIF complex associating with 
the HREs in the target gene regulatory regions, binding the coactivators (Lando et al., 2002). 
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1.7.3. Follicular blood flow 
Follicular vasculature, measured by blood flow power Doppler ultrasound, has been correlated to oocyte 
developmental competence, and even pregnancy potential (Chui et al., 1997; Van Blerkom, 1998). It 
seems that follicular vasculature has a significant influence on the oocyte that resides within (Merc et al., 
2006), which would be explained by the increased metabolism, respiration and removal of waste 
products. However, it is not known whether it is primarily the follicle driving the formation of vasculature 
through production of angiogenic growth factors, or vice versa with increased vasculature formation 
leading to the development of the dominant follicle. 
Oocytes from highly vascularised follicles have fewer chromosomal abnormalities (Bhal et al., 1999), as 
there are fewer defects in spindle organisation, cytoplasmic structure and chromosomes. Furthermore, 
development in poorly vascularised follicles is hindered considerably as they have reduced capacity in 
progressing past the 6-8 cell embryo stage (Van Blerkom et al., 1997). Oocytes are very sensitive to 
hypoxic stress, and so it is crucial to develop an adequate network of vasculature for normal oocyte 
development to occur (Monteleone et al., 2008). 
As VEGF is the primary angiogenic growth factor in the ovary, measuring its concentration in the follicular 
fluid would also seem to be a potential measure of the extent of peri-follicular blood supply. Indeed, VEGF 
concentrations in the follicular fluid seem to have a positive relationship with these oocyte quality, embryo 
development parameters as well as pregnancy rates (Van Blerkom et al., 1997), indicating a possible role 
for follicular VEGF measurement and power Doppler ultrasound as tools for oocyte selection in IVF 
(Moneteleone et al., 2008). There has, however, been some controversy in this area, as some studies 
found that VEGF in follicular fluid was, in fact, not related (Kim et al., 2004), or even negatively correlated 
(Barroso et al., 1999; Ocal et al., 2004) to IVF outcome in stimulated cycles. As a result, further research 
is needed to elucidate these relationships. The problem with a number of the studies is that the authors 
were unable to track the embryo developmental progress and hence relate the ultrasound and assay data 
to the individual embryos and consequentially, pregnancy rates (Shrestha et al., 2006). As a result, 
individual embryo culture and single embryo transfer would be advantageous, to enable embryo 
development tracking and allow the data to be related to pregnancy outcome. 
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1.8. Experimental models 
There is a wide range of methods commonly used for in vitro culture that have been used in follicular 
somatic cell culture, each with its own advantages and drawbacks. However, a reliable culture system 
that allows normal development from the very first stages of folliculogenesis up to antral stage has still not 
yet been developed. Although the culture systems explained below have been improved significantly over 
recent years, further work to develop more in vitro models is needed in order to make progress in 
elucidating the mechanisms underlying early follicular development (Webb and Campbell, 2007). 
Research using animals with naturally occurring or articifially produced mutations, such as those deficient 
in GDF9 and/or BMP15, has revealed a great deal of information regarding the role of these growth 
factors in vivo. In particular, sheep have become an extremely popular species for use as an 
experimental model, as in previous years there have been several breeds identified with genetic 
mutations that occur naturally, with considerable effects on ovulation rate, as well as aspects of 
folliculogenesis from the very first stages (McNatty et al., 2006). This has allowed research to reveal the 
considerable differences between the underlying mechanisms of follicular development in different 
species. For example mice and sheep with GDF9 deficiency (Dong et al., 1996; Hanrahan et al., 1998), 
and sheep (but not mice) with BMP15 deficiency (Martinez-Royo et al., 2008) are sterile due to a block of 
folliculogenesis at the primary stage. This is due to a failure of the granulosa cells to proliferate, and a 
lack of antrum and theca cell layer formation (Dong et al., 1996; Carabatsos et al., 1998), indicating that 
these are a vital requirement for follicular development in these species. Furthermore in the mouse, 
GDF9 deficiency results in excess oocyte growth, with consequent loss of the oocyte, and formation of 
steroidogenic granulosa cell clusters (Elvin et al., 1999b). However, these knock-out models can be 
limited in their usefulness, as they do not allow the study of the roles of the growth factors in later 
folliculogenesis involving oocyte capacitation, due to the cessation of development (Gilchrist et al., 2008). 
Research using human tissue has been held back by the fact that it is difficult to obtain normal, healthy 
tissue that has not been treated with high doses of gonadotrophins in vivo. As a result, animal models 
form the basis for research in this field, in order to overcome this problem. In particular, sheep and cows 
are widely used because they are predominantly monovular, in abundance, relatively inexpensive, and 
are large enough to obtain sufficient amounts of tissue for study (Campbell et al., 2003). Mice are also 
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frequently used, however the relevance of the rodent model to human physiology can be somewhat 
limited. 
In vitro experiments have been an extremely valuable source of information concerning the functions of 
OSFs and their effects on the follicular cells. Recombinant OSFs have been used to treat ovarian cells, 
yielding a considerable amount of new information, however in the past researchers have been met with 
extensive problems regarding being able to source high quality recombinants and reliable antibodies and 
immunoassays (Gilchrist et al., 2008). As a result, there is a great deal of inconsistency between 
laboratories, and hence their findings have often proved contradictory. Because of these difficulties, the 
current preferred method of study relies upon bioassay. 
 
1.8.1. Native OSF bioassays 
The underlying principal of OSF bioassays is to culture ovarian cells with denuded oocytes (DOs), and 
compare the response to cells cultured without DOs. The effects on co-culture of follicular cells with DOs 
are marked, as granulosa and cumulus cells completely alter in function, indicating OSFs as the source 
for regulation of cell function. In addition, cells can be cultured in medium which has previously contained 
oocytes; oocyte-conditioned medium (OCM), which elicits a cellular biological response (Buccione et al., 
1990). Furthermore, if more DOs are added to the co-culture, the response increases (Hussein et al., 
2005). 
Figure 1.10 shows the types of bioassay commonly used, where the target cells are in 3 different 
conditions; as a monolayer on the plate or dish surface [1 and 2], as oocytectomized complexes (OOX) 
[3], or as complete COCs [4]. Oocytectomy involves removing the oocyte contents from the COC, which 
creates a hollow ball of cumulus cells with the zona pellucida inside (Buccione et al., 1990). Without the 
presence of an oocyte to secrete paracrine phenotype-stabilising factors, these cumulus cells become 
more characteristic of mural granulosa cells by decreasing DNA synthesis and secreting progesterone, 
suggesting that this may be their default developmental pathway (Li et al., 2000). 
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Figure 1.10. Bioassays of native oocyte-secreted factors (Redrawn from Gilchrist et al., 2008) 
 
In all of the models illustrated above the source of oocyte-secreted factors is DOs, made by removing the 
cumulus cells of COCs which are then cultured at high density. [1] shows target cells being treated with 
medium previously containing DOs. [2] and [3] show co-culture of DOs with target somatic cells, which 
can be either as a monolayer or as an oocytectomized complex respectively. [4] shows culture of DOs 
with a complete COC. (DO, denuded oocyte; COC, cumulus-oocyte complex; OCM, oocyte-conditioned 
media). 
 
The problem with models 1-3 illustrated in figure 1.10 above is that the trans-zonal projections and gap 
junctions between the oocyte and cumulus cells are destroyed; hence their physical association is lost. 
However the major advantage of all of the systems is that because oocytes rather than recombinants are 
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used as the source of OSFs, the cell responses observed are much more physiological (Gilchrist et al., 
2008). 
Using the cow model for oocyte and ovarian cell studies is a viable option to using human material, due to 
the extensive similarities between the reproductive mechanisms and embryonic development (Adams and 
Pierson, 1995; Bettegowda et al., 2008). Using bovine material is particularly advantageous as it avoids 
the considerable ethical implications that are associated with research on humans, without compromising 
experimental relevance. 
 
1.8.2. Cell culture systems 
The development of a reliable and repeatable cell culture system for use in follicular somatic cell studies 
has facilitated research in the field of follicular dynamics. The system in place in our laboratory was 
conceived by Campbell et al. (1996), and was designed in such a way as to mimic physiological 
conditions as closely as possible, so that the results obtained from experiments based on challenges to 
the cells are physiologically relevant. As a general rule, cells obtained from physiological tissues are able 
to adapt to some extent to the environment in which they are cultured (Mandel, 1986), however it is vital 
to use a system in which cells secrete the same hormonal profile and respond as they would in vivo. 
The ovine culture system used in our laboratory utilises serum-free culture medium, and allows for 
granulosa cell FSH-responsive production of oestradiol by undifferentiated cells from small antral follicles, 
as well as maintained production by differentiated cells from large antral follicles (Campbell et al., 1996). 
In the past, medium has been supplemented with serum, from animal or human origin, as a means to 
provide the cultured cells with the different factors required for cell metabolism including growth factors, 
proteins, vitamins and minerals. However, the use of serum is frequently frowned upon, firstly because of 
the ethical issues associated with collecting foetal calf serum, secondly because of contamination by 
viruses, and thirdly due to the unreliable batch-to-batch variation of commercially available serum (van 
der Valk et al., 2010). These variations often cause experimental discrepancies and alter results; for 
example, the inclusion of serum in culture of follicular cells has been shown to affect oestradiol production 
significantly, as well as affecting FSH responsiveness (Campbell, 1989). As with many cell culture 
mediums in research, the medium that is in use in our laboratory is supplemented with insulin, transferrin 
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and selenium. It has been known since the 1920s that insulin is a vital ingredient for cell culture (Gey and 
Thalhimer, 1924) for stimulation of glycolysis. Transferrin is required for iron transfer across cell 
membranes (Bjare, 1992), and selenium is used to protect the cells from oxidative stress which is 
associated with extended cell culture (Helmy et al., 2000). In addition, bovine serum albumin is included 
in the medium as this is a lipid carrier, which also facilitates cell adhesion (Taub, 1990), as well as L-
glutamine which is an essential protein synthesis precursor and respiratory fuel (Zielke et al., 1984). 
 
 
1.9. Ultrasonography 
Following the original pioneering work performed by Edwards and Steptoe over 30 years ago, 
transvaginal ultrasound is now used routinely in assisted reproductive treatments in order to estimate the 
ovarian reserve and assess ovarian status, so that the ovarian response to stimulation can be both 
predicted and monitored respectively (Edwards and Craft, 1990).  
Conventionally, ultrasound is performed in 2 dimensions, and follicle size estimation performed by taking 
an average of two diameter measurements. However, as ovarian follicles are three-dimensional 
structures, it is more accurate to measure the mean diameter in three dimensions, or even measuring 
volume as a proxy for follicular size. As a result, 3D ultrasound techniques have been developed in order 
to more accurately deduce the size of ovarian follicles (Ata et al., 2011), as well as an extremely diverse 
range of other applications.  
The development of power Doppler technology in conjunction with 3D ultrasound has been developed to 
enable the non-invasive measurement of blood flow within a target area, which is more sensitive than the 
more established colour Doppler technique (Schulten-Wijman et al., 2008). 
 
1.9.1. Power Doppler 
Transvaginal power Doppler ultrasonography is a technique that has become well established as a 
valuable research tool in the field of reproductive medicine. The blood flow in the female ovary can be 
monitored accurately and non-invasively using Doppler ultrasound imaging, and the measurements that 
the technique gives could be used as predictors of fertility treatment outcome. Power Doppler technology 
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is relatively new in the field, and offers the advantages over conventional colour Doppler that the colour 
image produced is mapped on the amplitude of the frequency shift in terms of the integrated power of the 
Doppler spectrum, therefore facilitating measurement of low flow volumes and velocities that colour 
Doppler is unable to detect (Murphy and Rubin, 1997; Bhal et al., 1999). As a result, it is possible to 
visualize very small blood vessels (MacSweeney et al., 1996), for example those that surround the 
developing follicles. 
Relatively recent studies measuring peri-follicular blood flow have revealed that each fully developed 
follicle has individual blood flow characteristics and vessel configuration, indicating that power Doppler is 
able to detect differences between follicles that conventional ultrasound would not (Borini et al., 2001). 
Studies examining follicular vascularity have found that preovulatory follicles can be classed according to 
the extent of vascularity that surrounds them. In fact, Bhal et al. (1999) created an index of perifollicular 
vascularity, which was based on the percentage of the follicle circumference that depicted an echo signal. 
This group found a link between vascularity index and oocyte retrieval rate, fertilisation rate and 
pregnancy rate, as well as a negative correlation to chromosomal abnormalities, a result also supported 
by Borini et al. (2001).  
Huey et al. (1999) found that colour Doppler indices relate to oocyte developmental competence, by 
measuring pulsatility index (PI), resistance index (RI) and S-D ratio (peak systolic frequency shift [S] - end 
diastolic frequency shift [D]). Although the study was based on just 16 patients (79 oocytes), peri-follicular 
vascularity was significantly correlated to embryo cleavage at day 3, though there was no significant 
correlation to embryo morphology. There were a number of trends observed, however due to a relatively 
small sample size these were not significant. 
The combination of power Doppler with three-dimensional (3D) ultrasonography enables quantification of 
blood flow, within a specified area, which can be an extremely sensitive technique (Pairleitner et al., 
1999). There are three indices calculated by the ultrasound computer; vascularisation index (VI), flow 
index (FI) and vascularisation flow index (VFI) (Schulten-Wijman et al., 2008), which can be used to give 
an arbitrary indicator of blood flow around the ovary. These indices signify the extent of vascularity, and 
therefore could be used to predict the developmental competence of the oocyte within the follicle of 
interest (Monteleone et al., 2008). 
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1.9.2. Antral Follicle Count 
True ovarian reserve reflects the number and quality of the primordial follicle pool within the ovary, and as 
a result is not possible to measure whilst maintaining fertility (Visser and Themmen, 2005). Chronological 
age is correlated to ovarian reserve (Broekmans et al., 2004), and a model based on this has been 
produced (Wallace and Kelsey, 2010), but this alone is an inadequate basis for accurate ovarian reserve 
prediction. A number of tests have therefore been developed and researched extensively in order assess 
the ovarian function of the individual patient (Broekmans et al., 2009; Hansen et al., 2011). These include 
serum FSH level (Toner et al., 1989), clomiphene citrate challenge test (Loumaye et al., 1990), 
gonadotropin-releasing hormone agonist stimulation test (GAST) (Winslow et al., 1991), serum oestradiol 
level (Lucciardi et al., 1995), serum inhibin-B level (Seifer et al., 1997), and more recently ultrasound 
antral follicle count at the start of the menstrual cycle (Chang et al., 1998; de Carvalho et al., 2008) and 
serum anti-Mllerian hormone (Seifer et al., 2002; Jayaprakasan et al., 2010b).  
The number of growing follicles is thought to be directly related to the number of primordial follicles in the 
pool itself (Gougeon, 1996); consequently, counting the number of visible small antral follicles on 
ultrasound scan has become a popular method of estimating ovarian reserve. Transvaginal 
ultrasonography is now used routinely in assisted reproduction treatments to assess ovarian status and 
estimate ovarian reserve in order to predict and monitor ovarian response to stimulation (Moawad et al., 
2009). Conventionally, 2D assessment of the ovarian follicles, which has been studied in great depth, is 
performed manually by a skilled operator, with findings now suggesting that it may be both inaccurate 
(Amer et al., 2003) and time-consuming (Jayaprakasan et al., 2008; Lamazou et al., 2010). The antral 
follicle count involves estimating the total number of visible follicles from 2mm in diameter, to 10mm by 
convention (Deb et al., 2010), although some groups have used a lower cut-off of 5 or 6mm diameter 
(Chang et al., 1998; Pellicer et al., 1998; Haasdma et al., 2007) due to the hypothesis that smaller follicles 
are considered to form the so-called ÔfunctionalÕ ovarian reserve. These are the follicles that have the 
potential to develop to maturity and ovulate, and as a result these may be the most reflective of the true 
ovarian reserve (Jayaprakasan et al., 2009; 2010b).  
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Thesis rationale, objectives and hypotheses 
The rationale for this thesis is to investigate the relationship between the oocyte and its 
microenvironment, focussing on the bi-directional communication between the oocyte and somatic cells, 
and also the effect of vasculature on the individual follicle and oocyte within. The thesis will be based on a 
multi-faceted approach to further investigate the interactions that occur within the ovarian follicle, with a 
focus on oocyte-secreted factors and blood supply. 
Our overall hypothesis is that the measurement of growth factors secreted by the oocyte (for example 
BMP15 and GDF9), angiogenic growth factors from somatic cells (for example VEGF and HIF), and also 
constituents of the follicular fluid, such as steroid hormones and oocyte-secreted factors, could reflect the 
quality and developmental potential of the oocyte contained within. Assessment of follicular blood flow by 
3-dimensional power Doppler ultrasonography is a tool that could also be used for this purpose as 
follicular blood flow is thought to have a considerable influence on the development of the oocyte within. 
As the method is objective and non-invasive, and closely related to follicular development, we propose 
that it could serve as a good predictor of oocyte competence and embryo development so that the 
embryo with the best developmental competence can be selected for transfer. 
The overall objective of the thesis is to elucidate some of the mechanisms underlying follicular 
development relating specifically to oocyte development and quality. This will be achieved by completing 
the following specific objectives: 
1. Development of in vitro culture models to examine the molecular mechanisms regulating the 
expression of oocyte-secreted and angiogenic factors and their effect on follicular somatic cells 
cultured under controlled conditions. This will form the basis of the investigation of interactions 
between the oocyte and somatic cells, as well as the effects of hypoxia on a cellular scale. These will 
be examined on a molecular level using gene expression analysis, as well as measuring levels of 
steroid hormones and growth factors associated with angiogenesis. The hypothesis is that the oocyte 
influences the overall development of the follicle by producing factors that act locally to control the 
microenvironment in which it is subjected.  
2. Investigation into the effects of passively immunizing animals against oocyte-secreted factors on 
follicular development by directly infusing antiserum into the ovarian vasculature. This will further 
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examine the roles of BMP15 and GDF9 in vivo, which we hypothesise will have a significant 
synergistic effect on folliculogenesis. 
3. Development of phantom-based models in order to determine the accuracy and relevance of 
ultrasound assessment of ovarian blood flow, and also the 3D ultrasound measurement of follicular 
size and antral follicle count. Power Doppler ultrasound techniques will form the basis of the 
investigation of ovarian and peri-follicular blood flow on a histological scale, using a bovine phantom 
tissue model. Currently, the blood flow parameters given by the ultrasound machine are arbitrary in 
terms of units and so through relating true blood flow and vascularity information determined in 
perfused bovine ovaries, we hope to clarify the meaning of these ultrasound parameters. In addition, 
the accuracy of automated follicular measurement and antral follicle count will be examined using 
another phantom model. 
4. Amalgamation of the findings of the previously mentioned experiments in the form of a small scale 
clinical trial in human subjects undergoing fertility treatment. Patients will undergo ultrasound 
assessment of peri-follicular blood flow, and then the oocytes cultured individually in order to maintain 
individuality, so that the embryological data can be related back to that of the blood flow scans. 
Follicular fluid and somatic cells will be collected at oocyte retrieval and examined against the 
ultrasound and embryological data. This trial has been designed to examine the relationships 
between oocyte-secreted and angiogenic growth factors and hormones, as well as ultrasound blood 
flow assessment parameters, as well as IVF treatment outcome. We hypothesise that the levels of 
growth factors and steroid hormones in the follicular fluid will correlate to ultrasound blood flow 
parameters, as well as consequent oocyte and embryo quality. 
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Chapter 2 Ð Materials and Methods 
2.1. Cell Culture 
2.1.1. Follicle dissection and granulosa cell isolation 
Approximately 20-30 bovine ovaries were obtained from the abattoir and transported to the laboratory in a 
flask containing warmed dissection medium. They were washed in 70% ethanol, then warmed DulbeccoÕs 
PBS (DPBS), and then transferred to fresh warmed dissection medium (see appendix). Depending on the 
type of culture being used, follicles of various sizes were roughly dissected from the ovaries and 
transferred to petri dishes of warmed dissection medium using fine curved forceps. 
Once approximately 200 follicles had been obtained, they were cleaned of excess extraneous tissue if 
necessary, using fine forceps. The follicles were then hemisected in approximately 10ml of DPBS using 
fine bow scissors and forceps under a stereo microscope, to release the fluid and cells from within. 
The follicle halves were transferred into 25ml universal tubes and then flushed repeatedly using a 1ml 
syringe. After allowing the follicle shells to settle, the supernatant cell suspension was transferred to 15ml 
centrifuge tubes containing 5ml warmed granulosa culture medium (see appendix), along with the DPBS 
used for hemisecting. The tubes were centrifuged at 800rpm for 10 minutes, the supernatant discarded, 
and the cell pellets resuspended in 10ml warmed granulosa culture medium. This process of flushing the 
follicle shells was repeated to obtain more granulosa cells. 
Once the granulosa cells had been collected, a viable cell count was performed using trypan blue (Sigma 
T8154, 0.4%). 50#l of cell suspension and 50#l trypan blue were mixed, and used to fill a 
haemocytometer.  Only transparent cells (not blue) were considered to be viable and hence included in 
the cell count. These were counted in all 25 small squares of the haemocytometer, multiplied by 2 
(dilution factor), and then by 10
4
 to calculate the cells per ml. 
 
2.1.2. Granulosa cell culture 
Granulosa cells were cultured according to the serum-free method developed by Campbell et al. (1996). 
This method mimics physiological conditions in the follicular phase due to the inclusion of physiological 
amounts of FSH, IGF, insulin and LH (see appendix for full list of additives). Cells were seeded at 75,000 
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per well of a 96 well plate, in 250#l of granulosa cell culture medium, and incubated at 37¡C with 5% CO2 
for 8 days. Culture medium was changed every 48 hours, and used medium was kept and stored at -20¡C 
for later analysis.  Where the culture required a cell number estimation was to be performed, a flask of 
cells containing approximately 2 million cells in 5ml of granulosa medium was also cultured to be used at 
the end of the culture to construct a standard curve for neutral red staining. If cells were to be used for 
PCR, they were lysed and prepared at the end of the culture, as per the method outlined in 2.2.4.1., 
hence in this case cell counts were not performed. 
 
2.1.3. Estimation of viable cell count 
At the end of the culture, the total viable cell count was performed using neutral red staining (Sigma 
N6264), which is based on the uptake of dye that accumulates in viable cell lysosomes (Chiba et al., 
1998). The culture medium was removed and replaced with fresh culture medium containing neutral red, 
and incubated for 2 hours to allow uptake of the dye. Following this the neutral red culture medium was 
removed and replaced with 200#l per well of formol calcium (4% w/v formaldehyde and 1% w/v calcium 
chloride) to fix the cells to the bottom of the wells. This was then replaced with 200#l of acetic acid-
ethanol (50%v/v ethanol, 1% v/v glacial acetic acid), which lyses the cells. Absorbance at 540nm was 
then measured on a plate reader against a standard curve as prepared below. 
Cells were cultured in a flask under similar conditions to the main culture. At the end of the cell culture the 
medium was removed and replaced with 5ml of medium containing neutral red, and incubated for 2 hours 
to allow dye uptake. Following this the medium was discarded and replaced with 5ml trypsin-EDTA (0.2% 
w/v trypsin and 0.08% w/v EDTA in DPBS) for approximately 20 minutes, until the cells had become 
detached from the flask surface. The cell suspension was then transferred to a 15ml centrifuge tube with 
1ml of foetal calf serum to inactivate the enzyme. This was then centrifuged at 800rpm for 10 minutes, the 
supernatant discarded, and 2ml culture medium used to resuspend the pellet. A cell count was performed 
using trypan blue as previously described to estimate the total number of cells. 
The cells were centrifuged at 800rpm for 10 minutes, and the supernatant replaced with 2ml acetic acid-
ethanol solution. A serial dilution in acetic-acid ethanol was used to create a standard curve in 6ml bijou 
tubes, and 200#l of each concentration was transferred in quadruplicate into a 96 well plate. Absorbance 
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was read at 540nm by spectrophotometer, and the cell numbers from granulosa cell cultures estimated in 
comparison to the relative standard curve.  
 
2.2. Sample analysis 
2.2.1. Steroid Hormone ELISA 
Oestradiol Plasma Extraction 
Extraction on plasma samples was performed to improve the detection limit of the assay, by preventing 
interference from sex-hormone-binding globulins (Dighe and Sluss, 2004). A similar method to that of 
androstenedione was used for extraction of oestradiol. 400#l of plasma sample of QC was pipette into 
100x13mm glass tubes, and 4ml diethyl ether was added to each tube. The tubes were then vortexed for 
1 minute to allow mixing. They were then placed into a bath of IMS and dry ice in order to freeze the 
plasma. The supernatant was then poured off into 75x12mm glass tubes, and then dried down using a 
heated sample concentrator. 250#l of assay buffer was added to each tube to resuspend the oestradiol. 
 
ELISA 
Similar methods were used for oestradiol and progesterone ELISAs. Oestradiol intra-assay CV was 5.3% 
and 6.6% respectively, and inter-assay CV 8.0% and 9.3% respectively. Both had been optimised and 
validated in-house. 
 
Plate coating 
100#l of diluted oestradiol or progesterone antibody (ABCAM ab1024 and SAPU R7044X) at 1:64,000 for 
oestradiol or 1:32,000 for progesterone, in coating buffer (appendix 2) was pipette into each well of a 96 
well plate (Nunc F96 Maxisorp, Denmark), and incubated overnight at 4¡C. 
Plates were washed 4 times using wash solution, on a plate washer, and then 100#l of blocking solution 
(PBS/3%BSA) was pipette into each well. They were then incubated for 2 hours at room temperature. 
Following this, the plates were washed a further 4 times using a plate washer. 100#l of standard, sample 
or QC were pipette into each well (samples and QCs diluted 1:4). 100#l E2-HRP conjugate (ABIOX ED-
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006) at 1:64,000 in assay buffer was added to each well and the plates incubated for 2 hours at room 
temperature. 
Plates were then washed 4 times on a plate washer, and then 50#l of TMB (Sigma T0440) was pipette 
into each well. They were incubated at room temperature for approximately 10 minutes and then 50#l of 
stopping solution (1M H2SO4) was added into each well. Plates were read at 450nm absorbance 
(referencing at 620nm) and sample concentrations estimated compared to the standard curve. 
 
Reagents 
Standards were made from stock solutions as follows: 
• 10#l ÔStock BÕ (10#g/ml oestradiol [Sigma E2758] or progesterone [Sigma P0130] in ethanol) into 
10mls culture medium or assay buffer to obtain 1000pg/100#l. 
• Double diluted in culture medium or assay buffer to obtain 500, 250, 125, 62.5, 31.25, 15.6, 7.8 and 
3.9pg/100#l. Assay buffer is ÔzeroÕ standard. Stored frozen in LP4 tubes. 
 
2.2.2. AMH, BMP15 and GDF9 ELISA 
Follicular concentrations of AMH, BMP15 and GDF9 were measured in samples collected from patients in 
the clinical trial using ELISA kits. 
The human AMH kit from Cusabio Biotech Ltd. (CSB-E12756) was a simple competitive ELISA with a 
detection range of 8ng/ml to 0.32ng/ml. All reagents were supplied with the kit, and the plate was to be 
read at 450nm with a correction wavelength of 570nm. 50#l of undiluted samples were added in duplicate 
to the wells, and all fell within the detectable range with a CV of less than 10% between replicates. 
The human BMP15 and GDF9 ELISA kits from USCN Life Science Inc. (E92107Hu and E90427Hu) were 
sandwich enzyme immunoassays which used a biotinylated antibody and avitin conjugated to horseradish 
peroxidase. Both kits had a detection range of 10ng/ml to 0.156ng/ml. All reagents were supplied with the 
kit, and the plate was read at an absorbance of 450nm. 100#l of follicular fluid sample was used both neat 
and diluted 1:10 in PBS for BMP15 ELISA, and used undiluted, 1:10 and 1:100 in PBS for GDF9 ELISA in 
duplicate. All samples diluted 1:10 for BMP15 fell within the detectable range with a CV of less than 10% 
between replicates. GDF9, as later discussed, was not detectable in the follicular fluids, however a 
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standard curve was constructed with an r
2
=0.9992, indicating that concentrations in the follicular fluid 
were too low to be measured using this method. 
 
2.2.3. Radioimmunoassay 
Radioimmunoassays for FSH and LH were performed as previously described by Campbell et al. (1994) 
and Kendall et al. (2004). Intra-assay variation for the radioimmunoassays was 8.4% for FSH and 4.4% 
for LH, and inter-assay variation 12.6% and 11.6% respecitvely, as assessed by internal QCs. 
 
FSH radioimmunoassay 
Standards were set up using follicle stimulating hormone (NIDDK, USA oFSH-19-SIAFP) in assay buffer 
(0.01M PBS, 0.1% BSA and 0.1% sodium azide) at 0, 0.26, 0.52, 1.04, 2.08, 4.17, 8.34 and 16.67ng/ml. 
200#l of each standard or sample/QC was pipetted into LP4 plastic tubes in triplicate or duplicate 
respectively. A further 200#l of assay buffer was added to the tubes. 50ul of FSH antibody (Tucker 
Institute, ter.oFSH.AB.1) at 1:175,000 in assay buffer was added to each sample, QC and standard tube. 
50#l of FSH antigen-labelled I
125
 (iodination performed in house) was added to each sample, QC, 
standard, total binding and non-specific binding tube. The label was used at between 10,000 and 
12,000cpm. Tubes for non-specific binding (NSB) contained 450#l assay buffer with label, and total count 
(TC) tubes contained label only. Both were prepared in triplicate. The tubes were incubated at room 
temperature overnight. 
100#l of second antibody mixture was added to each tube (apart from TC), and the tubes were then left 
overnight at 4¡C once again. The second antibody solution consisted of donkey anti-rabbit serum (DARS) 
(SAPU anti-rabbit IgG 5022-220) at 1:80 and normal rabbit serum (NRS) (Sigma R4505) at 1:1600 in 
assay buffer. 500#l of assay buffer was added to each tube (apart from TC), and these tubes were 
centrifuged at 4¡C for 30 minutes at 3000RCF. The supernatant was then aspirated from the tubes (apart 
from TC), and the counts per minute were measured relative to the standard curve on a gamma counter.  
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LH radioimmunoassay 
Standards were set up using luteinizing hormone (NIDDK, USA oLH-I-4) in assay buffer (0.01M PBS, 
0.1% BSA and 0.1% sodium azide) at 0, 0.156, 0.31, 0.625, 1.25, 2.5, 5, 10, 20 and 40ng/ml. 
100#l of each standard or sample/QC was pipetted into LP4 plastic tubes in triplicate or duplicate 
respectively. A further 400#l of assay buffer was added to the tubes. 100ul of LH antibody (NIDDK, USA 
anti-oLH-1) at 1:420,000 in assay buffer was added to each sample, QC and standard tube. 100#l of LH 
antigen-labelled I
125
 (iodination performed in house) was added to each sample, QC, standard, total 
binding and non-specific binding tube. The label was used at approximately 10,000cpm. Tubes for non-
specific binding (NSB) contained 600#l assay buffer with label, and total count (TC) tubes contained label 
only. Both were prepared in triplicate. The tubes were incubated at room temperature overnight. 
200#l of second antibody mixture was added to each tube (apart from TC), and the tubes were then 
incubated overnight at 4¡C. The second antibody solution consisted of DARS at 1:80 and NRS at 1:400 in 
assay buffer. 500#l of assay buffer was added to each tube (apart from TC), and these tubes were 
centrifuged at 4¡C for 30 minutes at 3000RCF. The supernatant was then aspirated from the tubes (apart 
from TC), and the counts per minute were measured relative to the standard curve on a gamma counter.  
 
Androstenedione Plasma extraction 
Androstenedione was first extracted from the samples and QCs as outlined in 2.2.1. Radioimmunoassay 
was performed as previously described by Campbell et al. (1994). 
200#l extracted plasma sample or QC (low, medium and high) was pipetted into 75x12mm glass test 
tubes in duplicate, and 2ml hexane/diethyl (4:1) added. The tubes were then vortexed for 1 minute to 
allow mixing. The tubes were then placed into a bath of IMS and dry ice in order to freeze the plasma at 
the bottom of the tube. The solvent supernatant was then poured off into 75x10mm glass tubes, and then 
dried down using a heated sample concentrator. 100#l of PGel buffer was then added to each tube to 
resuspend the androstenedione. 
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Androstenedione Radioimmunoassay 
Standards were made up using androstenedione (Sigma A9630) in PGel buffer at 0, 0.039, 0.078, 0.156, 
0.31, 0.625, 1.25, 2.5, 5 and 10ng/ml. 200#l of each standard or sample/QC was pipetted into 75x10mm 
glass tubes in triplicate or duplicate respectively. 100ul of androstenedione antibody (ÔRabbit CÕ prepared 
in house) (1:15,000) was added to each sample, QC and standard tube. 100#l of androstenedione 
antigen-labelled I
125
 (Glasgow Royal Infirmary, Scotland) was added to each sample, QC, standard, total 
binding and non-specific binding tube. The label was used at between 10,000 and 12,000cpm. Tubes for 
non-specific binding (NSB) contained 200#l Pgel buffer with label, and total count (TC) tubes contained 
label only. Both were prepared in triplicate. The tubes were incubated at 4¡C overnight. 
250#l of second antibody mixture was added to each tube (apart from TC), and the tubes were then left 
overnight at 4¡C once again. The second antibody solution consisted of DARS at 1:80 in PGel, with NRS 
at 1:1600 in PGel. 250#l of Pgel buffer was added to each tube (apart from TC), and these tubes were 
centrifuged at 4¡C for 30 minutes at 3000RCF. The supernatant was then aspirated from the tubes (apart 
from TC), and the counts per minute were measured relative to the standard curve on a gamma counter.  
The intra-assay coefficient of variation was 9.1%, and inter-assay variation 10.6%. 
 
2.2.4. Reverse Transcriptase PCR 
2.2.4.1. mRNA extraction from somatic cells 
The cell lysates in RLT buffer with !-ME were first homogenized using QIAshredder columns (Qiagen 
79654). Briefly, the cell lysate was loaded onto the columns and centrifuged at 13,000rpm for 2 minutes, 
into a 2ml collection tube. This homogenized lysate was then used for mRNA extraction. 
The commercially available Qiagen RNeasy mini kit (Qiagen 74104) was used for mRNA preparation 
from the cell lysate, which uses a spin column containing RNA binding membrane. An equal volume of 
70% ethanol was added to the cell lysate before use, and then the mixture was loaded onto the RNeasy 
spin columns and centrifuged at 10,000rpm for 15 seconds. The flow-through was discarded and 350#l of 
buffer RW1 added to the columns. They were then centrifuged again at 10,000rpm for 15 seconds, and 
the flow-through discarded. At this point a DNase (Qiagen 79254) digestion step was used in order to 
remove unwanted DNA from the sample. The DNase for each column was prepared by adding 10#l of 
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DNase stock solution to 70#l RDD buffer supplied in the kit. 80#l of the DNase solution was added to 
each column and left at room temperature for 15 minutes. 350#l of RW1 buffer was added to the columns 
to remove the DNase, and then centrifuged at 10,000rpm for 15 seconds. The flow-through was 
discarded and 500#l RPE buffer added to each column, then centrifuged at 10,000rpm for 15 seconds. 
The flow-through was again discarded, and 500#l of RPE buffer was added to each column and 
centrifuged at 10,000rpm for 2 minutes. The columns were transferred to fresh 2ml collection tubes, and 
then centrifuged once more at 13,00rpm for 1 minute to remove all unwanted cell material. The columns 
were then transferred to 1.5ml Eppendorfs and 40#l RNase-free water (Qiagen 129112) added to elute 
the mRNA. The columns were centrifuged at 10,000rpm for 1 minute, and then the columns were 
discarded, leaving the mRNA in the RNase-free water. These tubes could then be stored at -80¡ for later 
analysis, or used straight away in the next step of the process; cDNA synthesis. 
 
2.2.4.2. cDNA synthesis 
cDNA was synthesised from mRNA by adding 11 #l of sample to 2#l random hexamer primers (Promega 
C1181). This was incubated at 70¡C for 5 minutes and then immediately held on ice for a minimum of 2 
minutes to stop the reaction. 7#l of mastermix was then added to make a 20#l reaction, and incubated 
first at 47¡C for 35 minutes, then 75¡C for 10 minutes. 
Mastermix was prepared using the following (per sample): 
5x first strand buffer (Invitrogen Y00146)    4#l 
0.1M DTT (Invitrogen Y00147)     1#l 
4dNTP mix (Invitrogen 10297-018)    1#l 
RiboLockª RNase inhibitor     0.5#l 
M-MLV reverse transcriptase (Invitrogen 28025-013)  0.5 #l 
cDNA samples were then stored at -20¡C for later PCR analysis. 
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2.2.4.3. Reverse-transcriptase PCR 
Mastermix was created using the following (per sample): 
SYBR Green (Applied Biosystems 4367659)   12.5#l 
Sense primer       0.5#l 
Antisense primer      0.5#l 
cDNA sample       2#l 
RNase-free water (Qiagen 129112)    9.5#l 
18S was used as a housekeeping gene, to be compared with the gene of interest (e.g. HIF-1!, VEGF, 
aromatase). Primers were diluted at 1:4 for 18S, 1:10 for HIF-1! and VEGF or 1:4 for aromatase. 
Samples were also diluted 1:10. 
The reaction conditions were as follows: 
Holding stage   95¡C for 10 minutes 
Cycling stage (x35)  95¡C for 20 seconds 
60¡C for 45 seconds 
72¡C for 1 minute 
 
2.3. Tissue processing and staining 
The ovine ovarian tissue collected from the immune-neutralisation study animals post-mortem was fixed 
in Bouins and prepared for histological staining by processing through a series of increasing 
concentrations of alcohol, followed by xylene and wax in an automated tissue processor (appendix 3). 
Serial 5#m sections were cut from the tissue blocks, and 2 sections mounted per slide (Superfrost
¨
 Plus; 
BDH Laboratory Supplies, Dorset, UK) and incubated overnight at 37¡C to allow adequate adhesion. 4 
slides were created from each tissue block, and each tissue block comprised of either a half or a third of 
an ovary, depending on its size. 
 
 51 
2.3.1. Hemotoxylin & eosin staining 
Follicle counts were performed on sections following haemotoxylin and eosin (H&E) staining (see 
appendix 3) according to a similar criteria to that defined by Lundy et al. (1999) (figure 2.1); 
" Primordial follicle Ð Single layer of flattened pre-granulosa cells 
" Transitional follicle Ð Single layer of granulosa cells with one or more with cuboidal structure 
" Primary follicle Ð Single layer of all cuboidal granulosa cells 
" Secondary follicle Ð Two layers of cuboidal granulosa cell layers with no antrum present 
" Preantral follicle Ð Three or more layers of cuboidal granulosa cell layers with no antrum present 
" Antral follicle Ð Multiple cuboidal granulosa cell layers with a visible antral cavity present 
 
Figure 2.1. H&E stained ovine (a) primordial and transitional follicles, (b) primary follicles, (c) small antral 
follicle and (d) large antral follicle wall.  
(Original magnification (a,b) x400; (c,d) x200) 
 
The tissue was initially mounted on slides using glycerine albumin to aid adhesion to the slide surface, 
followed by DPX (Sigma 44581). One slide was stained per ovarian section (2 or 3 per ovary), with 2 
tissue sections per slide. 
 
2.3.2. Aromatase immunohistochemistry 
Immunohistochemistry was used to detect aromatase expression on intermittent slices through the 
ovarian cortex using an automated staining machine (Leica BOND-MAXª, Milton Keynes, UK). Epitope 
retrieval was performed on the machine, before the Bond staining protocol was initiated (appendix 3). 
Homologous antibody for ovine aromatase is not commercially available, and so a monoclonal mouse 
a b c d 
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anti-human cytochrome P450 aromatase was used (MCA2077S, AbD Serotec, Oxford, UK). The Bond 
Polymer Refine Detection Kit (DS9800, Leica Microsystems, Milton Keynes, UK) was used in the 
machine, which included a 1 hour incubation with the antibody. This comprises of a peroxide block, post 
primary rabbit anti-mouse IgG linker, anti-rabbit poly-HRP-IgG, DAB (3,3Õ-Diaminobenzidine) chromogen 
and haematoxylin counterstain. The slides then undergo a dehydration process using alcohol and xylene, 
and are mounted with a coverslip using DPX mountant (Sigma 44581). 
 
2.4. Ultrasound 
For all of the phantom experiments used to study the efficacy of automated follicle measurement and 
counting, the bovine ovaries were obtained from the abattoir and assessed within two hours of collection 
in order to try and maintain blood vessel patency and restrict shrinkage. Bovine ovaries were selected for 
use in the phantom studies because of their morphological similarity to stimulated human ovaries; in 
particular, the dominant follicle in cattle grows to approximately 18-20mm, which is comparable in size to 
human stimulated ovarian follicles. 
For ultrasound scanning of bovine ovaries, a 5-9MHz transvaginal probe was used in combination with 
the Voluson E8 Expert ultrasound machine (GE Medical systems, Austria). This particular set-up is 
routinely used in the fertility clinic for ovarian assessment.  
Ultrasound gel was used on the surface of the tissue in order to ensure appropriate contact between the 
probe and the scanning surface, to avoid attenuation caused by air gaps. The ultrasound settings were 
kept constant for all scanning procedures, which was the default setting used in the department for 
patient examination. 
 
2.4.1. SonoAVCª 
The same analytical method for ovarian assessment was used for the bovine phantom studies as for 
human clinical use. The technique utilises SonoAVCª software application to a 3 dimensional dataset, 
which can be acquired at a time previous to analysis. 
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The first stage of the process of ovarian assessment using this technique is to load the dataset into the 
software. Then the ovary is then centered in all three planes of view so that the whole ovary is included in 
the analysis, but any outlying areas are excluded (see figure 2.2 below). 
 
Figure 2.2. 3D ultrasound scan image of bovine ovary with follicles visible as dark circular appearance 
The first step in the process is to prepare the image for SonoAVCª by centering the yellow box over the ovary, and 
sizing it to eliminate as much of the extraneous tissue as possible. 
 
The SonoAVCª software is then applied to the image and the follicle interior wall is drawn around in all 
three planes automatically, to form a 3D structure (figure 2.3). The software then measures each follicle in 
three dimensions and gives a mean value for the diameter (m-d), a volume (V), and a relaxed sphere 
diameter (d(V)) which is the diameter of the follicle calculated from the volume (measured in 3D pixels 
called voxels). The relaxed sphere diameter is generally used in clinical practice rather than the mean 
diameter. 
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Figure 2.3. Semi-automated SonoAVCª measurement of bovine ovarian follicles 
The software identifies hypoechoic regions and draws around the inner surface. Each follicle is assigned a different 
colour and its dimensions are displayed in the upper right hand corner. The diameter by volume [d(V)], mean 
diameter [m-d] from the dx, dy and dz planes, and volume [V] are given for each follicle detected by the software. 
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2.4.2. VOCAL power Doppler analysis 
VOCAL analysis is a technique commonly used for the assessment of blood flow in a target organ. In 
these experiments this target organ was the ovary. A bovine ovarian perfusion phantom was used to 
study the relevance of power Doppler analysis in VOCAL, and the same analytical technique was then 
used to assess blood flow around a target ovarian follicle in IVF patients for the purposes of the clinical 
trial. The only methodical differences were that the volume of interests analysed included the whole ovary 
or the selected follicle respectively. 
The computerised histogram facility in 4D View software was used for all power Doppler analyses (GE 
Medical Systems, Austria), whereby the scan is performed in 3D and the image stored on the computer to 
be analysed ÔofflineÕ. Figure 2.4 below shows the first stage of the process in whole ovary analysis.  
The user selects a volume of interest (VOI) using the Virtual Organ Computer-aided Analysis (VOCAL) 
tool (figure 2.4 below). 
 
 
Figure 2.4. A 3D ultrasound scan of a perfused bovine ovary in the VOCAL image analysis tool 
The 3D scan is able to be analysed in 3 planes; A, B and C in order to attain the most accurate outline of the target 
organ. The target of interest is drawn around in a series of 15 degree rotations (yellow dots on top left scan image), 
around a central point (red dashed line on top two images) until the whole organ is included in the selection. 
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Following the selection of the target organ by a series of manual drawing steps in 15¡ rotations, VOCAL 
measures the amount and intensity of the Power Doppler signal on the target volume of interest. The 
measured vascular indices are displayed as a histogram (Raine-Fenning et al., 2008b). The three indices 
calculated are vascularisation index (VI), flow index (FI), and the vascularisation flow index (VFI) (figure 
2.5). 
 
Figure 2.5. VOCAL analysis of Power Doppler blood flow in perfused bovine ovary  
The vascularisation index, flow index and vascularisation index are displayed in the Color Angio box in the top centre. 
The colour histograms are also displayed as graphs. 
 
 
Vascularisation index (VI) is based on the ratio of colour voxels to total voxels in the volume of interest, 
flow index (FI) is the mean power Doppler signal intensity for the defined volume, and the vascularisation 
flow index (VFI) is the multiplication of the VI and FI divided by 100. In order to measure peri-follicular 
blood flow around a selected follicle, a similar procedure was used for that of whole ovarian analysis. The 
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inner wall of the follicle was drawn around in the A plane, in order to select this as the volume of interest, 
in a series of 15¡ rotations (figure 2.6). 
 
 
Figure 2.6. The first stage of highlighting a follicular volume of interest in the human ovary, involving a series 
of 15¡ rotations around a central line of reference 
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The next stage of the process is to correctly align the selected area with the follicular wall, as this is 
required to be relatively accurate for a reliable analysis (figure 2.7).  
 
 
 
Figure 2.7. VOCAL contour selection adjustment in human ovarian assessment to achieve an accurate line 
trace around the interior follicle wall 
The contour is adjusted to perfectly align with the inner follicular wall. The volume of interest is displayed on the lower 
right as a 3D image. 
 
 
Once the line drawn correctly matches with the inner follicular wall, the contour is accepted, and the 
volume of the follicle displayed on the right hand side of the screen. A shell is then applied to the contour 
in order to analyse the area around the follicle for power Doppler signal. It was decided to use a 1mm 
shell around the follicle in order to include the entire relevant signal, but exclude signal from vessels of 
other follicles. In addition, an inner shell of 1mm was included because the nature of the power Doppler 
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signal means that the areas of flow present as spreading areas of colour that can infiltrate the inner 
follicle wall (figure 2.8). 
 
 
Figure 2.8. VOCAL shell application to human ovary for power Doppler analysis of peri-follicular blood flow 
A 2mm shell was applied across the contour so that an area of 1mm either side was included in the analysis. 
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Once the shell had been applied, this was selected as the volume of interest for the power Doppler 
analysis (figure 2.9), and the program could then measure the signal in this target area. 
 
 
 
Figure 2.9. VOCAL selection of power Doppler peri-follicular blood flow in a human ovary 
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Measurement of the selected follicle mean diameter was performed in 4D View by taking an average of 
the x and y measurements in the A plane, and the z measurement in the B plane (figure 2.10). These 
were taken at the largest points in each case. 
 
 
 
Figure 2.10. Human ovary mean follicular diameter measurement in 4D View 
The longest horizontal and vertical measurements are taken in the A and B plane, and displayed in the bottom right 
hand corner. 
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Chapter 3 Ð The Oocyte Effect on Granulosa Cells 
3.1. Introduction 
It is well established that the oocyte and somatic cells within the follicle share a close association from the 
beginning of folliculogenesis, and that this is a relationship that is critical in order to maintain normal 
development (Buccione et al., 1990). Oocyte-somatic cell communication is a bi-directional process, as 
the somatic cells produce vital nutrients and regulatory signals required by the oocyte to achieve 
developmental competence (Ka et al., 1997). In addition, the oocyte itself is known to play a key role in 
the developmental and functional regulation of the follicle, at every stage of folliculogenesis (Soyal et al., 
2000). It does this by secreting paracrine factors such as BMP15 and GDF9, which are thought to act 
synergistically to maintain the oocyte in a consistently optimal microenvironment for development, by 
regulating granulosa cell function (Moore and Shimasaki, 2005; Su et al., 2008). These oocyte-secreted 
factors act on the surrounding somatic cells, regulating a number of granulosa and cumulus cell functions. 
Most notably, the oocyte is thought to regulate proliferation and differentiation of granulosa cells before 
the LH surge (Gilchrist et al., 2003; Otsuka et al., 2005). 
In addition to factors secreted by the oocyte, granulosa cells are also subject to endocrine signalling by 
gonadotrophins such as follicle-stimulating hormone from the pituitary, which, as the name suggests, 
promotes follicular development in the follicular phase. In the early stages of folliculogenesis, follicles of 
250#m in diameter are responsive, but not dependant on gonadotrophin stimulation by FSH. As follicular 
development progresses the follicles enter a critical phase in which they become completely dependant 
on FSH for survival, from around 2-4mm in diameter in cattle, and 1-2mm in sheep (Campbell et al., 
1995; Webb et al., 1999a; Markstrom et al., 2002).  
 
The aim of this series of cell culture experiments was to investigate the effect of the oocyte and the 
factors it produces on granulosa cell proliferation and differentiation. An ovine model was chosen to base 
these experiments because of the similarities to the human in terms of certain aspects of reproductive 
physiology. In the first experiment aimed to investigate the effect of the cumulus-oocyte-complex on 
granulosa cells in vitro, and then to examine the additional effects of follicle-stimulating hormone on the 
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growth of granulosa cells from follicles at different stages of development in experiment 2. Finally, in 
experiment 3, the effect of oocyte-secreted factor supplementation on granulosa cells was explored. The 
effect on granulosa cell proliferation and differentiation was assessed. 
 
3.2. Materials and Methods 
3.2.1. Experiment 1 
Granulosa cells were harvested and cultured as previously described, according to the method developed 
by Campbell et al. (1996). Follicles of approximately 2-3mm in diameter were dissected from the ovaries 
for granulosa cell culture, and then COCs were collected by aspiration of the remaining ovaries using a 
19G needle and syringe. Only the highest grade oocytes collected were selected for culture. Granulosa 
cells were seeded at 75,000 per well. 
Follicles of other sizes were also dissected from the ovaries, and were individually hemisected in 
separate dishes of dPBS and the follicle shell snap frozen for storage at -80¡C. The follicular fluid in dPBS 
was snap frozen in Eppendorf tubes and stored at -20¡C. These were later used for angiogenic growth 
factor expression described in chapter 4. 
 
3.2.2. Experiment 2 
Ovine ovaries were collected from the abattoir follicles of all sizes were dissected. The follicles were then 
separated into 4 different size groups; <1mm, 1<2mm, 2<3.5mm and >3.5mm. Granulosa cells were 
harvested from the follicles as previously described, with the groups kept separate. COCs were also 
collected. 
Granulosa cells from the 4 follicle size groups were cultured for 192 hours as previously described, 
seeded at approximately 75,000 cells per well. Granulosa cells pooled from 1-3mm follicles were also 
cultured in wells with a COC in each well. In addition, COCs were cultured in individual wells at one per 
well with no additional cells. In addition, the culture medium (see appendix) was either supplemented with 
or without FSH (at 1ng/ml). 
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After 8 days, cell counts were performed, and oestradiol in the spent culture medium at 144 hours was 
measured by enzyme-linked immunosorbent assay (ELISA). This experiment was repeated a further two 
times. 
 
3.2.3. Experiment 3 
Ovine ovaries were collected from the abattoir and follicles of less than 3mm in diameter were dissected 
to harvest the granulosa cells using the method previously described. The cells were cultured for 192 
hours under the conditions also previously described, at 75,000 cells per well in a 96 well plate. 3 different 
doses of growth factor were added to the culture media, with 4 replications per treatment dose. BMP15 
and GDF9 were added to the media each at 1, 10 and 100ng/ml. After the first experiment it was decided 
to add additional intermediate doses of the combination of BMP15 and GDF9.  
The experiment was then repeated a further 3 times with these intermediate combination doses in order 
to investigate whether or not there was an additive effect of having 2 growth factors present. 
The BMP15, AMH and BMP6 used were all recombinant human (5096-BM, 1737-MS and 507-BP, R&D 
Systems Inc, USA), whereas GDF9 was recombinant mouse (739-G9, R&D Systems Inc, USA).  
The cells were plated according to table 3.1 below (COC+GC and GC control had no treatment added); 
BMP15 1ng/ml 1ng/ml 1ng/ml 10ng/ml 10ng/ml 10ng/ml 100ng/ml 100ng/ml 100ng/ml 
GDF9 1ng/ml 1ng/ml 1ng/ml 10ng/ml 10ng/ml 10ng/ml 100ng/ml 100ng/ml 100ng/ml 
AMH 1ng/ml 1ng/ml 1ng/ml 10ng/ml 10ng/ml 10ng/ml 100ng/ml 100ng/ml 100ng/ml 
BMP6 1ng/ml 1ng/ml 1ng/ml 10ng/ml 10ng/ml 10ng/ml 100ng/ml 100ng/ml 100ng/ml 
BMP15+GDF9 1ng/ml 1ng/ml 1ng/ml 10ng/ml 10ng/ml 10ng/ml 100ng/ml 100ng/ml 100ng/ml 
BMP15+GDF9 1ng/ml 1ng/ml 1ng/ml 5ng/ml 5ng/ml 5ng/ml 50ng/ml 50ng/ml 50ng/ml 
COC+GC NT NT NT NT NT NT NT NT NT 
GC control NT NT NT NT NT NT NT NT NT 
Table 3.1. 96 well plate format for TGF! dose response culture. NT=No treatment. n=4 for each dose, 
n=12 for granulosa cells with a COC in each well, for and granulosa cell control. 
 
The doses were selected in 10 fold increments from 1 to 100ng/ml in the culture medium. 100ng/ml was 
used as the highest dose because although higher doses had been used in other studies published in the 
literature (Spicer et al., 2006), this culture was of a significantly longer duration, and so treatment 
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differences were likely to be observed at these lower concentrations. In addition, it was thought unlikely 
that the growth factors would be present in the follicular fluid at concentrations as high as those used in 
other published studies, and so our cell culture model should, in theory, be more physiologically relevant. 
 
Oestradiol and progesterone were measured in the culture media take-off every 48 hours by ELISA. Cell 
numbers were estimated using neutral red staining as previously described. 
 
All results were analysed using ANOVA in SPSS (Version 15, SPSS Inc). Significance was set at P<0.05 
for all experimental analyses. Total cell numbers in experiment 1 were compared between the three 
groups; Granulosa cell control, Granulosa cells with a COC in each well, and individually cultured COCs. 
Within-group data from experiment 2 was analysed for effect of inclusion of FSH using t-testing in 
Microsoft Excel 2007, and comparison between the five treatment groups performed by ANOVA in SPSS. 
All data in experiment 3 was analysed using ANOVA in SPSS to investigate effect of dose response 
compared to the granulosa cell control. 
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3.3. Results 
3.3.1. Experiment 1 
The total cell numbers after 192 hours in culture can be seen in figure 3.2 below. The co-culture of a COC 
with the granulosa cells was observed to significantly increase cellular proliferation (P<0.05). 
 
Figure 3.1. Total cell number estimation of ovine granulosa, granulosa with COC, and COC alone, after 192 
hours in culture 
Error bars indicate SEM. (a = P<0.05 compared to COC, b = P<0.05 compared to GC control). n=14 for each group. 
 
 
3.3.2. Experiment 2 
The data shown in figures 3.2 to 3.4 is from the average across the 3 experimental repeats.  
The cell numbers after 8 days of culture were estimated by neutral red staining based on a standard 
curve. Overall, FSH had no significant effect on cellular proliferation, as cell numbers after 8 days were 
not different in the cell groups that had been cultured with FSH and the control groups. 
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Total granulosa cell number was retained in follicles 1-3.5mm to the end of culture, however cell numbers 
from follicles less than 1mm in diameter and greater than 3.5mm in diameter were significantly lower than 
those 1-3.5mm, and in fact, the total cell number at the end of the culture was lower than at the start. 
Cell numbers in the COC wells were significantly lower than the other treatment groups as would be 
expected, and the number of cells in this group was estimated to be around 10,000 per well. 
 
 
Figure 3.2. Mean total cell numbers after 192 hours in culture for granulosa cells from different sized follicles, 
with and without FSH 
Error bars indicate SEM. Different letters indicate significant difference in cell number across follicle sizes regardless 
of the presence of FSH (P<0.05). 
 
Although FSH did not significantly affect cellular proliferation in this series of experiments, the results 
across the size classes were analysed. Total cell number was significantly lower for granulosa cells 
originating from follicles <1mm diameter than all other size classes other than >3.5mm, as well as the GC 
+ COC group. The largest follicle group cell totals were also significantly lower than than those from 
follicles 1-2mm and 2-3.5mm diameter.  
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Oestradiol in the spent culture medium at 192 hours (after a previous 48 hour media change) was 
measured by ELISA. The presence of FSH in the culture medium increased oestradiol production, with 
the greatest effect seen in cells from the largest follicle group, and was significant in the presence of a 
COC (P<0.05) (see figure 3.3). 
 
 
Figure 3.3. Oestradiol production by granulosa cells originating from different follicle sizes after 192 hours in 
culture with or without FSH 
Error bars indicate SEM. * denotes P<0.05 FSH compared to absence of FSH. Different letters denote significant 
difference across follicle sizes regardless of the presence of FSH (P<0.05). 
 
Oestradiol production per 10,000 cells was calculated in order to determine whether the effects of FSH 
observed were due to increased oestradiol production or as a result of increased cell numbers.  
As seen in figure 3.4, oestradiol production per cell was highest in the large follicle group (P<0.05). There 
was no significant difference in oestradiol production per cell observed between the <1mm, 1-2mm and 2-
3.5mm follicle size groups. Oestradiol production per cell was highest in the wells in which a COC was 
cultured alone (P<0.01). 
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Figure 3.4. Oestradiol production per 10,000 granulosa cells, originating from different sized follicles, after 
192 hours in culture with or without FSH 
Error bars indicate SEM. *denotes P<0.05 compared to absence of FSH. Different letters denote significant difference 
across follicle sizes regardless of the presence of FSH (P<0.05). 
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3.3.3. Experiment 3 
The oestradiol (E2) production results across the 4 media change timepoints are shown in figures 3.5 to 
3.8 below.  
 
 
Figure 3.5. Ovine granulosa cell oestradiol production in media after 48 hours in culture 
Error bars indicate SEM. *P<0.05; **P<0.01, compared to the granulosa cell control in both graphs. 
 
Figure 3.6. Ovine granulosa cell oestradiol production in media after 96 hours in culture 
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Figure 3.7. Ovine granulosa cell oestradiol production in media after 144 hours in culture 
Error bars indicate SEM. *P<0.05; **P<0.01, compared to the granulosa cell control in both graphs. 
 
Figure 3.8. Ovine granulosa cell oestradiol production in media after 192 hours in culture 
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Oestradiol production was significantly increased following treatment using a combination of BMP15 and 
GDF9 in a dose-dependent manner from 96 hours in culture onwards. The most marked effects were 
observed at 144 and 192 hours of the culture. 
BMP6 also increased granulosa cell oestradiol production in a dose-dependant manner, as did the 
presence of a COC in culture. Conversely, high dose BMP15, GDF9 and AMH appeared to decrease 
oestradiol production at 96 hours of culture. 
 
Progesterone in the culture media was also measured every 48 hours following media change. The 
results of the progesterone ELISA can be seen in figures 3.9 to 3.12 below.  
 
 
Figure 3.9. Ovine granulosa cell progesterone production in media after 48 hours in culture 
Error bars indicate SEM. *P<0.05; **P<0.01, compared to the granulosa cell control. 
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Figure 3.10. Ovine granulosa cell progesterone production in media after 96 hours in culture 
Error bars indicate SEM. *P<0.05; **P<0.01, compared to the granulosa cell control. 
 
 
Figure 3.11. Ovine granulosa cell progesterone production in media after 144 hours in culture 
Error bars indicate SEM. *P<0.05; **P<0.01, compared to the granulosa cell control. 
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Figure 3.12. Ovine granulosa cell progesterone production in media after 192 hours in culture 
Error bars indicate SEM. *P<0.05; **P<0.01, compared to the granulosa cell control. 
 
 
Progesterone production was significantly decreased by both BMP6 and the BMP15/GDF9 combination 
treatments (P<0.01) after 96 and 144 hours respectively. Conversely, GDF9 and AMH appeared to 
increase progesterone production at the highest doses at 96 and 144 hours of culture. 
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The oestradiol and progesterone production per cell was calculated based on the neutral red estimation 
of cell numbers at the end of the culture (see figures 3.13, 3.14 and 3.15).  
 
Figure 3.13. Ovine granulosa cell neutral red cell number estimation after 192 hours in culture 
Error bars indicate SEM. *P<0.05; **P<0.01, compared to the granulosa cell control. 
 
 
Figure 3.14. Ovine granulosa cell oestradiol production per 10,000 cells after 192h in culture 
Error bars indicate SEM. *P<0.05; **P<0.01, compared to the granulosa cell control. 
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Figure 3.15. Ovine granulosa cell progesterone production per 10,000 cells after 192h in culture 
Error bars indicate SEM. *P<0.05; **P<0.01, compared to the granulosa cell control. 
 
 
Overall it seemed that addition of the various growth factors or a COC did not have a marked effect on 
cellular proliferation, although cells cultured with the combination dose of BMP15 and GDF9 were 
significantly greater in number than the control cells cultured alone (P<0.01). 
Oestradiol production per cell was significantly increased by both BMP6 and the combination of 
BMP15/GDF9, in a dose-dependant manner (P<0.01). These two factors also significantly decreased 
progesterone production (P<0.01). The addition of a COC to the granulosa cells had the same effect on 
progesterone, although the effect was more subtle than addition of BMP6 and BMP15/GDF9 factors 
(P<0.05). 
 
In a separate culture, mRNA aromatase expression was measured by PCR after 144 hours in culture, as 
this was the peak of oestradiol production measured in the culture medium. The treatment doses were 
50ng/ml for each factor, and as before, a COC was included as an additional treatment. Figure 3.16 
below shows aromatase expression by the granulosa cells at 144 hours, which indicates expression 
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significantly higher with a 50ng/ml combination dose of BMP15 and GDF9 (P<0.05). Aromatase 
expression was also higher in the GDF9 and COC treatment groups, however this was not statistically 
significant. 
 
 
Figure 3.16. Ovine granulosa cell aromatase expression at 144 hours in culture  
(Combo50 = Combination dose of BMP15 and GDF9 at 50ng/ml). *P<0.05 relative to control. 
 
 
3.4. Discussion 
This study showed that co-culture of COC or exposure to oocyte-secreted factors had a marked effect on 
granulosa cell proliferation and differentiation, supporting the hypothesis that oocyte is likely to be a key 
player in regulating follicular development by directly influencing the cells that surround it. Overall, the 
results of this study have indicated a role for the COC in promoting granulosa cell proliferation, and that 
factors it secretes act together as powerful promotors of granulosa cell oestradiol production, and 
suppressors of progesterone production. As such they may have a role in the prevention of follicular 
luteinisation. 
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The results from experiment 1 show that granulosa cell proliferation is significantly increased in the 
presence of a COC (P<0.01). This is likely to be as a result of oocyte-secreted factors, such as BMP15 
and GDF9, acting on the granulosa cells to increase proliferation, a result also observed by McNatty et al. 
(2005a). Numerous previous studies have found oocytes to increase granulosa cell proliferation in a 
number of species (reviewed in Gilchrist et al., 2008); using murine, porcine and bovine oocytes (Gilchrist 
et al., 2006; Hickey et al., 2005; Gilchrist et al., 2003). Notably, in the bovine model it seems that IGF-I is 
a requirement for this to occur (Gilchrist et al., 2003), which was a constituent of the culture medium used 
in this experiment. 
Although neutral red staining indicated relatively large numbers of cells present in the COC-only wells, 
this was likely to be partly as a result of the size of the cell, as the oocyte would take more of the staining 
media than a single granulosa cell, and therefore the actual number of cells present would be a great deal 
lower than estimated in these wells. However, when in culture the cumulus cells can frequently be seen to 
gradually detach from the oocyte itself, and differentiate to form monolayers that are similar in 
appearance to the mural granulosa cells in culture. Consequently, these cells may also behave like mural 
granulosa cells in culture, and so can proliferate and synthesise steroid hormones. This contrasts  the 
frequently observed lack of proliferation in in vitro maturation, where the cumulus cells mucify in response 
to the gonadotrophin ovulation stimulus (Vanderhyden et al., 1990; Zhuo and Kimata, 2001). When inside 
the follicle, there must be factors, which may or may not include BMP15, GDF9 and BMP6 that maintain 
these cumulus cells attached to the oocyte, and once in culture, these factors are not present any longer 
and so the cells desert the oocyte and begin to behave like mural granulosa cells. 
 
FSH supplementation attenuated granulosa cell proliferation, but increased oestradiol production, as 
previously seen in ovine granulosa cell cultures by Campbell et al. (1996) and bovine granulosa cultures 
by Gutierrez et al. (1997). Follicles of 1-3.5mm exhibited the greatest cellular proliferation, which is 
consistent with granulosa cell gonadotrophin dependence commencing at around 2-3mm diameter 
(Scaramuzzi et al., 1993). A fall in proliferation was observed in the largest follicle size group, a result 
which not seen in the 3
rd
 experimental repeat. This is one of the reasons for the relatively large error bars. 
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The larger follicles were found to produce more oestradiol, an expected result as these follicles become 
increasingly gonadotrophin-dependant from around 1-2mm onwards (Webb et al., 1999a) and become 
highly oestrogenic once they reach 3.5mm in diameter (McNeilly et al., 1991). The presence of a COC 
appeared to increase cellular proliferation, a result supported by McNatty et al. (2005a), but did not have 
a major effect on steroidogenesis, although levels were slightly elevated. It is thought that certain oocyte-
secreted factors, such as BMP6, may increase oestradiol production (Campbell et al., 2009), and others, 
such as BMP15 and GDF9, could have divergent effects on oestradiol production (Knight and Glister, 
2006), therefore these factors may balance in such a way that overall oestradiol production by the 
granulosa cells was unaffected. Alternatively, the addition of one COC in culture may not have induced a 
large enough response in the granulosa cells to be measured, and it it thought that the ability of the COC 
to secrete oocyte-secreted factors in vitro may actually decline over time (Sfontouris and Campbell, 
unpublished observations). 
The media taken from the cultured COCs had relatively high concentrations of oestradiol, which would not 
be expected as there were relatively few cells attached to the oocytes. However, it was observed that in 
culture the oocyte would separate from the surrounding cumulus cells, and these cells would then visibly 
change in appearance from a spherical form to a more flattened one, spreading across the plate surface. 
It is therefore likely that these cumulus cells were differentiating, and hence increasing in steroidogenic 
capacity, explaining the marked increase in oestradiol production. 
 
BMP6 and the combination of BMP15 and GDF9 had a significant effect on both oestradiol and 
progesterone production, without affecting cellular proliferation to any great degree, as measured in both 
the media, and on a per cell basis. These factors significantly increased oestradiol production in a dose-
dependant manner, and also decreased progesterone production, although this was not seen to be dose-
dependant. Aromatase expression was also significantly increased with treatment of BMP15 and GDF9 in 
combination (figure 3.16) further confirming the upregulation of oestradiol production. This promotion of 
oestradiol production was found to mimic the addition of a COC to the culture, which also significantly 
increased oestradiol production, at the later stages of culture. AMH appeared to have a converse effect 
on steroidogenesis, suppressing oestradiol production and promoting progesterone production.  
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Steroidogenesis 
Overall, BMP15, GDF9 and AMH alone did not appear to have a major effect on steroidogenesis, 
although at 96 hours these factors did significantly suppress oestradiol production at the highest dose. 
GDF9 and AMH significantly increased progesterone production, also at 96 hours as well as at 144 hours 
for AMH. This result was then not observed for the remainder of the cultures, and did not occur when 
calculating steroid production on a per cell basis, which suggests that at 96 hours these factors may have 
become temporarily toxic to the cells at these increased levels. 
The presence of a COC significantly increased oestradiol production at 48, 144 and 192 hours, which is 
consistent with the oocyte-secreted factors BMP6, BMP15 and GDF9 also increasing granulosa cell 
oestradiol production. However, no effect of addition of a COC on progesterone was observed. 
 
The current literature regarding the effects of BMP15 and GDF9 in vitro is conflicting due to discrepancies 
between species of culture model, origin and dose of oocyte-secreted factor, and culture methodology, 
and as a result the true role of these factors is still unclear. In comparison to GDF9, there have been 
relatively few studies published on the effects of BMP15 in vitro with reference to steroidogenesis. 
McNatty et al. found ovine BMP15 to decrease progesterone production in bovine granulosa cells (2005a) 
and rat granulosa cells (McNatty et al., 2005b), but not ovine cells. However, doses of just 4ng/ml and 
8ng/ml were used, and so it is unclear as to what the effect at higher doses such as those used in our 
experiments would be in comparison. 
Otsuka et al. (2000) observed that hBMP15 depressed progesterone production by rat granulosa cells, 
and therefore suggested a role for BMP15 in the prevention of premature luteinisation. The fact that in our 
experiments oestradiol production was increased and progesterone decreased by treatment with BMP15 
and GDF9 suggests a likely synergistic role to this effect, thereby inhibiting premature luteinisation and 
promoting further follicular development. The combination of these two factors had a much larger effect 
than either one alone, which indicates increased bioactivity, possibly resulting from their 
heterodimerization, which has been previously demonstrated in vitro using an ovine cell culture model 
(Liao et al., 2003), and also in vivo using a mouse model (McIntosh et al., 2008). 
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Spicer et al. (2006) found that in bovine granulosa cells from follicles of all sizes, treatment with high 
doses (150-600ng/ml) of rat GDF9 significantly decrease both progesterone and oestradiol production. 
However, this study had several key differences to our own, making comparison relatively difficult. The 
culture system used had several major differences to ours, in that the granulosa cells were collected for 
culture by aspiration, were then cultured for 24 hours with serum, and then transferred to serum-free 
media for 48 hours of treatment. By the authorsÕ own admission, the exposure of the cells to serum may 
caused partial luteinization, and therefore the luteal activity of these cells may have affected the results. 
Discrepancies between methodologies such as these could explain the differences in conclusions drawn 
from in vitro cell cultures such in this case. 
 
Interestingly, BMP6 treatment significantly increased oestradiol production in a dose-dependent manner, 
and decreased progesterone production across all doses, without affecting cellular proliferation (figures 
3.13, 3,14 and 3.15). This result suggests that BMP6 mimics the effects seen with BMP15 and GDF9 
effect on oestradiol production, albeit in a more subtle manner. Also BMP6 significantly suppressed 
progesterone production similar to the effects of the combination treatment, and had no significant 
proliferative effect. This result supports findings of the study by Campbell et al. (2006), which showed 
BMP6 to be a potent promoter of FSH-induced ovine granulosa cell oestradiol production, without 
affecting proliferation. In this study it was also noted that progesterone production was suppressed 
(Campbell, unpublished observations). The results are also similar to those found by Glister et al. (2004), 
who used a bovine in vitro model to demonstrate that BMP6 enhanced oestradiol production while 
modulating secretion of progesterone, although in this study a small but significant increase in cell 
proliferation was observed. It is important to note, however, that FSH was not included in these cell 
cultures, and as a result our experiments are unfortunately not completely comparable. 
There seems to be marked differences in the actions of BMP6 in different species. For example, Otsuka 
et al. (2001) found that recombinant human BMP6 had no effect on oestradiol production, although a 
decrease in FSH-induced progesterone production in rat granulosa cells was observed, without any effect 
on cellular proliferation. This response was also observed in a study conducted by Miyoshi et al. (2007), 
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again using rat granulosa cells. In a study conducted by Juengel et al. (2006), recombinant human BMP6 
had a suppressive effect on progesterone production by ovine granulosa cells, again without affecting 
cellular proliferation. However, in this study rat granulosa cell progesterone production was again 
decreased, but proliferation was increased, again highlighting species differences.  
It therefore seems that in a number of species, although BMP6 may have different effects on proliferation 
and oestradiol production, in most cases granulosa cell progesterone production is decreased. This may 
suggest a universal key role as a premature luteinization-inhibitor for dominant follicles (Otsuka et al., 
2001; Juengel et al., 2006), which is likely to be based on the involvement of somatic cell sensitivity to 
gonadotrophins (Campbell et al., 2009). 
Notably, the addition of a cumulus-oocyte complex (COC) to granulosa cells increased oestradiol 
production, indicating that the oocyte-secreted factors used in this experiment are likely to have the same 
effects as those induced by a COC.  
 
Treatment of the granulosa cells with AMH had no significant effect on steroidogenesis or proliferation in 
this study, although a slight dose-dependant depression was observed. Little research has been carried 
out in this particular area, however Seifer et al. (1993) implicated AMH as a potential inhibitor of 
granulosa cell mitosis after observing a difference in intrafollicular AMH concentrations in relation to 
granulosa cell proliferation, with 2 different ovarian stimulation regimes.  
AMH is produced by the granulosa cells themselves right through to the preovulatory stage in sheep 
(Durlinger et al., 2002), and so it is likely that higher doses would be needed to induce a response by the 
cells, which would be expected to result in a decreased responsiveness to FSH, and hence a depression 
in proliferation and oestradiol production. In fact, the most noticeable effect would have been observed in 
theca cells, which would serve as a further avenue of research following these experiments. 
 
Cellular proliferation 
Cellular proliferation was unaffected by any of the treatments used in this study, apart from an increase at 
some of the higher combination doses of BMP15/GDF9 (figure 3.13). This result was also observed by 
McNatty et al. (2005a), as this study found the combination of mGDF9 with oBMP15 to increase ovine 
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granulosa cell proliferation as measured by 
3
H-thymidine incorporation, although a much higher dose of 
mGDF9 was used. However, in contrast to our study, this study also found that mGDF9 alone had a small 
but significant effect of decreasing cellular proliferation, although notably the doses were more than 10-
fold higher than those used in our study. This is in contrast to the rat model, in which mGDF9 increases 
cellular proliferation (Vitt et al., 2000), further indicating species-specific roles for these factors. 
Interestingly, McNatty et al. observed a promotional effect of oBMP15 on proliferation when used alone, 
which was not seen in our study. However again this may simply further highlight species-specific 
interactions of BMP15. Spicer et al. (2006) also found that GDF9 increased cellular proliferation in vitro, 
however the study used rat GDF9 and bovine granulosa cells, which makes the drawing of comparative 
conclusions somewhat difficult.  
 
It would be interesting to expand and develop this study to utilise ovine sources of BMP15 and GDF9 with 
ovine granulosa cells, as this would elucidate the differences between the effects of the origin of the 
factors and clarify their roles in this particular species, which could be attributed to the mono versus 
polyovulatory nature of the species in question (Galloway et al., 2000). This was not performed in the first 
instance because of the difficulties in obtaining ovine BMP15 and GDF9. 
If indeed the oocyte-secreted factors BMP15 and GDF9 form highly bioactive heterodimers in vivo, and 
play such a key role in the prevention of premature luteinisation through regulation of steroidogenesis, 
this brings major implications for the role of the oocyte in the hypothalamic-gonadal axis that have not 
been previously considered (Paulini and Melo, 2011). In fact, it may be possible that the single female 
gametocyte contained within a follicle of an ovary can at the very least dictate the outcome of its own 
development, and perhaps even as far as being a key player in regulating the entire follicular cycle. 
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Chapter 4 Ð Hypoxia and Angiogenesis in the Ovarian 
Follicle 
4.1. Introduction 
In hypoxic conditions, cell metabolism is considerably reduced, as oxygen availability is decreased. Under 
these conditions the transcription factor HIF-1! is stable, thereby inducing expression of angiogenic 
growth factors such as VEGF. When oxygen supply is adequate once again, following the formation of 
new blood vessels, the then adequate supply of oxygen causes destabilisation of the !-subunit of HIF-1, 
which suppresses its activity (Neeman et al., 2007). 
An alternative method for inducing hypoxia in cell cultures is to use chemical agents, such as cobalt 
chloride and sodium azide. Cobalt chloride is used widely in cell cultures for this purpose, as HIF-1! 
levels increase as degradation is prevented. The only drawbacks to these chemicals is that they are toxic 
and so have to be used in strictly controlled quantities in order for them to be used effectively (Semenza 
et al., 1994). 
 
HIF-1 is a heterodimeric transcription factor of particular importance in angiogenesis, as it regulates and 
maintains expression of a number of factors involved in the process. It is of primary importance in the 
induction of gene expression of angiogenic and metabolic growth factors that allow cellular adaption and 
survival in a continuously changing environment (Semenza, 1998). The patterns of HIF-1 expression 
during the development of the follicle have not yet been explained. It seems likely that as the follicle 
develops, HIF-1 expression should increase as the metabolic needs of the follicle increase, however this 
is difficult to demonstrate as it is thought that follicles approaching or undergoing atresia exhibit different 
genetic expression patterns. As a result, in this experiment the follicular fluids were collected in order to 
perform hormone analyses to help indicate the health status of the follicle from which the cells were 
obtained. It is well established that dominant follicles have increased oestradiol concentrations in the 
follicular fluid (Fortune et al., 2001; Ryan et al., 2007), due to an elevated steroid hormone synthetic 
ability, and steroid hormone profiles have been used as indicators of follicular health. However, this must 
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be done with the consideration in mind that these hormone concentrations change with growth and 
development, in addition to atresia (Rodgers and Irving-Rodgers, 2010). 
 
Aims: 
" To investigate the effect of hypoxic conditions on ovine granulosa cell steroidogenesis in culture, 
using different volumes of culture medium to mimic hypoxic conditions. 
" To investigate the effects of induced hypoxia on ovine granulosa cell steroid hormone production and 
the expression of factors relating to angiogenic mechanisms, using both physiological and chemical 
methods. 
" To measure HIF-1! expression in ovine follicle shells by real-time PCR to compare expression levels 
with follicle size, follicular fluid hormone concentrations and angiogenic growth factor expression. 
 
 
 
4.2. Materials and Methods 
4.2.1. Experiment 1 
Follicles of all sizes were dissected from ovine ovaries collected from the abattoir and their granulosa 
cells harvested as previously described. A 48 well plate was seeded with 220,000 cells/well, with half the 
wells containing 0.5ml of media (with or without 1ng/ml FSH), and the other half containing 1.25ml of 
media (with or without 1ng/ml FSH) to simulate hypoxic conditions. The cells were cultured using the 
same method as in chapter 3. Culture medium was changed every 48 hours, and oestradiol in the culture 
medium was measured by ELISA. 
Statistical comparison of oestradiol production in the two media volume groups, and the inclusion or 
exclusion of FSH at each timepoint, was performed by ANOVA in Genstat (Version 12.0, VSNi). 
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4.2.2. Experiment 2 
Declaration: This experiment was performed alongside Dr Peter Marsters and Maria Fakiridou for MariaÕs 
Masters thesis. As a result, I did not perform the transfections and gene analyses myself. 
Three types of culture were set up as follows; 
 
1. High and low density cultures 
Granulosa cells were seeded in 24-well plates at 2 different densities; 1x10
6
 cells/well (HD) and 1x10
5
 
cells/well as a control (LD). In addition, two further groups of cells were formed; one was cultured with the 
addition of 250#M cobalt chloride (LDCC) to the media, and the other cultured with the addition of 10#M 
sodium azide (LDSA), to mimic hypoxic conditions. The cells were harvested after 66 hours and used for 
gene expression analysis by real-time PCR for HIF-1! and VEGF.  
 
2. Density gradient cultures 
Granulosa cells were seeded in 24-well plates at 4 different densities; 1x10
5
 cells/well, 2.5x10
5
 cells/well, 
5x10
5
 cells/well and 1x10
6
 cells/well. The cells were harvested after 66 hours. Culture medium was 
collected and the oestradiol and progesterone content measured by ELISA. 
 
3. Time course cultures with HRE transfections 
Granulosa cells were seeded in 24-well plates at 2.5x10
5
 cells/well. Half of the cells were transfected with 
hypoxia responsive element-luciferase with Tfx-50ª (Cignal HIF Reporter Assay Kit, Tebu-Bio, UK) after 
24 hours. Following this, untransfected and transfected cells were split into three groups; one group 
cultured in the presence of 250#M cobalt chloride, one cultured in the presence of 10#M sodium azide, 
and the other left untreated. Cells were left for 24 hours to settle, and then harvested at 24 hour intervals 
for gene expression analysis; 24, 48 and 72 hours after cobalt chloride addition. Cells were then lysed 
and analysed by luminometer to measure HRE activation. 
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Statistical analysis was performed by ANOVA using Genstat (Version 12, VSNi), to compare differences 
between each of the treatment groups for each timepoint. 
 
 
4.2.3. Experiment 3 
Ovine follicles of various sizes from abattoir ovaries were dissected and hemisected individually in dPBS. 
The individual follicle shells were crushed in liquid nitrogen using a pestle and mortar. They were then put 
into lysis buffer and allowed to dissolve. mRNA was extracted from the lysed cell suspension using QIA 
Shredder (Qiagen 79654) columns followed by RNA mini spin columns (Qiagen RNeasy Mini kit 74104). 
Any excess DNA was digested on the columns using RNase-free DNase (Qiagen 79254). mRNA was 
eluted from the columns using RNase-free water. 
 
Following cDNA synthesis, reverse transcriptase PCR was performed in triplicate (see methods section 
for details), in order to quantify the relative expression of HIF in each follicle. A medium sized follicle 
(follicle no.12) was chosen as a calibrator, in order to compare expression levels in the other follicles. 
The follicular fluid from the follicles was individually collected in order to compare steroid hormone 
concentrations to the results from PCR. 
 
Data was analysed by linear regression using GraphPad Prism (Version 5.0) with significance set at 
P<0.05. 
 
 
4.3. Results 
4.3.1. Experiment 1 
Oestradiol production was significantly lower in the high level medium wells across all timepoints 
(P<0.01), and in the normal medium level wells, FSH significantly increased oestradiol production at the 
later 2 timepoints (P<0.05) (figure 4.1). However, when the oestradiol concentrations were corrected for 
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total well media volume, there was found to be no significant difference in oestradiol production between 
the high and normal medium, and presence or absence of FSH. 
 
 
Figure 4.1. Oestradiol production per 48 hours by ovine granulosa cells over a course of 4 timepoints, in the 
presence of normal or high levels of media, with or without FSH 
(Error bars indicate SEM) 
 
4.3.2. Experiment 2 
The results from culture 1 can be seen in figure 4.2 below. Gene expression is shown relative to cells 
cultured at low density. HIF-1! expression was significantly increased in the high cell density group 
(P<0.001) by 2-3 fold, however cobalt chloride and sodium azide had no significant effect on HIF-1!. 
 
VEGF expression was 3-4 fold higher in the high cell density group than in the low density and sodium 
azide-treated groups (P<0.001), and VEGF expression was significantly higher in the cobalt chloride 
group than in all 3 of the other groups (P<0.001). 
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Figure 4.2. Culture 1 ovine granulosa cell (a) HIF-1" expression and (b) VEGF expression relative to low 
density control  
(Groups with the same superscript are not significantly different; groups with different superscripts are significantly 
different) 
 
 
The second culture results are shown in figure 4.3. The rate of oestradiol production/million cells/hour 
decreased markedly as cell density increased (P<0.001), although a significant difference was not 
observed between the two higher cell density groups. There was no significant difference in oestradiol 
production with addition of cobalt chloride. 
 
The rate of progesterone production also decreased significantly as cell density increased (P<0.001), 
although the rate observed in the 2.5x10
5
 group was slightly lower than expected and as a result did not 
follow this trend. Cobalt chloride addition significantly reduced progesterone production by the cells 
across all of the groups (P<0.001). 
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Figure 4.3. Culture 2 ovine granulosa cell (a) oestradiol and (b) progesterone production by cells seeded at 
different densities and cultures with or without cobalt chloride  
(Groups with the same superscript are not significantly different, groups with different superscripts are significantly 
different) 
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The results of culture 3 are shown in figure 4.4. The oestradiol production graph (a) shows that in the 
control group (no treatment, untransfected), oestradiol production rate increases significantly over time 
(P<0.001). Treatment with cobalt chloride on untransfected cells resulted in an initial decrease, then a 
significant increase (P<0.001) in oestradiol production rate after 48 hours of treatment. Following this, a 
significant depression in production rate was observed (P<0.001). Unexpectedly, transfection significantly 
depressed oestradiol production rate during the first 24 hours in both the treated and untreated groups 
(P<0.001), which remained unchanged for the later timepoints also. 
As would be expected, progesterone production rate increased significantly in the control group (P<0.001) 
(no treatment, untransfected), however the rate of production fell significantly after 96 hours in culture 
(P<0.001). The untreated transfected group exhibited a steady increase in progesterone production rate 
across the timepoints (P<0.001), but this was lower than the control group. Cobalt chloride significantly 
decreased progesterone production rate in both transfected and untransfected cells, although there was a 
small increase in production rate in the untransfected cell group at 72 hours of culture, which was 
significant (P<0.001). 
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Figure 4.4. Culture 3 rate of ovine granulosa cell (a) oestradiol and (b) progesterone production in 
transfected and untransfected cells with or without cobalt chloride.  
The x axes are numbered as the hours after the treatment (with/without cobalt chloride), numbers in brackets indicate 
total time in culture. 
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4.3.3. Experiment 3 
Table 4.1 below shows the quantities of mRNA and cDNA, as well as HIF-1! expression and follicular 
fluid oestradiol concentration in relation to follicular size. 
Follicle no. Size (Grat. Units) Size (mm) mRNA (ng/!l) cDNA (ng/!l) HIF-1" RQ E2 concentration 
(ng/ml) 
23 21 1.7 60.5 388.9 1.2075 20.31 
28 21 1.7 26.5 371.3 0.3984 20.95 
18 22 1.8 49.6 384.5 1.5317 20.52 
24 23 1.9 56.4 387.9 2.8469 14.89 
27 24 1.9 49.1 382.2 0.2797 10.43 
17 25 2.0 22.9 373.4 0.7162 12.77 
15 28 2.3 29.9 379.0 0.5659 11.64 
26 28 2.3 42.2 368.2 0.5466 7.20 
13 30 2.4 10.5 300.3 0.3291 6.24 
14 30 2.4 32.7 312.5 0.8677 8.79 
16 31 2.5 40.4 380.6 0.3714 12.07 
21 31 2.5 169.9 474.1 0.8816 9.30 
25 31 2.5 142.8 442.9 1.1272 5.47 
12* 35 2.8 104.5 376.0 1 6.52 
19 35 2.8 40.4 376.0 0.3635 8.04 
20 35 2.8 74.9 402.2 0.938 6.24 
22 39 3.2 69.0 394.7 0.3585 4.78 
10 50 4.0 90.0 344.0 1.1985 7.49 
11 55 4.4 79.0 356.0 0.6721 3.11 
7 62 5.0 185.9 420.6 2.443 57.64 
8 63 5.1 117.0 363.9 2.1628 40.31 
1 66 5.3 33.7 352.9 1.9044 32.77 
5 66 5.3 79.5 354.2 0.4698 1.50 
9 69 5.6 219.0 437.8 0.5978 2.55 
2 70 5.7 274.0 487.6 1.3921 72.93 
4 75 6.1 50.3 336.0 0.9214 43.02 
3 85 6.9 163.5 415.5 0.6967 44.67 
6 85 6.9 95.3 360.3 0.5434 8.87 
 
Table 4.1. HIF-1! expression and follicular oestradiol concentration for a range of follicle sizes. 
(*reference sample 12) 
 
Granulosa cell mRNA expression of HIF-1! had a significantly positive relationship to follicle size 
(P<0.01), with Pearsons correlation coefficient of 0.11 and coefficient of determination of 0.0122 (figure 
4.5). 
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Figure 4.5. Ovine granulosa cell HIF-1" expression against follicular size 
 
Follicular fluid oestradiol was significantly positively correlated to follicular size (P<0.01), with a Pearsons 
correlation coefficient of 0.47 and coefficient of determination of 0.22 (figure 4.6). 
 
 
Figure 4.6. Ovine follicular fluid oestradiol concentration against follicle size 
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Oestradiol concentration in the follicular fluid was found to be significantly positively correlated to HIF-1! 
mRNA expression (P<0.001), with Pearsons correlation coefficient of 0.51 and coefficient of 
determination of 0.26 (figure 4.7). 
 
 
Figure 4.7. Ovine follicular fluid oestradiol concentration against granulosa cell HIF-1" expression 
 
The follicles were grouped into oestrogenic and non-oestrogenic, based on an intrafollicular oestradiol 
concentration threshold of 10ng/ml. T-testing in SPSS revealed that HIF-1α expression was significantly 
higher in granulosa cell originating from follicles with an intrafollicular oestradiol concentration greater 
than 10ng/ml (figure 4.8). 
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Figure 4.8. Ovine granulosa cell HIF-1α expression for follicles with low and high levels of oestradiol in 
the follicular fluid 
Error bars denote SEM 
 
 
4.4. Discussion 
Unfortunately culture 1 was unable to demonstrate an effect of inducing a hypoxic state by using an 
increased depth of culture media for cell culture, and therefore the consequent cultures to study hypoxia 
were not performed based on this methodology. There was found to be no significant difference in 
oestradiol production between the normal and high media volumes. Furthermore, presence or absence of 
FSH in this experiment had no significant effect. 
Increased cell seeding density was successful in inducing hypoxic conditions in in vitro culture. It was 
observed that at a much higher density, the granulosa cells formed clumps, which seem to make oxygen 
availability to the cells fairly limited. As a result, an increase in HIF-1! expression was observed at this 
very high cell density, which in turn upregulated VEGF expression by the cells in an attempt to increase 
thecal vascularisation and hence increase oxygen tension.  
The artificial hypoxia-mimicking chemicals sodium azide and cobalt chloride had different effects on the 
granulosa cells in a hypoxic environment, and acted via different pathways. Sodium azide appeared to 
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interfere with these activation pathways, at least at the concentrations that were used. In fact, this was 
observed to have a cytotoxic effect. Cobalt chloride however, actually induced VEGF expression, but 
appeared to have no effect on the expression of HIF-1!, indicating a completely different mechanism of 
action. We believe that reactive oxygen species (ROS) may have a role in these observations, as cobalt 
chloride has been shown to increase ROS generation, which in turn stabilise HIF-1! in hypoxia (Chandel 
et al., 2000). In addition, ROS bind to the VEGF promoter sequence, leading to an increase in expression 
(Monaghan-Benson and Burridge, 2009). 
It is clear from the results of culture 2 that steroid hormone production was significantly decreased in 
hypoxic conditions. Oestradiol decreased rapidly as cell density was increased, which we believe may be 
as a result of decreased metabolic capacity by the cells due to hypoxia and/or due to a build-up of ROS 
causing a depression in aromatase activity, as proposed by Winnett et al. (2003) in a study using breast 
cancer cells. Portela et al. (2010) also observed a decrease in oestradiol production as plating density 
increased, using bovine granulosa cells in a serum-free culture system, and suggested that this was as a 
result of stressing of the cells and increased apoptosis.  Cobalt chloride had no additional depressive 
effect on oestradiol production, but significantly decreased cellular progesterone production rate further. It 
seems likely therefore that cobalt chloride has an effect on the enzymes involved in the conversion of 
cholesterol to pregnenolone and progesterone; cytochrome P450 and 3"-hydroxysteroid dehydrogenase. 
Culture 3 showed that over a long time course, cobalt chloride suppressed the oestradiol production rate 
by the granulosa cells, however it took 48 hours of exposure for this effect to become inhibitory. 
Transfection heavily suppressed the production of oestradiol by the cells, which was not expected. 
Perhaps this is due to an effect on the granulosa cell membrane permeability causing a restriction in 
small molecule transport, however this speculative, and as a result would need to be further investigated. 
 
HIF-1! mRNA expression was significantly correlated to follicular diameter, as seen in figure 3.28 
(P<0.001). However, the Pearsons correlation coefficient was just 0.11, suggesting that the line is only 
weakly linear. In addition the coefficient of determination (r
2
) was 0.0122, indicating a considerable 
amount of variation within the dataset. This is likely to be because of the diversity of the developmental 
stage of the follicles included in the experiment, as a number of the follicles would have been atretic, or 
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approaching atresia, which would have affected the expression levels.  As a result, it is arguably more 
important to take into account the follicular fluid hormone measurements, which give more of an indication 
of the health status of the follicles. 
Oestradiol was significantly positively related to follicular size, as would be expected. This is because as 
follicles develop to preovulatory size, the granulosa cells become increasingly oestrogenic (Scaramuzzi 
and Baird, 1977; McNatty et al., 1985; McNeilly et al., 1991; Scaramuzzi et al., 2011).  
Interestingly, follicles with oestradiol levels in the follicular fluid higher than 10mg/ml had significantly 
higher granulosa cell HIF-1! expression than those with lower oestradiol concentrations (P<0.05). This 
finding suggests that the oestrogenic follicles, which are more likely to be the healthiest, express higher 
levels of this transcription factor, and could also therefore have increased expression of angiogenic 
factors. It is possible therefore that oestrogenic follicles have increased angiogenic activity, which would 
suggest that the healthiest follicles with the highest oestrogenic activity may have the highest potential for 
vascularisation and this could contribute to the follicle acheiving dominance. 
The major limitation of this study was that it is unable to answer whether oestradiol drives the production 
of angiogenic factors such as HIF-1! in granulosa cells, or whether the converse is true, although it has 
been previously demonstrated that VEGF expression increases in the presence of oestradiol using a 
bovine model both in vitro and in vivo (Shimizu and Miyamoto, 2007), as well as in murine endothelial 
cells (Morales et al.1995; Schnaper et al., 1996). It is also thought that progesterone may also have this 
effect (Shimizu and Miyamoto, 2007). It may therefore be the case that higher levels of steroid hormones 
promote angiogenic factor expression acting through HIF-1!. 
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Chapter 5 Ð In vivo immuno-neutralisation study 
5.1. Introduction  
The two TGF-! superfamily members BMP15 and GDF9 are essential for follicular development in sheep 
(Juengel et al., 2002a). It is thought that these two factors are able to cooperate and heterodimerize to 
form a more bioactive compound (Yan et al., 2001; McNatty et al., 2005a). Both active and passive 
immunization against each of these factors has previously yielded some interesting results, however thus 
far the BMP15 and GDF9 antisera have not been administered at the same time. 
Following the effect of the combination of BMP15 and GDF9 observed in the in vitro cell cultures on 
increasing oestradiol production, in order to explore whether this phenomenon would be observed in vivo, 
an ovine infusion experiment was performed. Antisera to these two factors were used, as opposed to 
infusing the peptides themselves, primarily for cost reasons, as these recombinant factors are extremely 
expensive to produce. Consequently, the effect of blocking the action of these factors was explored, 
rather than the promotional effect on steroidogenesis as previously described. 
 
5.2. Aim 
The aim of this experiment was to investigate the effects of knocking down local availability of BMP15 and 
GDF9 in sheep, by direct infusion of a combination of antisera against both growth factors. 
 
5.3. Method 
Six Scottish black face ewes were actively immunised against BMP15 and GDF9, 6 months before the 
infusion study took place, so that antiserum could be collected from these animals and used for the 
infusion. 
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5.3.1. Active Immunisation 
The vaccination consisted of BMP15 or GDF9 peptides specific for conserved regions of each molecule, 
synthesized and conjugated to keyhole limpet hemocyanin (KLH). The peptide sequences were the same 
as those used previously by Juengel et al. (2002a and 2004); KKPLVPASVNLSEYFC (GDF9) and 
SEVPGPSREHDGPESC (BMP15) 2ml of each conjugate emulsified at 0.1mg/ml in FruendÕs incomplete 
adjuvant (Sigma F5506) was initially administered subcutaneously at 4 injection sites to the 
corresponding ewes, followed by appropriate booster injections as needed. Antibody titres were checked 
regularly to measure titre response. Blood was collected from these animals (6ml/kg), and the plasma 
extracted by centrifugation to be used in this trial. Pooled plasma samples were added to physiological 
saline to give antibody titres of 1:500 for both GDF9 and BMP15. This was later infused directly into the 
ovarian arteries of the animals used in the infusion study.  
 
5.3.2. Oestrous synchronisation 
Six mature Scottish Blackface ewes had their oestrous cycles synchronised with intravaginal progestagen 
(medoxy-progesterone-acetate) impregnated sponges (Dunlop, Dumfires, Scotland) approximately 10 
days before the infusion study began (figure 5.1).  
 
 
Figure 5.1. Immuno-neutralisation in vivo study summary diagram 
 
5.3.3. Ovarian vascular cannulation 
In order to cannulate the ovarian vasculature, the animals were first anaesthetised. General anaesthesia 
was induced using thiopentone, and maintained throughout surgery with isoflurane via a ventilator.  
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A 15cm incision was made parallel to the midline, between the umbilical scar and the udder to allow 
access to the abdominal cavity. A trocar was used to make an opening on either side of the skin, through 
to the abdominal cavity in order to pass the infusion lines through to attach to the ovarian arterial and 
venous cannulae. A section of 0.6mm silastic tubing was used for each ovarian vein, and a 1.02mm 
vascular cannula for each ovarian artery. 
The reproductive tract was exteriorised and held in place so that the ovarian vasculature could be 
accessed, as seen in figure 5.2.  
 
 
 
Figure 5.2. Photograph of exteriorised ovine reproductive tract with vasculature. 
 
The utero-ovarian vein bloodflow was temporarily restricted and a small opening made in the vessel wall 
distal to the utero-ovarian vein bifurcation, to allow passage of the silastic tubing into the vessel lumen. 
The tubing was advanced until the tip lay in the body of the common utero-ovarian vein and held in place 
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with fine suture thread (6/0 Prolene). Blood flow was then restored following capping of the silastic tubing 
to prevent blood loss. 
A section of a branch of the ovarian artery which supplies the oviduct was blunt dissected and the distal 
portion tied off (figure 5.3). A bulldog clamp was applied to the proximal end of the dissected vessel to 
temporarily stop arterial bloodflow, and a small incision was made in the vessel wall. A fine vascular 
cannula equipped with internal spring (Leaderflex
©
, Vygon, UK)
 
was inserted into the lumen until it was 
around 10mm inside. The spring was then carefully removed, and the cannula sutured in place (5/0 
Mersilk). Heparin (5000IU/ml) was passed into the tube before it was capped to prevent blood clot 
formation. 
 
Figure 5.3. Diagram illustrating ovarian arterial cannulation in the ewe 
Redrawn by McNeilly from Lee et al. (2010) 
Infusion 
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When the ovarian vein and artery had been cannulated on both ovaries, the arterial cannulae were 
clamped once again, the cannula caps removed, and the cannula tubing attached to the previously 
placed trans-abdominal infusion lines. 
The excess tubing was pulled through and the reproductive tract repositioned back in the abdominal 
cavity. The midline incision was then sutured closed. The jugular veins on each side were cannulated with 
a 14G IV catheter (Terumo Surflo
¨
), which were secured with a single suture. The animals were allowed 
to recover in individual holding crates for 6-9 hours before the infusion was started.  
 
5.3.4. Ovarian stimulation 
The progestagen sponges were removed following surgery, and then each animal was given 100μg 
intramuscular cloprostenol (Estrumate, Intervet, Cambridge, UK) to induce luteolysis and initiate the 
oestrous cycles at the time of infusion in order to synchronise the follicular phase. 
At the time of laparotomy it was observed that all animals were in anoestrus, which was not expected. 
Following sponge withdrawal, it was decided to induce an artificial follicular phase using an established 3, 
2, 1 regime (Dobson et al., 1997) which involved administration of pulses of 2.5µg of LH (NIH-S26 in 
0.9% w/v saline with 0.1% v/v normal sheep plasma) every 3 hours for 12 hours, every 2 hours for 12 
hours, then every hour for a further 12 hours. Pulses were administered via an infusion pump connected 
to a timer, set to deliver 1ml/minute. 
 
5.3.5. Ovarian infusion 
The BMP15/GDF9 antiserum was administered into the ovarian artery of the treatment ovary at a rate of 
2ml per hour for 24 hours, and normal sheep plasma to the ovarian artery of the control ovary. The 
control plasma was collected from blood taken from the ewes previous to surgery (i.e. normal sheep 
plasma).  The infusion pumps were set up according to figure 5.4. 
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Figure 5.4. Ovine in vivo ovarian infusion study set-up 
LH was infused directly into the jugular vein, and blood sampling taken from the other jugular vein. One ovary 
received direct infusion of BMP15/GDF9 antiserum and the other received control plasma in the same manner. 
 
5.3.6. Blood sampling 
Blood samples (5ml) were taken every 4 hours from each ovarian vein and the jugular vein. The blood 
was centrifuged with latex beads containing heparin in order to remove the red blood cells, and the 
plasma supernatant was transferred to 5ml tubes and stored at -20¡C for later analysis. 
 
5.3.6. Tissue collection 
The animals were sacrificed approximately 36 hours after surgery, using an IV sodium pentobarbital 
overdose. The ovaries from each animal were collected post-mortem and fixed in Bouins fixative 
(appendix 3) for 24 hours, before being transferred to 70% IMS until tissue processing (section 2.3). 
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5.4. Results 
Although all cannulations apart from one were successful, it was found that the sampling lines would 
intermittently become obstructed resulting in some missed data points. Problems with some of the LH 
infusion lines meant that in some animals, the infusion had to be continued down the sampling line. LH 
levels measured in these animals were therefore artificially high as a result of residual LH in the line. 
Consequently, LH levels in the samples taken from the ovarian venous blood were used, rather than the 
jugular vein. However, the overall trend of a steadily increasing LH level was observed, indicating that the 
infusion had been successful. 
 
The mean ovarian LH and FSH concentrations across all animals can be seen in figure 5.5. The mean 
FSH across all animals was maintained at approximately 3ng/ml throughout the infusion, and mean LH 
increased from 0.5 to a maximum of 1.75ng/ml over the 36 hour timecourse.  
 
 
Figure 5.5. Infusion study mean ovarian FSH and LH across all animals 
Error bars indicate SEM. 
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5.4.6. Follicle counting 
Follicle counts were performed following haematoxylin & eosin staining as described in section 2.4 in 
order to examine any differences in the various follicle classes between the treatment and control ovaries. 
In particular, the effect on the larger follicles, as these were expected to show the most pronounced effect 
due to their high oestrogenicity.  
 
The average counts for each follicle type for each ovary can be seen in table 5.1. 
Ewe Treatment Primordial Primary Secondary Tertiary Pre-antral 
Small antral 
(<3.5mm) 
Large antral 
(>3.5mm) 
1L Treatment 46 4 1 0 3 0 6 
1R Control 118 6 2 0 3 1 3 
2L Control 9 1 2 0 1 1 6 
2R Treatment 6 1 1 0 1 1 4 
3L Treatment 9 4 1 0 1 0 4 
3R Control 14 2 0 1 0 0 1 
4L Control 21 1 1 0 2 2 4 
4R Treatment 19 1 0 1 1 4 6 
5L Treatment 65 0 1 1 0 0 4 
5R Control 85 0 0 0 0 1 1 
6L Treatment 70 0 1 0 3 0 1 
6R Control 50 1 0 0 0 1 3 
 
Control 49.3 ± 20.1 1.7 ± 0.7 0.7 ± 0.3 0.1 ± 0.0 0.9 ± 0.4 0.7 ± 0.3 2.9 ± 1.2 
Treatment 35.6 ± 11.9 1.6 ± 0.7 0.6 ± 0.2 0.3 ± 0.2 0.9 ± 0.4 0.8 ± 0.6 4.1 ± 1.0 
 
Table 5.1. Mean follicle counts following H&E staining on ovarian sections. (L=left ovary; R=right ovary; 
Mean values ± SEM). 
The follicle count data for treated and control ovaries was compared to see if there was any effect of the 
BMP15/GDF9 antiserum treatment on follicular development (table 5.1). Following within-group statistical 
analysis by paired T-testing, the antiserum treatment was found to have no significant effect on the 
number of follicles, of any size group, present in the ovary. There was found to be a greater number of 
large antral follicles in the treated ovaries than those of the controls, however this was not significant 
(P=0.177). 
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5.4.7. Aromatase immunohistochemistry 
Aromatase immunohistological staining confirmed the presence of aromatase in the granulosa cell layer 
in at least one follicle of one or both ovaries in all but one of the animals (table 5.3), indicating 
steroidogenic activity in these follicles. The large antral follicles with positive staining were measured in 
order to ascertain their developmental stage. Notably, in the treatment infusion ovaries, the very large 
follicle of ewe 2, which was over 5mm in diameter, was seemingly unaffected in terms of staining 
intensity, whereas the smaller follicles of treated ovaries in other animals had lower aromatase activity.  
 
Ewe Ovary Treatment Aromatase Staining (follicle size in mm) 
Staining Intensity 
Score (1-4) 
1 Left Treatment Negative 1 
1 Right Control Negative 1 
2 Left Control Negative 1 
2 Right Treatment Positive (5.66) 4 
3 Left Treatment Some positive staining (2.44 and 2.34) 2 
3 Right Control Negative 1 
4 Left Control Positive (5.04) 3 
4 Right Treatment Positive on one large follicle side (4.48) 2-3 
5 Left Treatment Some slightly positive staining (4.8 and 4.52) 2 
5 Right Control Negative 1 
6 Left Treatment Slight positive staining (4.8) 2 
6 Right Control Positive (4.52) 4 
Table 5.2. Aromatase immunohistological staining results of ovarian sections (1=no staining, 2=light 
staining, 3=moderate staining and 4=heavy staining). 
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Figure 5.6. Ewe 2 positive aromatase staining of the granulosa cell layer in a large antral follicle on the 
treatment ovary at (a) x50 and (b) x200 
(Brown staining indicates cells positive for aromatase.) 
 
a 
b 
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Figure 5.7. Ewe 3 treatment ovary weak positive aromatase staining of granulosa cells (x200)  
Brown staining is weak but positive. 
 
 
Figure 5.8. Ewe 4 control ovary positive aromatase staining of granulosa cell layer (x200) 
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5.4.8. Ewe 1 
The right ovary of ewe 1 had ovarian vasculature that proved extremely difficult to dissect, and as a result 
only the vein could be cannulated. This meant that the control plasma could not be administered to the 
right ovary. In addition, the sampling line became blocked and so blood could not be taken after 24 hours 
of infusion. 
 
Figure 5.9. Ewe 1 oestradiol profile over 36 hours  
(LO = Left ovary; Tx = Treatment) 
 
 
Figure 5.10. Ewe 1 androstenedione profile over 36 hours 
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As there were several large antral follicles on each ovary it would be expected that the granulosa cells of 
these follicles would be highly oestrogenic. However, immunohistological staining of ovarian sections 
from both ovaries revealed an absence of aromatase in the granulosa cells of these follicles, which would 
explain the low circulatory and ovarian venous concentrations of oestradiol. Androstenedione 
concentrations were also relatively low, therefore it is not certain whether the low oestrogenic capacity of 
the treated ovary was as a result of the antiserum treatment, or that steroidogenesis was limited by the 
availability of androgens to the granulosa cells.  
The lack of a control ovary in this animal makes it relatively difficult to draw definitive conclusions, and the 
fact that the surgery for this animal had several complications associated with cannulating ovarian 
vasculature, however it seems that ultimately the infusion in this animal unfortunately did not work and 
that data derived from this animal is unreliable. 
 
5.4.9. Ewe 2 
The treatment infusion line of ewe 2, originally from the left ovary, was blocked after approximately 2 
hours, and so the treatment was changed to the right side instead. Following post-mortem examination it 
was discovered that the line to the left ovary had detached from the cannula and as a result, this ovary 
was not perfused with control sera for an unknown period during the treatment infusion phase. 
 
 
Figure 5.11. Ewe 2 oestradiol profile over 36 hours 
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Figure 5.12. Ewe 2 androstenedione profile over 36 hours 
 
Oestradiol concentration in the samples taken from the right ovary, which received the antiserum 
treatment, increased steadily over the 36 hours of sampling. The androstenedione profile also displayed 
this profile, which would explain the oestradiol increase. 
Following immunohistochemical staining it was observed that the right ovary had a very large antral 
follicle with intense aromatase staining, which is consistent with the increased oestradiol concentration in 
the ovarian venous blood. 
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5.4.10. Ewe 3 
 
Figure 5.13. Ewe 3 oestradiol profile over 36 hours 
 
 
Figure 5.14. Ewe 3 androstenedione profile over 36 hours 
 
The oestradiol profile of the treatment ovary decreased over the first 24 hours of infusion. The control 
ovary sample oestradiol increased gradually after 16 hours following infusion. Aromatase staining of 
ovarian sections was negative for the control ovary, and weakly positive for the treatment ovary. 
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5.4.11. Ewe 4 
 
Figure 5.15. Ewe 4 oestradiol profile over 36 hours 
 
 
Figure 5.16. Ewe 4 androstenedione profile over 36 hours 
 
Oestradiol levels in both ovaries decreased progressively over the infusion time course, which could have 
been as a result of the relatively low androstenedione concentrations. 
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Interestingly, although staining for aromatase was positive on large follicles from both the treatment and 
control ovaries, the staining on the large antral follicle in the treatment ovary was present in the granulosa 
cells located on one side of the follicle only. Upon closer examination of this follicle, it was observed that a 
very large blood vessel was present in between the theca cell layers at the opposite side to the 
aromatase positive cells (figure 5.17). The granulosa cells adjacent to this vessel did not stain for 
aromatase on any of the sections taken.  
 
 
Figure 5.17. Major peri-follicular blood vessel on large antral follicle of ewe 4 treated ovary (x50) 
 
 
 
 
82!m 
 116 
5.4.12. Ewe 5 
 
Figure 5.18. Ewe 5 oestradiol profile over 36 hours 
 
 
Figure 5.19. Ewe 5 androstenedione profile over 36 hours 
 
Oestradiol concentration in the treatment ovary decreased over the first 8 hours of infusion, and remained 
at a low level similar to that of the main circulation, whereas the control ovary oestradiol concentration 
increased steadily from 8 hours of infusion. 
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Androstenedione concentrations were extremely low until 24 hours of infusion, when a peak in the 
ovarian blood samples was observed.  The immunohistochemistry observations of these ovaries were 
somewhat conflicting, as aromatase staining was in fact negative in the control ovary, which had just one 
large antral follicle, whereas the treated ovary did show some slight staining on a small number of cells on 
a large antral follicle. 
 
5.4.13. Ewe 6 
 
Figure 5.20. Ewe 6 oestradiol profile over 36 hours 
 
Figure 5.21. Ewe 6 androstenedione profile over 36 hours 
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Oestradiol production in ewe 6 was similar in the ovarian samples for the first 24 hours, after which the 
treated ovary production fell, while the control ovary production peaked dramatically. This result was also 
seen in the androstenedione secretion profile, which indicated a large peak in the control ovary at 28 
hours.  
Immunohistochemistry revealed positive staining for aromatase in both ovaries, although this was 
observed to be much weaker in the treated ovary, which had only one large follicle. 
 
Mean data 
The individual data summarised above indicates a large degree of inter-animal variation that has been 
somewhat compounded by technical issues with the in situ cannulation technique in some animals. 
Nevertheless, in four of the five animals in which large oestrogenic follicles were observed, there did 
appear to be a consistent decline in oestradiol secretion in treated ovaries (animals 3-6), which were 
secreting considerable amounts of oestradiol at the start of the treatment period, indicating the presence 
of an oestrogenic follicle at the start of the infusion in these individuals. 
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Figure 5.22 shows the mean ovarian oestradiol concentration for animals 3 to 6, for which oestradiol level 
started above 0.5ng/ml. Ewe 2 oestradiol is not included in the analysis as the converse profile of 
oestradiol was observed in this animal, suggesting recruitment of an oestrogenic follicle following luteal 
regression. Ewe 1 data was also excluded due to the lack of control.  
 
 
Figure 5.22. Mean ovarian oestradiol plasma concentration across all timepoints for ewes 3 to 6  
Error bars indicate SEM. 
 
The data was log transformed due to non-normality, and following repeated measured ANOVA in SPSS 
(Version 15, SPSS Inc), there was found to be no significant difference between mean oestradiol 
concentration in the ovarian venous blood in the treatment and control ovaries.  
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The data was then analysed in terms of change in oestradiol concentration from baseline (figure 5.23). 
Repeated measures ANOVA revealed a statistically significant suppressive treatment effect of 
BMP15/GDF9 antiserum on oestradiol production (P<0.05). 
 
 
Figure 5.23. Mean percentage change in ovine serum oestradiol concentration from baseline against time in 
animals passively immune-neutralised against BMP15 and GDF9 
Error bars indicate SEM. 
 
 
5.5. Discussion 
In this study it was hypothesised from the in vitro studies (Chapter 3) that the infusion of BMP15/GDF9 
antiserum directly into the ovarian blood supply would cause a suppression of oestradiol secretion by the 
larger antral follicles, as the effect of these two factors secreted by the oocyte on the granulosa cells 
would be blocked.  
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Overall the hypothesised result was seen in 2 of the animals, variable results in 3 animals, and the 
converse effect seen in 1 animal; ewe 2 (table 5.3). 
 
Ewe Aromatase Staining Endocrinology 
1 Inconclusive Positive 
2 Negative Negative 
3 Negative/Ambiguous Positive 
4 Positive Ambiguous 
5 Negative/Ambiguous Positive 
6 Positive Ambiguous 
Table 5.3. Summary of aromatase staining and encrocrine profiles in relation to initial hypothesis. 
 
Ewes 3 and 5 had clearly decreasing oestradiol levels with infusion of antiserum, suggesting that this was 
having a negative effect on steroidogenesis in these treated ovaries. This supports the hypothesis that 
passively immunization against BMP15 and GDF9 suppresses granulosa cell steroidogenesis. The 
endocrine results from ewe 1 concur with this, however no control was present which makes it difficult to 
draw definitive conclusions. 
There was little difference between the treated and control ovaries of ewe 6, apart from a peak of 
oestradiol at 28 hours in the control, which was not observed in the treated ovary. 
The results of ewe 2 were contradictory to the original hypothesis, as both oestradiol and 
androstenedione increased dramatically with the antiserum infusion. Furthermore, aromatase staining 
was only present in the treatment ovary. Although these results therefore do not support the original 
hypothesis, this is likely to be as a result of a follicle being recruited from the gonadotrophin-responsive 
follicles during the early follicular phase, as the oestradiol levels in this animal were initially low, but 
increased markedly during the treatment period. This scenario could be explained by the antiserum 
having no effect on the actual induction of aromatase, as opposed to the inhibitory effect on the 
maintenance of aromatase observed in other animals in which a large oestrogenic follicle was present at 
the time of luteal regression. 
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5.5.6. Follicle count 
The ovaries that received BMP15/GDF9 antiserum infusion had fewer primordial follicles than those of the 
control ovaries, which, although not statistically significant, was observed in 5 of the 6 animals. As these 
two factors have previously been implicated in the initiation of primordial follicle growth (Martins et al., 
2008; Peng et al., 2010; Kedem et al., 2011), local passive immunization against these factors may have 
yielded this result by detrimentally affecting the primordial follicle pool. However, in a trial utilising such a 
short infusion period, it is unlikely that an effect on the primordial follicle population would be observed, 
and so this result could be simply down to coincidence. 
 Because follicle counts could not be performed before infusion, the use of one ovary of each animal as a 
control was the best comparison that could be made. Ideally a Ôbefore and afterÕ follicular assessment 
would be carried out in order to assess the effects of the infusion on the follicle population, perhaps by 
ultrasound, although this would, of course, be useful only in determining antral follicle numbers. 
These results differ from those of an in vivo ovine study by Juengel et al. (2002a), in which passive 
immunization of GDF9 or BMP15 alone had marked effects on ovarian morphology. GDF9 antiserum 
caused alterations in follicular appearance, as the oocytes appeared much larger in size and had 
irregularly arranged granulosa cell layers. BMP immunization caused a dramatic reduction in antral follicle 
numbers, and was seen to decrease ovulation rate as a result. The study methodology, however, differed 
from ours in that the antisera were not used together, a large bolus of antisera was administered 
systemically, and the period of exposure was considerably longer. Our study used a much slower, direct 
infusion of combined BMP15/GDF9 antiserum, and the data was collected after 36 hours of treatment, 
and so major differences in results could be expected. Perhaps if our study was continued for a longer 
period of time then these effects may have been observed. 
In a more recent in vivo study by Juengel et al. (2009) in cattle, active immunization again decreased 
antral follicle numbers and resulted in abnormally large oocytes. However, again the study period took 
place over a number of weeks, and so the effects could be observed over a longer timecourse. 
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5.5.7. Aromatase and oestradiol 
As previously mentioned, the use of the second ovary as a comparative control was not ideal, as the 
physiological status of the ovaries would not necessarily have been the same before the infusion 
treatment began. This effect was most noticeable in the aromatase immunohistochemistry results, as due 
to the nature of the study, it was unclear which follicles had been previously oestrogenic or atretic and so 
determining the effect of the antiserum treatment is relatively difficult. 
The expected result of negative (or weakly positive) antiserum-treated ovary staining and positive control 
staining was only seen in 2 of the animals; ewes 4 and 6. Interestingly, a large antral follicle in the treated 
ovary of ewe 4 had aromatase staining on only one side of the follicle wall, opposite a large blood vessel. 
This finding may indicate that this large peri-follicular blood vessel was delivering the blood supply to the 
follicle in such a way that the antiserum infusate had a local effect on suppressing aromatase activity on 
the granulosa cell layer adjacent to the vessel. A similar suppressive effect was seen in the ovaries of 
ewe 6, as only some slight staining was observed in granulosa cells of a follicle in the treatment ovary, 
compared to considerable positive staining in the control.  
As before, ewe 2 exhibited a contradictory result to the proposed hypothesis, as the treatment ovary 
contained positively stained granulosa cells, whereas there was no staining present in the control ovary. It 
is possible that the very large oestrogenic follicle on the treatment ovary in this animal had become so 
dominant that any negative effect of antiserum treatment was unable to overcome steroidogenesis at the 
levels given. Also the infusate may not have been able to directly reach this large antral follicle, and if the 
hypothesis that the antiserum can only have a local effect is indeed true, the blood supply to this follicle 
may not have been directly from the canulated vessel, and so the exposure to infusate would have been 
minimal. 
The aromatase results of ewes 1, 3 and 4 were not indicative of an effect of the antiserum infusion on 
aromatase expression, as in these animals the control ovaries did not show any staining for aromatase. 
Some staining was present in follicles from treated ovaries of ewes 3 and 5, however this was fairly weak 
and so a definitive conclusion is difficult to draw. 
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In summary, it seems that the hypothesised result of an antiserum knockdown of aromatase staining was 
observed in just 2 of the 6 animals. With regard to the other animals, aromatase staining was either 
inconclusive, or in one case, contradictory to the hypothesis. 
 
The endocrine profiles of 3 of the animals supported the proposed hypothesis of a negative effect of the 
antiserum on oestradiol production. Ewes 1, 3 and 5 had decreasing oestradiol levels in the treated ovary 
(though ewe 1 did not have a control for comparison), indicating that the antiserum had a suppressive 
effect on steroidogenesis in these animals. There was no treatment effect observed in the endocrine 
profiles of ewes 4 and 6. 
Ewe 2 was the only animal in which the hypothesis was not supported in both the aromatase 
immunohistochemistry and the oestradiol profile. As previously mentioned, this animal had a very low 
oestradiol level at the start of infusion, which increased steadily throughout the infusion period. This 
suggests that the antiserum may have been effective only in follicles which had cells already expressing 
aromatase, and that it would not have an inhibitory effect on aromatase expression induction. 
 
Overall, the infusion was observed to have a significant treatment effect on ovarian oestradiol production, 
but due to the small number of animals further replication would be needed to confirm this effect, not least 
because an even smaller number of animals exhibited the expected endocrine response profile. 
 
5.5.8. Limitations of the study 
During the surgical procedures, it was noticed that none of the animals were found to have corpora lutea 
present on the ovaries, indicating that the animals were unexpectedly still seasonally anoestrous. 
Although the study took place at the end of January, in Edinburgh, it was probably as a result of being 
kept indoors these animals had not exhibited reproductive cycling. Clearly this was not ideal in terms of 
using these animals to determine the effect of the growth factors on reproductive physiology, but the 
impact of this complication was minimised by the imposition of a standard LH pulsatile stimulation regime 
designed to mimic the normal follicular phase that has been previously shown to be highly effective. 
Some conclusions can therefore still be drawn from the study. 
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If this study were to be repeated, it might yield more consistent results if down regulation with GnRH 
agonist/antagonist and ovarian stimulation were to be used; this would allow complete control over the 
animalsÕ reproductive cycle, thereby bypassing the issues associated with seasonality in this breed. 
The experimental design employed was designed to allow each animal to be used as its own control, but 
one drawback of this design is that the control ovary used in each case may not necessarily be the the 
same physiologically as the treatment ovary. For example, larger, more oestrogenic follicles may be 
present on one ovary than the other, which would have affected the endocrine profiles obtained from the 
ovarian blood samples.  This problem is more likely to arise in breeds of sheep with lower ovulation rates, 
and the only way to overcome this issue in the Scottish Blackface animals used in this study would have 
been to use more animals, and clearly this study needs to be repeated to increase the sample number.  
 
In conclusion, this pilot study has provided some preliminary data to suggest that BMP15/GDF9 may 
positively regulate aromatase activity in vivo, as infusion of BMP15/GDF9 antiserum had a knockdown 
effect on aromatase and oestradiol production, however it is evident that further experimentation is 
required to confirm and investigate this finding in more detail.  
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Chapter 6 Ð Ultrasound phantom studies 
6.1. Introduction 
Technology for evaluating blood flow to and around the ovary has progressed rapidly over recent years, 
which has proven extremely valuable both in terms of research on ovarian blood flow from a scientific 
point of view, and also improving patient treatment regime by facilitating ovarian monitoring by the 
clinician.  
This new technology has enabled measurement of blood flow around individual follicles, as the technique 
is highly sensitive, however the indices given by the ultrasound machine are in arbitrary units that have 
not yet been correlated to known parameters such as speed of blood flow (Deane, 2001). As a result, the 
relevance of these measurements is not yet fully understood. It seemed appropriate, therefore, to utilise a 
physiologically relevant phantom model in order to clarify the relevance and also the accuracy of these 
measurements, thereby qualifying its use as both a research and clinical tool. 
The basis for the model is that bovine ovaries can be cannulated and blood passed through the ovarian 
artery at a determined flow rate. The ultrasound scan Doppler information can then be compared to the 
blood flow data in order to determine quantification of the vascular indices given by the machine. 
6.2. Blood flow phantom models 
The combined utilisation of three-dimensional (3D) ultrasound alongside power Doppler enables the 
quantification of blood movement within a defined area of interest (Pairleitner et al., 1999), and hence is a 
valuable tool for studying blood flow in the ovary. The technique is completely non-invasive and safe as 
there is no requirement for contrast agents or radiation exposure (Raine-Fenning et al., 2008b).  
Three indices of vascularity and blood flow are given by power Doppler analysis; Flow index (FI) 
represents the mean power Doppler signal intensity from all of the coloured voxels, vascular index (VI) is 
the ratio of coloured voxels to total voxels in the volume of interest (expressed as a percentage), and 
vascular flow index (VFI) is a combination of the two multiplied by 100 (Pairleitner et al., 1999). FI is 
thought to signify the intensity of the blood flow and VI the number of vessels within the volume of 
interest, and by combining them an overall indication of vascularity and blood flow can be observed. 
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These vascular indices given by the software are arbitrary in terms of units, and hence their relationship 
to actual blood flow and vascularisation is not currently known. If the technique is to be used effectively in 
a clinical setting then this issue must be addressed (Raine-Fenning et al., 2008b). This study was 
designed to investigate this relationship, based on a phantom blood flow model using bovine reproductive 
tracts. Phantom models to investigate ultrasound measurement have been performed a number of times 
before (Rubin et al., 1995; Guo and Fenster, 1996; Nilsson et al., 1997; Cloutier et al., 2000; Raine-
Fenning et al., 2008b), however these have all been based on utilisation of submerged tubing, with 
relatively high flow rates. It is somewhat difficult to set up a model with physiologically low flow rates due 
to the sensitivity to attenuation, which causes high amounts of artifact. Schulten-Wijman et al. (2008) 
even went as far as to say that power Doppler cannot currently be used for measuring blood flow in small 
blood vessels due to poor sensitivity causing overestimation. However, this group used a blood-mimicking 
fluid pumped through polyurethane tubing, and scanning was performed through a liquid barrier, making 
the whole set-up somewhat artificial. By using a more physiological approach, we hoped to investigate 
the power Doppler measurement of blood flow in a phantom model. 
 
6.2.1. Aim 
To investigate the relationship between power Doppler ovarian vascular indices measured in clinical IVF, 
and true flow parameters using an in vitro phantom model by perfusing bovine ovaries with blood under 
differing flow rates. It is not currently known how these vascular indices presented by power Doppler 
analysis actually relate to blood flow, and so this experiment was designed to mimic ovarian vascular 
dynamics under controlled conditions. A bovine model was chosen to due ovarian morphological 
similarities to the human. 
 
6.2.2. Method 
Bovine reproductive tracts were collected from the abattoir and those with ovaries containing a large 
follicle and a corpus luteum were selected for use, as these would be expected to have a suitable degree 
of vasculature to allow detectable blood flow.  
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The ovarian artery on each side of the reproductive tract was cannulated and secured in place with 
suturing thread.  
Human red blood cells were obtained from the blood transfusion department of Clinical Pathology at the 
Queens Medical Centre. This solution was centrifuged and resuspended in PBS to obtain a physiological 
packed cell volume (PCV) of approximately 50%. As it is the red blood cell portion of the blood that is 
detected by power Doppler ultrasound (Missaridis and Shung, 1999), this would serve as an accurate 
representation of whole blood for ultrasonic measurement of blood flow indices. 
After a small number of replications of the experiment it was found that using human blood in the 
phantom model was unsustainable due to variable availability from the transfusion unit, and therefore the 
source was consequently changed to bovine whole blood, as this was more readily available. Analysis 
was performed separately to avoid possible discrepancies between blood types.  
Excess whole bovine blood was obtained from a bovine pathology laboratory (NUVetNA Diagnostic 
Services, Nottingham), and used at a PCV of approximately 50%. Normal human parameters for packed 
cell volume are between 36% and 54% (Billett, 1990) so 50% PCV was chosen for simplicity.  
 
 
The blood was perfused at various flow velocities into the ovaries using a syringe attached to a syringe 
pump (Precidor by Infors-AG, Basel, Switzerland), as shown in figure 6.1. The ovaries were covered with 
a tissue barrier of bovine uterus in order to move the ultrasound probe off the surface of the ovary, and 
then scanned in 3D using a transvaginal probe on a Voluson E8 Expert ultrasound machine (GE Medical 
Systems, Kretz, Austria). The VOCAL tool on the 4D software was used as previously described, with 15¡ 
rotations drawn in the B plane. 
 
Statistical analysis was performed using SPSS (Version 15, SPSS Inc). R
2
 values were used to assess 
the data goodness of fit and P values to determine the correlation between the perfusion flow rates and 
the ultrasound vascular indices. 
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Figure 6.1. Ultrasound set-up for the measurement of blood flow in a bovine ovary at different flow rates 
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6.2.3. Results 
Blood Type Infusion Rate (ml/min) n FI ± SEM VI ± SEM VFI ± SEM 
Human 0.75 3 19.588 ± 0.40 0.056 ± 0.04 0.011 ± 0.01 
 
1.5 5 25.123 ± 2.84 0.186 ± 0.06 0.054 ± 0.02 
 
2.25 2 20.222 ± 1.25 0.782 ± 0.71 0.167 ± 0.15 
 
3 4 27.320 ± 2.76 0.257 ± 0.12 0.080 ± 0.04 
 
3.75 1 22.483 ± 0.00 0.05 ± 0.00 0.011 ± 0.00 
 
4.5 4 34.008 ± 4.21 0.642 ± 0.29 0.253 ± 0.13 
 
5.25 1 36.258 ± 0.00 0.191 ± 0.00 0.069 ± 0.00 
 
6 3 30.434 ± 1.54 0.595 ± 0.31 0.300 ± 0.06 
Bovine 0.75 11 20.464 ± 1.10 0.475 ± 0.19 0.095 ± 0.04 
 
1.5 11 21.259 ± 1.17 0.495 ± 0.20 0.124 ± 0.05 
 
2.25 9 23.627 ± 1.43 0.658 ± 0.32 0.179 ± 0.10 
 
3 8 23.239 ± 1.49 1.65 ± 0.43 0.410 ± 0.11 
 
3.75 9 26.451 ± 1.36 1.81 ± 0.61 0.485 ± 0.18 
 
4.5 10 26.886 ± 1.26 1.963 ± 0.45 0.537 ± 0.14 
 
5.25 9 26.992 ± 1.58 3.935 ± 1.26 1.124 ± 0.38 
  6 9 26.379 ± 1.83 4.633 ± 1.21 1.148 ± 0.32 
Table 6.1. Flow index, vascular index and vascular flow index for 8 defined infusion rates using human 
and bovine blood. 
 
Figure 6.1. Mean vascular index against flow rate using human blood 
Error bars indicate SEM 
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Figure 6.2. Mean flow index against flow rate using human blood 
Error bars indicate SEM 
 
Figure 6.3. Mean vascular flow index against flow rate using human blood  
Error bars indicate SEM 
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Figure 6.4. Mean vascular index against flow rate using bovine blood  
Error bars indicate SEM 
 
Figure 6.5. Mean flow index against flow rate using bovine blood  
Error bars indicate SEM 
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Figure 6.6. Mean vascular flow index against flow rate using bovine blood 
Error bars indicate SEM 
Following statistical analysis a significantly positive correlation was found between infusion rate and the 
ultrasound measured vascular indices VI, FI and VFI (P<0.001). 
 
6.2.4. Discussion 
This study revealed complex relationships between the controlled flow rate and the flow index and 
vascular index using a bovine blood phantom model. 
Analysis of the vascular index against flow rate indicated a best fit obtained with a third order polynomial 
relationship (P<0.01). The VI is thought to represent the number of vessels in the volume of interest 
(Guimares Filho et al., 2008), however as VI increased with flow rate, this cannot be the case, as the 
number of vessels did not change. One possible explanation is that as the flow rate increased, the 
increment in blood pressure could have caused the blood vessels to dilate and hence smaller vessels 
became detectable at higher flow rates. This is unlikely to be the primary cause, however, as another 
study also found an increase in VI with flow rate using tubing rather than physiological tissue vessels 
(Raine-Fenning et al., 2008b).  
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The observed complex third order polynomial (cubic) relationship between VI and flow rate differs from 
that of Jones et al. (2009), who conducted a phantom study based on a placental model, which found flow 
rates to relate to VI in a linear relationship. However, the study included flow rates up to 10ml/min, and 
used haematocrits of 0.5% and 5%, which may explain the discrepancies between our studies. Power 
Doppler indices have been shown to be significantly affected under haematocrits of 26%, and so these 
low haematocrits used will differ to normal physiological conditions, and indeed the results presented in 
our study (Wu and Shung, 1999). In addition it is important to note that human haematocrit is 36-48% in 
women and 40.7-54% in men (Dacie and Lewis, 1995), and so it could be argued that our study was 
more physiologically applicable.  
In a study published by Hope et al. (2009), the mean VI observed was 12, mean FI 39 and mean VFI 5.1 
(n=368), compared to the ultrasound parameters measured in this experiment peaking at 4.5, 27 and 1.2 
respectively. This indicates that the perfused flow rates used in our particular set-up could have been 
somewhat lower than those in vivo, and therefore this experiment may not have strictly replicated in vivo 
ovarian blood flow in the human. Unfortunately the nature of this set-up was that the maximum flow rates 
that could have been used were performed with the equipment available. Furthermore, the perfusion 
cannulae in the ovaries would not have been able to sustain the flow rates that would have been required 
to mimic human in vivo conditions, as although the ovaries were perfused as quickly as possible, 
inevitably there would have been some blocking of ovarian blood vessels. However, even though the flow 
rates had to be restricted in this experiment, the relationship between flow rate and ultrasound 
parameters of blood flow could be demonstrated. 
The best fit relationship between measured flow index and flow rate was found to be a second order 
polynomial (quadtratic) regression (P<0.01), which appeared to reach a plateau at a flow rate of 
approximately 5ml/min. As a result, it seems that flow rate is a relatively poor indicator of blood flow, 
which has also been the conclusion reached by some other studies (Dubiel  et al., 2006; Jones et al., 
2009). 
The VFI, obtained by multiplying the VI and FI together, was also related to flow rate in a non-linear 
correlation, with the line of best fit following a quadratic regression (P<0.01). This would be expected as it 
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would be likely that the combination of the VI and FI would result in a similar relationship to the 
components, and hence this does not elucidate any additional information concerning flow rate. 
Overall it seems that vascular index is the measure most reflective of flow rate, although the relationship 
is relatively complex and non-linear, and also that flow index has limited as a flow rate indicator, and as a 
result should be interpreted with caution. It would seem pertinent to interchange the names of these 
parameters, as in actual fact, in this study at least, VI reflects blood flow, and FI may better reflect the 
vascularity. 
 
On a number of the ultrasound images there was a significant degree of power Doppler artifact at 
analysis, which rendered the scans unusable as it affects the blood flow measurement considerably, and 
cannot be removed post-scanning. This artifact appears as striated areas of colour, perpendicular to the 
ultrasound probe, which is interpreted by the software as being blood movement.  
Power Doppler artifact was particularly noticeable on the scans on ovaries with a dense corpus luteum 
(figure 6.7). This is likely to be as a result of the additional artifact from the ultrasound itself, as a result of 
attenuation by the very dense tissue, causing the whole dataset to become subject to misinterpretation by 
the software. Because of the relatively small volume of interest required to analyse blood flow in the 
ovary, even minor differences in tissue density, probe depth and tissue barrier characteristics can 
significantly affect the ultrasound image acquired, and hence the consequent analysis. 
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Figure 6.7. Visible artefact on the ultrasound scan image 
The artefact can be seen in planes B and C on the image as red striated areas, which cannot be excluded from the 
image for analysis once the scan has been performed. 
 
In addition it is important to note that due to the sensitivity of the technique, any movement of the probe 
during image acquisition, however slight, will cause a certain degree of attenuation of the ultrasound 
signal, potentially resulting in image artefact. A clinician performed this study by hand, and although the 
individual is extremely experienced in the field, it is physically impossible to hold the transducer absolutely 
stationary for the duration of these procedures. It was decided to utilise human input for holding the probe 
because the study needed to be as physiologically relevant as possible, and as in a clinical setting 
ultrasound scanning is performed by clinicians, it was deemed suitable to mimic these conditions. 
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Although a certain amount of artifact is expected, and considered a normal part of the scanning process 
in human patients, only scans with a very small amount of artifact were included in the study in order to 
determine the relationship to true flow.  
  
One drawback of the phantom method used in this experiment was that the pump used produced a 
continuous flow, which obviously is not a truly accurate reflection of physiological blood flow in vivo. 
Pumps that mimic circulatory pulsatility are available, and could be used for in vitro phantom systems 
(Raine-Fenning et al., 2008b), however it was decided that a simple continuous flow would be more 
appropriate for the purpose of ascertaining the correlation of blood flow to ultrasound vascular indices. 
In addition, whilst this study was able to show a relationship between flow rate and the ultrasound 
generated vascular indices, the results cannot necessarily be directly extrapolated to an in vivo setting, as 
additional external factors such as depth of the volume of interest come into effect (Jones et al., 2009). 
 
 
6.3. SonoAVCª 
SonoAVCª software (sonographic automated volume count) (GE Medical Systems, Kretz, Austria), as 
the name suggests, is designed to automatically count and measure ovarian follicles from a 3D 
ultrasound scan. Ultrasound ovarian follicle counting and developmental monitoring is a well established 
and useful tool used to indicate ovarian reserve in addition to monitoring ovarian response to stimulation 
(Ritchie, 1985), and the novel 3D technique is proving to be an important development in the process, 
due to increased reliability and a decreased time requirement (Murtinger et al., 2009; Raine-Fenning et 
al., 2009b). Follicular volume and diameter can also be measured using this technique, which is of value 
as follicle size is considered to be a key indicator of oocyte development and maturity (Raine-Fenning et 
al., 2008a).  
Follicles appear as dark areas on the ultrasound image, as they are fluid-filled and hence low echoic 
regions that are fairly easy to distinguish in the ovarian tissue. As a result, the technique is reported to be 
very easy to perform, with good reproducibility and reliability (Salama et al., 2009). 
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It is thought that because of the way in which SonoAVCª measures volume in objects of interest in 
ultrasound scanning, it may systematically underestimate the volume of the object in question (Rousian et 
al., 2008; Raine-Fenning et al., 2009a). This is because it is only able to draw around the inside of the 
hypoechoic space, thereby excluding the ovarian follicle wall. As a result, the extent of this 
underestimation was examined. 
 
6.3.1. SonoAVC measurement of follicular size 
Previously, ultrasound assessment of ovarian follicles for the purpose of monitoring ovarian stimulation 
during ovulation induction or IVF treatment has been performed using two-dimensional ultrasound, with 
the aim of measuring follicular size and development (Hackeloer et al., 1979). This method was based on 
the mean of two linear measures of follicular diameter, as described by Haadsma et al. (2007), however 
due to the irregularly-shaped nature of ovarian follicles (Ritchie, 1985; Rodrgues-Fuentes et al., 2010), 
this measurement is relatively difficult to perform and hence relatively inaccurate, with poor reproducibility 
(Forman et al., 1991). Inaccuracies in follicular measurement can result in suboptimal timing of ovulation 
induction, thereby reducing the success of IVF (Wittmack et al., 1994, Deutch et al., 2009). In addition, 
current 2D ultrasound is unable to resolve structures less than 2mm in diameter (Baerwald et al., 2009), 
making small follicle identification for antral follicle count relatively inaccurate. 
With the advent of three-dimensional (3D) ultrasound along with novel computing software, the technique 
has developed and improved considerably. Sonography-based Automated Volume Count (SonoAVCª: 
GE Healthcare Ultrasound, Zipf, Austria) allows improved, automated identification and measurement of 
ovarian antral follicles (Raine-Fenning et al., 2008a; Deutch et al., 2009) which decreases the time 
needed for ultrasound follicular assessment to take place (Raine-Fenning et al., 2007). The software 
identifies hypoechogenic regions on scan, and calculates the size and volume of these structures by 
extrapolating from the number of voxels in the space (Lamazou et al., 2010). 
A number of studies have validated SonoAVCª against a manual rotational method of follicular 
assessment from 3D ultrasound; Virtual Organ Computer-aided Analysis (VOCAL). Salama et al. (2008) 
and Lamazou et al. (2010) found SonoAVCª to correlate strongly with VOCAL results, and previously 
our own research group concluded that SonoAVCª measurement of follicular volume and diameter may 
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even be more valid than the 2D and VOCAL methods (Raine-Fenning et al, 2008a and 2009a), although 
follicular diameter was systematically underestimated slightly by SonoAVCª. Deutch et al. (2009) utilised 
an artificial phantom model to examine validity of SonoAVCª, and found it to be accurate in measuring 
both diameter and volume of the ultrasound phantom, as well as in comparison to manual measurement 
from a 3D scan. Conversely, Rodrguez-Fuentes et al. (2010) found that 3D measurement of ovarian 
follicles has poor correlation with 2D measurement. However, previous work in this area has attempted to 
validate the SonoAVCª technique compared to other ultrasound-based methods only, and not to ÔtrueÕ 
measurements.  
 
6.3.1.1. Aim 
The objective of this study was to examine the accuracy of the SonoAVCª technique of measuring 
follicular diameter compared to true diameter utilising a physiologically relevant animal model. 
 
6.3.1.2. Method 
24 Bovine ovaries from the abattoir, which are structurally similar to that of the human, were scanned in 
3D using the Voluson E8 Expert ultrasound (GE Medical Systems, Zipf, Austria), with a 5-9MHz 
transvaginal probe. So that the whole organ could be seen in all planes, a bovine uterine tissue barrier 
was used to create a 30-50mm space between the ovary and the ultrasound probe, by placing the ovary 
beneath a non-pregnant uterus. The 3D image was acquired and then analysed offline using SonoAVCª 
on 4D View software (GE Healthcare Ultrasound), using the method similar to Deb et al. (2010). The 
follicles appear as dark areas on the ultrasound scan due to their hypoechogenicic characteristic.  
The software calculates the relaxed sphere diameter from the follicular volume measured (d[V]), and the 
mean follicle diameter is also calculated, from the average measurement in the x,y,z planes [m-d]. The 
d[V] was calculated in duplicate and the m-d from the second replicate. 
The follicles were then blunt dissected from the ovaries and measured by comparison to a linear scale 
while submerged, in order to obtain a ÔtrueÕ relaxed sphere diameter. This was performed by firstly cutting 
away the tough hilus from the edge of the ovary with scissors, and then proceeding to carefully tear the 
ovarian stroma with forceps so as to expose individual follicles. The follicles could be seen relatively 
 140 
easily in the tissue as the ovaries were dissected on a light box, so that they stood out from the 
surrounding tissue. The exposed follicles could then be removed gently from the ovary without bursting 
them and each was measured by comparison to a linear scale while submerged in phosphate buffered 
saline, in order to obtain an accurate ÔtrueÕ relaxed sphere diameter, as seen in figure 6.8. 
 
 
Figure 6.8. Manual dissection of a bovine ovary 
Bovine ovaries (a) were dissected manually using forceps (b and c), and the follicles removed and measured 
compared to a linear scale, while submerged (d). 
 
Follicles larger than 10mm in diameter were included in the study, as these were easily individually 
identifiable on the ultrasound scan. In addition, follicles of more than 10mm are the most relevant for 
oocyte retrieval in clinical IVF. 
The ÔtrueÕ relaxed sphere diameter was compared to the d(V) and m-d values calculated by the software. 
Data was statistically analysed using paired student t-testing, with significance set at P<0.05. 
 
 141 
6.3.1.3. Results 
Dissection SonoAVC Diameter (mm) m-d Diameter m-d  
Diameter (mm) 1 2 Average (2nd rep) Difference (%) Difference (%) 
10 7 6.2 6.6 7 30.00 30.00 
11 8 8.8 8.4 9.3 27.27 15.45 
11 6.8 6.8 6.8 7.1 38.18 35.45 
11 9.6 10.3 9.95 10.8 12.73 1.82 
11 8.9 8.3 8.6 9.1 19.09 17.27 
11 9.5 9.7 9.6 10.8 13.64 1.82 
12 8.4 8.4 8.4 9 30.00 25.00 
12 9.8 9.8 9.8 10.8 18.33 10.00 
12 13.3 13.3 13.3 14.1 -10.83 -17.50 
12 11.2 11.4 11.3 12 6.67 0.00 
12 10.7 10.1 10.4 10.8 10.83 10.00 
12 10 10.6 10.3 11.7 16.67 2.50 
12 10.4 11 10.7 11.6 13.33 3.33 
13 12.4 13.1 12.75 14.4 4.62 -10.77 
13 10.8 10.8 10.8 11.2 16.92 13.85 
13 11.5 10.9 11.2 11.5 11.54 11.54 
14 10.3 11.1 10.7 11.9 26.43 15.00 
14 8.1 10.1 9.1 10.6 42.14 24.29 
14.5 13.3 14.1 13.7 15 8.28 -3.45 
15 13.4 14 13.7 14.4 10.67 4.00 
15 11.5 11.2 11.35 12.4 23.33 17.33 
15 13.5 13.5 13.5 14.1 10.00 6.00 
15.5 13.6 12.5 13.05 15.6 12.26 -0.65 
16 14.3 14 14.15 14.6 10.63 8.75 
17 13.1 13.9 13.5 14.9 22.94 12.35 
17.5 15.8 15.5 15.65 17 9.71 2.86 
18 13.8 13.9 13.85 14.3 23.33 20.56 
18 17 17.3 17.15 18 5.56 0.00 
18.5 9 10.2 9.6 10.7 51.35 42.16 
18.5 15 14.4 14.7 15.6 18.92 15.68 
19 13.9 15.5 14.7 16.2 26.84 14.74 
19 13.2 13.8 13.5 14.7 30.53 22.63 
        Average 18.50 11.00 
Table 6.2. Follicle measurements taken at dissection and by SonoAVC software. 
 
The relaxed sphere diameter (d[V]) and the mean follicular diameter (m-d) measured by SonoAVCª was 
significantly different from that of the manual follicle dissection. The software detected 100% of follicles 
larger than 10mm in diameter, however when calculating the follicular diameter from the volume, 
SonoAVCª significantly underestimated the d[V] by 2.56mm (SD=1.88), or 20.40% (SD=14.77) 
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(P<0.001). The software also significantly underestimated follicular diameter when calculating from the 
mean follicular diameter (m-d) by 1.6mm (SD=1.91), or 12.6% (SD=14.76) (P<0.001). 
 
 
As seen in figures 6.10 and 6.11, SonoAVCª and dissection diameter measurements had a strong linear 
correlation, with Pearsons correlation coefficients (r) of 0.76 and 0.77 respectively, although the 
coefficients of determination values (r
2
) of 0.58 and 0.59 respectively indicate a considerable amount of 
variation in the data. 
 
 
 
Figure 6.10. SonoAVCª d(V) measurement of follicular diameter against the dissection diameter measured 
manually following dissection 
Equation of the line of best fit y=0.6997+1.6934, r
2
=0.5775. 
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Figure 6.11. SonoAVCª m-d measurement of follicular diameter against the dissection diameter measured 
manually following dissection 
Equation of the line of best fit y=0.754+1.8761, r
2
=0.5871. 
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Figure 6.12. Bland-Altman plots of dissection diameter minus the measured SonoAVCª diameter by volume 
d(V) as (a) absolute difference and (b) percentage difference. 
The central dashed line indicates the mean, and dotted lines are the upper and lower 95% confidence intervals. 
Overall, SonoAVCª underestimated follicular diameter by an average of 2.56mm, which equates to 20.4%. 
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Figure 6.13. Bland-Altman plots of dissection diameter minus the measured SonoAVCª mean diameter m-d 
as (a) absolute difference and (b) percentage difference  
The central dashed line indicates the mean, and dotted lines are the upper and lower 95% confidence intervals. The 
m-d calculated by SonoAVCª underestimated follicular diameter by an average of 1.6mm, which equates to 12.6%. 
 
In this study we found that we were unable to analyse a small number of scans confidently due to poor 
image quality, and as a result these were not included in the analysis (n=2; 7.7%). Although the resolution 
of ultrasound has been improved over recent years, the technique continues to require development in 
order to increase image resolution and hence improve scan quality. Once the 3D image has been 
acquired there is no way of improving the image quality in order to facilitate analysis any further, therefore 
it is very important to acquire an image of sufficient quality before examination. 
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6.3.1.4. Discussion 
This is the first study to compare the accuracy of the SonoAVCª technique of three-dimensional 
ultrasound compared to large follicles manually dissected from ovaries. In our study it was found that 
SonoAVCª significantly underestimated the follicular diameter when calculating from the volume and 
from the mean diameter (P<0.001) and as this measurement is commonly used by clinicians to determine 
the timing of hCG ovulation induction during fertility treatment this finding has clinical relevance.  
In IVF treatment it is important to aspirate follicles of an optimal size in order to optimise success 
(Wittmaack et al., 1994), which is normally decided based on the size of the lead follicle (Rosen et al., 
2008). As a result, underestimating follicular size could lead to prolonged ovarian stimulation that extends 
the growth of follicles to the detriment of oocyte quality due to post-maturation (Arnot et al., 1995; Rosen 
et al., 2008). 
Comparable studies examining efficacy of SonoAVCª have analysed the software in relation to 2D 
ultrasound techniques (Deb et al., 2010; Rodrguez-Fuentes et al., 2010), other software such as VOCAL 
(Salama et al., 2009; Lamazou et al., 2010) and artificial phantoms (Deutch et al., 2009). One explanation 
for the discrepancy is that due to the nature of our study, the manual dissection of follicles from the 
ovaries included the follicle wall in the measurement of the follicular diameter. However, the wall 
thickness of follicles of this size are between 40 and 120#m (Singh and Adams, 2000), therefore the wall 
thickness of the follicles in this study would not have affected the results to any significant degree. 
Due to the linear correlation between SonoAVCª and dissection diameter, it would seem that applying a 
correction factor to the software results could be a viable means to convert measurements made by 
SonoAVCª to true diameter. In addition, the mean diameter m-d measurement appears to be more 
accurate than that of the SonoAVCª diameter by volume d(V), suggesting that this may be a more 
appropriate measure to consider. 
The quality of the acquired 3D ultrasound image is key when analysing the ovary using SonoAVCª 
(Rodrguez-Fuentes et al., 2010). This is of particular importance because once the image has been 
acquired, little can be done in order to improve image quality to facilitate analysis.  
In conclusion, SonoAVCª appears to underestimate follicular size by approximately 20% following 3D 
ultrasound scan, therefore clinicians should take care when interpreting the results from the software, or 
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apply a correction factor to bring the diameter in line with current clinical practice, in order to avoid 
prolonged ovarian stimulation. 
 
 
6.3.2. SonoAVC measurement of ovarian reserve 
Three-dimensional (3D) ultrasound offers an alternative method for estimation of the number of antral 
follicles with improved intra- and interobserver reliability than the conventional 2D technique (Deb et al., 
2009). Manual measures of follicle size are still time consuming and liable to error both in terms of the 
number and size of the follicles. Sonography-based automated volume count (SonoAVCª: General 
Electric Healthcare, Zipf, Austria) is a new software which automatically identifies and quantifies fluid-
filled, hypoechoic areas within a three-dimensional datatset (Raine-Fenning et al., 2008). Whilst it was 
developed for larger follicles, and follicle tracking in particular, it may be applied to the unstimulated ovary 
and be used to identify and measure antral follicles (Deb et al., 2009; 2010). Previous work from our 
research group has demonstrated that the software is more reliable (Deb et al., 2010) and valid 
(Jayaprakasan et al., 2008) than 2D equivalent techniques (Raine-Fenning et al., 2007; 2008; 2009), 
however in relation to actual follicle number the validity of SonoAVC has not yet been determined. 
 
6.3.2.1. Aim 
The objective of this study was to examine the validity of SonoAVC for the identification and quantification 
of antral follicles by comparing the automated ultrasound measures with actual measures derived by 
dissection in a physiologically relevant animal model.  
 
6.3.2.2. Method 
23 bovine ovaries, which are morphologically similar to those of the human (Adams and Pierson, 1995), 
were obtained from an abattoir. The ovaries were surrounded by a bovine uterus to create a tissue barrier 
of 3-5cm in order to distance the ultrasound transducer a set distance from the ovary and create a 
physiological interface comparable to that encountered in the clinical situation. The ovaries were 
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visualised by applying a 7.5MHz transvaginal ultrasound transducer (Voluson E8 Expert: GE Medical 
Systems, Zipf, Austria) manually held in place to locate and demonstrate the ovary in 2D.  
A 3D acquisition was then performed using the high quality mode and wide angle. The resultant image 
was checked to ensure the whole ovary had been included and then saved to the ultrasound machine, 
before being transferred to disc for later analysis. The ultrasound settings were standardised and kept 
identical for all of the ovarian scans. 
All of the follicles were then manually dissected from the ovaries using forceps, under a magnifier lamp 
using the same method previously described for the follicular measurement study.  
All data were analysed offline using 4D View software (version 7.0, GE Medical Systems) using the 
method described in the methods section 2.4.1.  
Deb et al. (2009) showed that the software is not capable of detecting all of the visible follicles from the 
scan automatically, and so post-processing was used so that any follicles that had been missed by 
SonoAVC could be added manually to the dataset by clicking on the dark areas of the scan. This process 
simply adds follicles to the list from the automated analysis, so the automated measurement is also still 
performed on the manually selected follicles. This does negate some of the advantages of using 
automated software, however post-processing was necessary to ensure that all visible follicles were 
included in the antral follicle count.  The total number of follicles detected both automatically and manually 
was considered to be the antral follicle count for each scan dataset. 
The smallest structures identifiable on ultrasound are around 2mm in diameter (Broekmans et al., 2009) 
and this was considered, therefore, to be the lower detection limit for the study. Follicles measuring up to 
10mm in diameter were included in the analysis as these are the largest follicles used for the assessment 
of antral follicle count; larger follicles being considered more likely to be atretic (Khairy et al., 2008). The 
follicles were grouped into sizes based on their mean diameter measured at dissection, into those of 
interest in current literature; 2-5mm (Chang et al., 1998; Pellicer et al., 1998; van Rooij et al., 2002), 2-
6mm (Haadsma et al., 2007; Deb et al., 2009a; Jayaprakasan et al., 2010a), 2-8mm (Weenen et al., 
2004), 2-9mm; which is the Rotterdam criteria for polycystic ovary syndrome diagnosis, defined in 2003 
(Scheffer et al., 2003; Ng et al., 2005; Jayaprakasan et al., 2008) and 2-10mm (Broekmans et al., 2009). 
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Data distribution was tested for normality using the DÕAgostino and Pearson omnibus test in GraphPad 
Prism (version 5.03), and then the software was used to statistically analyse the data using chi-squared 
testing. Statistical significance was set at 0.05.  
 
 
6.3.2.3. Results 
Following DÕAgostino and Pearson omnibus testing, the data was found to be normally distributed. In this 
study the SonoAVC software significantly underestimated the antral follicle count for follicle ranging from 
2 to 10mm in diameter (P<0.001), by an average of 13.96 (SD±15.05) follicles per scan, equating to 
38.64% (SD±24.19). Table 6.3 below shows the dissection and SonoAVC antral follicle counts.  
 
Ovary Dissection AFC SonoAVC AFC Follicles missed by software 
1 31 24 7 
2 14 10 4 
3 9 8 1 
4 21 13 8 
5 16 8 8 
6 31 25 6 
7 8 1 7 
8 68 30 38 
9 61 38 23 
10 64 21 43 
11 5 4 1 
12 54 17 37 
13 39 24 15 
14 18 9 9 
15 16 14 2 
16 73 22 51 
17 5 5 0 
18 14 8 6 
19 19 6 13 
20 14 13 1 
21 55 29 26 
22 33 19 14 
23 31 30 1 
  
Mean 13.96 
  
SD 15.05 
Table 6.3. Antral follicle counts performed following ovarian dissection and using SonoAVC software. 
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Figure 6.14 shows SonoAVC antral follicle counts plotted against the follicle count at dissection. Notably, 
all of the SonoAVC data points lie below the expected direct linear relationship dashed line, and so the 
line of best fit falls lower than expected, indicating that the software persistently underestimates the 
follicle count. In addition it seems that the number of follicles missed increases as the antral follicle count 
increases. 
 
 
Figure 6.14. SonoAVC antral follicle count against follicle count at dissection. 
The solid black line of best fit (y=0.3665x + 5.2956) has a coefficient of determination of 0.63, and correlation 
coefficient of 0.79. The dashed line indicates a linear relationship y=x, which would be the line of best fit if the two 
method measurements were identical. 
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Figure 6.15  shows the average number of follicles missed by SonoAVC, per scan, grouped according to 
the number of follicles counted at dissection. This further demonstrates that as the number of follicles in 
the ovary increases, the number missed by the software also increases. 
 
 
Figure 6.15. Average number of follicles missed by SonoAVC compared to the count at dissection, grouped 
into 3 groups of low (<25), medium (25-50) and high (>50) follicle numbers 
Error bars indicate SEM. 
 
Follicle visibility was calculated as the percentage of follicles detected by SonoAVC compared with the 
count at dissection. It was found that this increased with follicular size, as seen in table 5.4 below. The 
follicles were grouped into sizes into equal or smaller than 2mm, 2-3mm, 3-4mm, 4-5mm, 5-10mm and 
greater than 10mm. In this study we found that 100% of follicles larger than 6mm in diameter were 
successfully detected by the software. 
 
%2mm 2-3mm 3-4mm 4-5mm 5-10mm >10mm 
Dissection AFC 227 184 159 52 46 31 
SonoAVC AFC 123 109 55 28 42 31 
% visibility 54.19 59.24 34.59 53.85 91.30 100.00 
Table 6.4. Antral follicle counts at dissection and by SonoAVC with percentage visibility for follicles in 
different size groups. 
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Follicles were also grouped in to small, medium and large diameter groups; 2-4mm, 4-6mm and 6-10mm 
respectively. The smaller follicles had the poorest rate of detection with only 47.4% of follicles measuring 
2-4mm in diameter being detected by SonoAVC. Follicle detection increased with follicular size; 60.56% 
of follicles 4-6mm in diameter were detected, and the larger follicles 6-10mm in diameter were all 
detected by the software when post-processing was applied (figure 6.16). 
 
Figure 6.16.  Overall SonoAVC percentage follicle visibility in three major follicle size classes 
 
The results were analysed both in terms of overall follicle visibility and also on a per scan basis, as seen 
in table 6.5 which shows the percentage follicle visibility grouped into relevant follicle sizes classes 
according to the literature (see method section) as well as mean follicle visibility per scan. 
 2%5mm 2%6mm 2%8mm 2%9mm 2%10mm 
Dissection Count 395 417 433 440 441 
Sono AVC 192 207 223 228 234 
% Visibility 48.61 49.64 51.50 51.82 53.06 
      
Average % Visibility 
per Scan 
56.04 ± 31.26 54.48 ± 27.79 58.29 ± 29.95 58.00 ± 29.99 54.85 ± 30.53 
Table 6.5. Overall visibility of antral follicles detected by SonoAVC software in major AFC size classes 
used in the literature, and mean percentage follicle visibility per scan (±SD). 
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6.3.2.4. Discussion 
To date this is the first study to examine the validity of SonoAVC for the identification and quantification of 
antral follicle number and size compared to a physiological phantom model. Our results show that 
SonoAVC significantly underestimates the number of antral follicles compared to the manual count 
obtained through dissection of the ovary, although the degree of underestimation depended on both 
follicle size as well as the number of follicles present in the ovary. 
For follicles 6-10mm in diameter SonoAVC detected all follicles, but this high visibility declined 
dramatically to less than 50% for small antral follicles measuring 2-4mm in diameter. As small antral 
follicles are more numerous, collectively antral follicles visibility was low when total AFC from 2-10mm 
was calculated (table 2). 
The software underestimated the antral follicle count by an average of 38.64% per scan, equating to 
13.96 follicles, indicating that SonoAVC may not be an accurate method for estimating ovarian reserve. 
Antral follicle visibility ranged from 48.6% for follicles 2-5mm in diameter, to 53% for follicles 2-10mm in 
diameter, and therefore it is worth noting that follicle visibility differs slightly depending on the follicle size 
inclusion criteria for antral follicle count (table 6.5).  
As illustrated by figure 5.15, as the total number of follicles in the ovary increased, the number of follicles 
missed by the software also increased. This suggests that the proportion of follicles missed by the 
software increases exponentially; therefore error is highest in the ovaries containing the highest numbers 
of follicles. From a clinical standpoint, this may mean that the discrepancy between estimated and actual 
AFC may not be of major significance as very few human patients for IVF have AFCs greater than 25 
(Almog et al., 2010). Conversely, for those women who do have unusually high numbers of small antral 
follicles, SonoAVC AFC determination may lead to patients being administered higher doses of 
gonadotrophin that would be considered appropriate. 
The software is capable of successfully identifying all of the follicles greater than 6mm in diameter, 
indicating that the resolution of 3D ultrasound is sufficient for the software to identify these follicles with 
relative ease. The software was able to identify these large follicles automatically, without the need for 
adding them through post-processing, however detection of smaller follicles required additional 
processing in order to be detected. 
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Follicles in the cohort larger than 6mm in diameter are not considered to contribute to the so-called 
ÔfunctionalÕ ovarian reserve (Gougeon and Lefvre, 1983; Webb and Campbell, 2007). Recently our 
research group found that it is the antral follicles measuring between 2 and 4mm in diameter that may be 
the most predictive of pregnancy following assisted reproductive treatment (Deb et al., 2009b). In 
addition, the number of follicles 2-4mm in diameter was significantly predictive of fertilisation and embryo 
cleavage rates, supporting the theory that the smaller follicles are a more reliable representation of the 
true ovarian potential. 
The results indicate that the program may be inaccurate in detecting small antral follicles, 2-6mm in 
diameter, within a three-dimensional ultrasound dataset. The small follicles had the poorest visibility, 
which is of particular significance as it seems probable that it is the smaller sized follicles that form the 
functional ovarian reserve, bear the closest correlation to serum AMH levels and are also form the best 
predictor of ovarian response in assisted reproductive treatments (Weenen et al., 2004; Haadsma et al., 
2007; Jayaprakasan et al., 2009). The software appears to miss a large proportion of these follicles, 
which is almost certainly as a result of the current resolution limit of ultrasound, as it was found that these 
small follicles were relatively difficult to distinguish on the ultrasound image.  
It is important for the clinician to consider that when estimating the ovarian reserve using SonoAVC, the 
technique does not detect a significant proportion of small antral follicles that form the functional ovarian 
reserve. Therefore it would be advisable to utilise additional methods in order to provide a more robust 
estimation of ovarian reserve estimation, such as serum AMH, which has a good correlation to ovarian 
reserve (Jayaprakasan et al., 2009). Utilising these methods side-by-side would be likely to offer a 
reliable indication of ovarian responsiveness to stimulation during fertility treatment (de Vet et al., 2002; 
van Rooij et al., 2002; Hansen et al., 2011; Majumder et al., 2010). 
In conclusion, SonoAVC is a novel and promising technique for automated large antral follicle tracking as 
it is capable of detecting all large antral follicles without the need for post-processing and editing. The use 
of this software for antral follicle counting does however have some limitations, as a considerable amount 
of operator processing and editing is required, and it is unable to detect a significant proportion of small 
antral follicles from the growing cohort. These limitations should therefore be considered when utilising 
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this technology at the present time. Currently the SonoAVC is more suited to be used as a research tool 
rather than a routine clinical method of AFC assessment (Deb et al., 2009a). 
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Chapter 7 - Clinical Trial: Peri- llicular bl d  
molecular markers and follicular fluid constituents as 
predictors of oocyte and embryo quality 
 
7.1. Introduction 
Despite 30 years of development and extensive research, the success rate of in vitro fertilization (IVF) is 
still relatively poor, and as a result there is a continuous drive to improve the technique for the benefit of 
both practitioners and patients (Pennings and Ombelet, 2007). Relatively recently, the focus has shifted 
toward single embryo transfer (SET), to avoid the negative financial and health implications associated 
with multiple gestations (Fauser et al., 2006). As a result, it has become even more important to select 
individual embryos for transfer with the highest chance of producing a pregnancy (Assou et al., 2008). 
Oocyte quality is a major limiting factor in female fertility, and currently there is a lack of objective and 
reliable predictors of oocyte developmental competence (Li et al., 2008). Morphological parameters, 
which at present form the basis for oocyte selection in the clinical setting, are based on appearance of 
cytoplasm, polar body and cumulus cells, making the process highly subjective and as a result, 
inaccurate (Balaban et al., 1998; Nicholas et al., 2005; Wang et al., 2007). As a result, a key goal of 
improving IVF outcome is to define objective and non-invasive markers of oocyte quality that are capable 
of predicting oocyte developmental competence (Li et al., 2008). 
One source of material for analysis of oocyte developmental competence is the somatic cells to which the 
oocyte is associated in the follicle, as it is thought that the health status of the oocyte is directly related to 
that of the surrounding cells (Gilchrist et al., 2008). Recently, research using cumulus cells has shown 
gene expression to reflect oocyte and embryo quality, and even pregnancy outcome (Assou et al., 2008; 
Feuerstein et al., 2007). Granulosa cells, which line the inside of the ovarian follicle, are thought to 
harbour the same potential. 
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The follicular fluid in which the oocyte resides can be considered as a Ôbiological windowÕ, which reflects 
the metabolic and hormonal status of the oocyte microenvironment prior to ovulation or egg retrieval, and 
consequently is an additional potential target for analysis relating to oocyte quality and consequent IVF 
outcome (Wiener-Megnazi et al., 2004). The follicular fluid of each individual follicle is unique, and is also 
different to that of the circulatory system, and its composition changes continuously throughout 
folliculogenesis, both in terms of steroid hormones (Andersen, 1993) and growth factors such as 
endothelial growth factor (Westergaard et al., 1990). Measurement of growth factors secreted by the 
oocyte (for example BMP15 and GDF9), angiogenic growth factors from somatic cells (for example VEGF 
and HIF), and also constituents of the follicular fluid such as steroid hormones (for example oestradiol 
and progesterone) could potentially be used as indicators of oocyte quality. 
Assessment of blood flow to the follicle by 3 dimensional power Doppler ultrasonography is a tool that 
could also be used for the purpose of assessing follicular status. Peri-follicular blood flow has a 
considerable influence on the development of the oocyte within. As the method is objective and non-
invasive, and closely related to follicular development, it could serve as a good predictor of oocyte 
competence and embryo development. The measurement of peri-follicular blood flow is more likely to 
directly relate to the quality of the oocyte within than quantifying the blood flow to the whole ovary itself, 
as the microenvironment of the individual follicle is directly affected by its locally available vasculature. 
Although ovaries with high blood flow are associated with improved response to stimulation (Pan et al., 
2004), measurement of stromal flow is not predictive of oocyte quality or IVF outcome (Ng et al., 2005; Ng 
et al., 2006). Therefore measuring peri-follicular blood flow would seem like an ideal candidate to relate to 
oocyte developmental competence. 
 
Hypothesis 
The follicular fluid and follicular somatic cells are discarded during clinical IVF and ICSI, as they currently 
serve no further purpose, however we hypothesise that analysis can be performed on these by-products 
in order to relate peri-follicular blood flow with oocyte and embryo developmental competence, and later 
pregnancy rates. Molecular and gene expression analyses are techniques that can be applied to the 
follicular fluid and somatic cells that are normally discarded during the procedures involved in IVF. The 
 158 
results of such analyses could be related to the non-invasive assessment of follicle health by 3D power 
Doppler ultrasound and the developmental competence of the embryo, so as to develop novel quality 
assessment techniques to be used alongside the morphology-based method in place. This would ensure 
that the embryo selected for transfer has the best possible chance of producing a pregnancy, and hence 
improve IVF outcome. 
 
7.2. Aim 
The principle aims of the study are to determine whether follicular growth rates and peri-follicular blood 
flow are related to levels of expression of local factors that regulate angiogenesis and metabolism within 
ovarian follicles which, in turn, provide information on the developmental competence of oocytes within 
these follicles. We intend to do this by carrying out the following objectives: 
1. To measure follicular size and rate of growth by 3D ultrasound in patients undergoing ovarian 
stimulation. 
2. To measure peri-follicular and ovarian blood flow by 3D Power Doppler ultrasound in patients 
undergoing ovarian stimulation. 
3. To track developmental progress of embryos from fertilization until clinical pregnancy. 
4. To measure antral fluid concentrations of sex steroid hormones such as oestradiol and progesterone, 
oocyte secreted factors such as BMP15 and GDF9 and ovarian somatic cell factors such as AMH. 
5. To measure levels of mRNA and protein expression of markers of angiogenesis such as VEGF and 
HIF-1! in granulosa and cumulus cells. 
 
7.3. Study outline 
Participants are recruited from the cohort of female patients undergoing infertility treatment using ICSI in 
the NURTURE fertility clinic, as the oocytes and embryos in this treatment regime can be tracked through 
development with relative ease. In addition the cumulus cells can be collected from around the oocytes as 
part of this technique. 
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Initially, a pilot study was performed in approximately 100 patients, after which the distribution of the data 
was analysed. Following appropriate statistical analysis it was then be determined how many patients are 
needed to power a study suitably. 
The NURTURE fertility clinic has around 600 patients per year, half of which have ICSI treatment. This 
would indicate a potential sample size of 300 patients, with approximately half of these patients having 
single embryo transfer under the new NHS funding system. 
Due to the study requiring human participants, ethical approval had to be sought from a local NHS 
research ethics committee through the Integrated Research Application System (IRAS). The study 
received full ethical approval from the Derbyshire NHS Research Ethics Committee (Project reference 
number 09/H0401/81), following peer review from Professor Helen Picton of Leeds University. 
 
Screening (Visit 1) 
The screening visit takes place a maximum of 2 months prior to commencement of fertility treatment. 
¥ The patients attend a consultation and antral follicle count by 3D ultrasound scan, between day 2 and 
day 5 of the menstrual cycle, as per normal protocol. Eligible patients who are expected to have ICSI 
are invited to participate in the study, provided that the inclusion/exclusion criteria are met. 
¥ The study is explained in detail and the participant given the patient information sheet and written 
consent form, which the patient is given a minimum of 24 hours to read and sign. 
 
Trial period 
Participants are managed as per the normal clinical practice for ICSI treatment protocol with some 
alterations; 
¥ At ovulation induction, the patient undergoes 3 dimensional ultrasound to identify follicles that are 
likely to be aspirated. This does not require an additional visit, but adds a maximum of 15 minutes 
onto the normal time required. 
¥ Before oocyte retrieval, the participant undergoes 3 dimensional transvaginal ultrasonography and 
around 6 individual follicles identified for aspiration. Follicles of 10-26mm in diameter are chosen at 
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random and scanned using power Doppler ultrasound to examine their peri-follicular blood flow. The 
selected follicles are then aspirated and the fluid and cells used for analysis in the study. 
¥ This additional scan adds no more than 10 minutes onto the normal protocol, which currently requires 
30 minutes. A 45 minute window is allowed for the whole procedure so as not to delay the patients 
which follow. 
¥ As per the normal ultrasound scanning procedure, the 4D scans obtained are stored on the scanning 
machine computer and may be used for future research in retrospect, with signed permission from 
the participant. 
¥ Following ICSI on the selected individual oocytes, fertilized zygotes are cultured individually in 
microdrops in order to allow tracking and identification. This is not considered to be detrimental to the 
development of the embryo. 
¥ Embryo transfer of 1 or 2 embryos is performed at the discretion of the patient and clinician, at day 2-
3 or day 5 for blastocyst transfer. During embryo transfer, 3D ultrasound is used instead of 2D in 
order to examine the status of the endometrium. This is not expected to result in any significant 
increase in the amount of time taken for the procedure. Post-implantation data is used only for the 
participants undergoing single embryo transfer, as tracking of individual embryos is not possible for 
double embryo transfer patients. 
 
The number of embryos to be transferred is entirely at the discretion of the patient and clinician, and 
unaffected by the study.  
Post-transfer data from patients undergoing single embryo transfer (SET) is kept separate from those 
having two embryos transferred, so that individual follicle data can be tracked through to pregnancy for 
SET patients. Data from double embryo transfer patients is also recorded and may be used, in a separate 
analysis, as even though individual embryo tracking is lost, the final outcomes can still be related back to 
some pre-transfer data. 
 
 
 
SCHEMATIC DIAGRAM OF POEM STUDY DESIGN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1. Schematic diagram of POEM study design 
Yellow boxes indicate the additional 3D ultrasound scans required for the POEM study. The first two yellow boxes indicate study scans to be used in another 
study, the data from which are not utilised for the purposes of the POEM study. 
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7.4. Data Collection 
7.4.1. Transvaginal ultrasonography 
All data was acquired using the same ultrasound machine and a 5-8 MHz transvaginal probe for all 
patients. Scans were performed in the standard manner with the patient in a supine position with knees 
flexed and hips abducted. The individual conducting each ultrasound scan was recorded, and the 
ultrasound settings used for every scan were kept constant for every patient. 
3D Power Doppler and pulse wave Doppler analysis of and ovarian blood flow was carried out as per 
normal treatment protocol, with an additional scan at the time of oocyte retrieval. Vascularisation Index 
(VI), Flow Index (FI) and Vascular Flow Index (VFI) around individual follicles was generated from the 
Power Doppler analysis, as well as follicle volume using shell imaging (Jayaprakasan et al., 2009). 
 
7.4.2. Blood sampling 
Blood samples were taken as per the regular treatment protocol, to determine levels of serum 
gonadotrophins (FSH, LH) and sex steroids (oestrogen, progesterone), as part of the normal treatment 
regime. 
 
7.4.3. Ovarian cells and follicular fluid 
Follicular fluid was collected following aspiration of individually identified follicles. If the follicles require 
aspiration to find the oocyte, the aspirate fluid was also collected from these flushes. Once the oocyte had 
been retrieved from the follicular aspirate by the embryologist, the remaining follicular fluid with cells was 
collected and processed. 
All follicular fluids and aspirates were collected in separate tubes and labeled with patient initials, date of 
birth, patient ID number, follicle number, and F or A (for follicular fluid or aspirate). The oocyte associated 
with the follicular fluid was given a patient ID number, and the same follicle number as its follicular fluid.  
Oocytes were kept separate from each other in order to maintain individual identity throughout. 
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Following maturation, the cumulus cells were stripped from the oocyte before fertilization, as per the 
normal ICSI protocol, and the cumulus cells collected into labelled tubes. Cumulus cell tubes were 
labelled with patient initials, date of birth, patient ID number and follicle number, followed by a C (for 
cumulus cells). Identifiers were kept identical on all study documents. 
 
Example of complete dataset from an aspirated follicle from one patient; 
JB-050475-102-1-F  Josephine Bloggs, D.O.B., Patient 102, Follicle 1, Follicular fluid 
JB-050475-102-1-A1  Josephine Bloggs, D.O.B., Patient 102, Follicle 1, First aspirate 
JB-050475-102-1-A2  Josephine Bloggs, D.O.B., Patient 102, Follicle 1, Second aspirate 
JB-050475-102-1-C  Josephine Bloggs, D.O.B., Patient 102, Follicle 1, Cumulus cells 
JB-050475-102-1-G  Josephine Bloggs, D.O.B., Patient 102, Follicle 1, Granulosa cells* 
*(Following separation from follicular fluid and aspirates by centrifugation) 
 
7.4.4. Granulosa cell and follicular fluid collection 
Follicular aspirates from egg collection were transferred from petri dishes to 1.5ml Eppendorf tubes under 
a stereo microscope to ensure all cells had been collected. Tubes were labelled with the participant ID 
and the aspirate type (follicular fluid or flush), and then centrifuged at 10,000rpm for 3 minutes. 
The supernatant (follicular fluid) was transferred into 1.8ml cryotubes and snap frozen in liquid nitrogen 
before being moved into a -80¡C freezer for storage. The cell pellets were resuspended in PBS and 
centrifuged at 10,000rpm for 3 minutes to wash the cells. The supernatant was discarded, and 350!l RLT 
lysis buffer (Qiagen 79216) with !-mercaptoethanol (!-ME) at 0.01% added to lyse the cells. The cell 
suspension was then transferred to cryotubes and snap frozen in liquid nitrogen and stored at -80¡C. 
 
7.4.5. Cumulus cell collection 
Cumulus cells were stripped as part of the normal ICSI procedure in hyaluronidase. The cells were 
transferred to 1.5ml Eppendorf tubes under a stereo microscope, and labelled with participant ID and 
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ÔCCÕ, before being centrifuged at 10,000rpm for 3 minutes. The supernatant was discarded, and the cells 
taken through a wash step of 200!l PBS. The cell pellet was resuspended, and then then centrifuged at 
10,000rpm for 3 minutes once again. The supernatant was discarded, and 200!l RLT lysis buffer with !-
mercaptoethanol (Qiagen, UK) was added to lyse the cells. The cell suspension was then transferred to 
cryotubes and snap frozen in liquid nitrogen and stored at -80¡C. 
 
7.4.6. Molecular analysis 
Follicular fluid and aspirates were thawed centrifuged in order to separate out the granulosa cells, as well 
as any other contaminants such as erythrocytes.  
Sex steroid hormones were measured in follicular fluid using antibody-based quantification techniques; 
ELISA and radioimmunoassay. In addition, oocyte-secreted growth factors (BMP15, GDF9) and somatic 
cell factors (AMH) were later quantified using specific ELISAs as per the procotol supplied with the kits 
(chapter 2). 
In the future when 2 samples are able to be collected from a single participant, the granulosa and 
cumulus cells will analysed for gene expression of growth factors, including the angiogenic growth factors 
VEGF and HIF, as well as a range of RNA and protein expression profiles, by extracting the mRNA and 
synthesizing cDNA, followed by real-time PCR. A proportion of the cumulus cells will also be collected to 
be used for staining to indicate their redox state and hence oxidative stress, which has been shown to 
relate to oocyte and embryo quality (Tarn, 1996; Tamura et al., 2008). 
 
  
 165 
7.5. Results 
The amount of time required for the planning, ethical approval and implementation of the clinical trial 
meant that the number of patients successfully recruited and completed was much lower than anticipated. 
A summary of the study participant outcomes can be seen in figure 7.2 below. 
 
Figure 7.2. POEM study patient outcome flow diagram 
 
A total of 38 patients were recruited during the 6 months that the trial ran for, and 24 egg collections were 
performed. Of the 24 patients that underwent egg collection, 2 converted to IVF treatment due to an 
improved ejaculate sample being received on the day of collection. As a result, these patients were 
excluded from the embryo tracking part of the study, but their study scans were retained for analysis. 
¥ Twenty eight follicles were aspirated in total due to 4 patients having both right and left ovaries 
aspirated for a selected oocyte. This was performed if an oocyte was not found in the aspirate of the 
first ovary. Twenty two oocytes were retrieved in total, all of which were assessed as being 
metaphase II and therefore suitable for fertilization. Six of the aspirated follicles did not contain a 
retrievable oocyte, and so no embryological data could be collected from these individuals. 
38 recruited patients 
24 egg collections 
with 
28 follicle aspirations 
2 converted to 
IVF 
6 failed follicle 
aspirations 
8 failed ICSI 
fertilisations 
2 arrested 
embryos 
3 Day 2 
embryos 
3 Embryo 
transfers 
2 Negative 
preg. tests 
1 Pregnancy 
7 Blastocysts 
1 frozen 
Embryo did not 
survive 
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¥ Eight of the oocytes retrieved did not fertilise successfully following intracytoplasmic sperm injection. 
Of the oocytes that did fertilise, 3 embryos were transferred on day 2 after egg collection, with 2 failed 
embryo implantations, and 1 confirmed positive pregnancy by foetal heartbeat on ultrasound. 
¥ Two embryos arrested on day 5 at 4 cell and 8 cells, however 7 embryos continued to develop to 
blastocyst stage. None of these blastocysts were selected for transfer, however one was frozen to be 
used in a later frozen embryo cycle. Unfortunately this embryo did not survive the thawing process 
and so was not able to be transferred. 
 
Initially the addition of the power Doppler scan at egg collection caused the procedure to take slightly 
longer than usual. As a result it was decided to aspirate only one follicle from each patient, so that the 
increase in time required for egg collection would not cause damage to the oocyte. When an oocyte was 
not retrieved from a selected follicle and sufficient time was available, the aspiration needle was replaced 
and a follicle on the other ovary was scanned and aspirated. Although no oocyte was found in these 
follicles, the scans were kept and analysed, and the follicular fluid and granulosa was collected. 
 
Ovarian Stimulation 
Patients were down-regulated from day 21 of the cycle by buserelin subcutaneous injection or nasal 
spray, or nafarelin nasal spray. Following this ovarian stimulation was administered using Menopurª 
(Ferring Pharmaceuticals, Berkshire, UK) (n=17), Pergoverisª (n=1) or Gonal-Fª (both Merck Serono, 
Geneva, Switzerland) (n=6). Ovulation was induced using Ovitrelle
¨
 or Pregnyl
¨
 (Merck Serono, Geneva, 
Switzerland). 
 
7.5.1. Case Report 
One patient recruited for the POEM study successfully became pregnant, following ICSI treatment with 
frozen semen obtained by electroejaculation. This 32 year old patient originally had what would be 
considered to be a relatively poor prognosis, due to this cycle being her third and her partner suffering 
from ejaculatory dysfunction.  
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At the hCG scan, the patient had 18 visible follicles on both ovaries, with an endometrial thickness of 
approximately 14mm, and so was administered hCG 36 hours before egg collection. 
 
 
Figure 7.3. 3D power Doppler ultrasound scan of the ovarian follicle at hCG scan, later selected for aspiration 
The measured follicular dimensions can be seen in the lower right hand corner. Mean follicular diameter was 1.66cm, 
and volume 2.59cm". 
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Figure 7.4. 3D power Doppler ultrasound scan of the ovarian follicle selected for aspiration at egg collection 
The follicle had a mean diameter of 1.83cm and a volume of 3.32cm". 
 
A total of 9 oocytes were retrieved at egg collection, 6 of which were found to be metaphase II and 
suitable for ICSI. Just 1 of these oocytes fertilized successfully, and developed to a 4 cell, grade I embryo 
by day 2 of culture. This embryo was transferred, and a biochemical pregnancy test performed after 
approximately 7 days, the result of which was positive. The patient then returned to the clinic for an early 
pregnancy scan after 8 weeks, which revealed the foetal heartbeat of a singleton uterine pregnancy, with 
a crown rump length of 17mm, which is due to be born on 27
th
 August of this year. This is the first 
reported case of successful tracking of a human pregnancy from hCG scan through to 8 weeks gestation. 
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7.5.2. Power Doppler Ultrasound 
The data from prehCG and egg collection ultrasound measured vascular indices and follicular 
measurements are shown in table 7.1 below. 
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Table 7.1. Power Doppler ultrasound and follicular size parameters measured at prehCG scan and egg 
collection, grouped according to oocyte retrieval, fertilisation and embryo transfer (± SEM). n = Number of 
replicates, VI = Vascular Index, FI = Flow Index, VFI = Vascular Flow Index, D = Mean follicular diameter 
in mm and vol = Follicular volume in cm". 
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7.5.3. Oocyte Retrieval 
The relationships between follicular size and ultrasound vascular indices with oocyte retrieval were 
examined as seen in figures 6.5 to 6.9 below.  None of the measures of follicular size or peri-follicular 
blood flow at prehCG or egg collection were significantly different in follicles from which an oocyte was 
retrieved. 
 
Figure 7.5. Mean follicular diameter against oocyte retrieval 
Error bars indicate SEM. 
 
 
Figure 7.6. Follicular volume against oocyte retrieval 
Error bars indicate SEM. 
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Figure 7.7. Vascular index against oocyte retrieval 
Error bars indicate SEM. 
 
 
 
Figure 7.8. Flow index against oocyte retrieval 
Error bars indicate SEM. 
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Figure 7.9. Vascular flow index against oocyte retrieval 
Error bars indicate SEM. 
 
7.5.4. Oocyte Fertilisation 
The relationships between follicular size and the ultrasound vascular indices with oocyte fertilisation were 
examined. Measures of follicular size were not significantly related to oocyte fertilisation, although 
oocytes that were not fertilised did tend to come from follicles with a larger volume, as measured at both 
prehCG and egg collection (figure 7.11). 
 
Figure 7.10. Mean follicular diameter against ooyte fertilisation 
Error bars indicate SEM. 
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Figure 7.11. Follicular volume against oocyte fertilisation 
Error bars indicate SEM. 
 
Fertilisation rates were compared in relation to the vascular indices measured at prehCG and egg 
collection, as seen in figures 7.12 to 7.14 below. Vascular index was slightly lower at prehCG scan for 
follicles that did not contain an oocyte that fertilised, although this was not significant (P<0.06) (figure 
7.12). Flow index and vascular flow index were significantly lower at prehCG scan for follicles that 
contained an oocyte did not fertilise (figures 7.13 and 7.14) (P<0.01 and P<0.05 respectively). 
 
Figure 7.12. Vascular Index against oocyte fertilisation 
Error bars indicate SEM. 
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Figure 7.13. Flow Index against oocyte fertilisation 
Error bars indicate SEM. ** P<0.01 compared to fertilised group. 
 
 
Figure 7.14. Vascular flow index against oocyte fertilisation 
Error bars indicate SEM. * P<0.05 compared to fertilised group. 
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7.5.5. Embryo Transfer 
The relationships between follicular size and ultrasound vascular indices with embryo transfer were 
examined. There was no significant relationship between follicular mean diameter and volume measured 
at prehCG and egg collection with embryo transfer (figures 7.15 to 7.19), however a total of just 3 of the 
embryos were transferred, and so statistical power was lacking. 
 
Figure 7.15. Mean follicular diameter against embryo transfer 
Error bars indicate SEM. 
 
 
Figure 7.16. Follicular volume against embryo transfer 
Error bars indicate SEM. 
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Figure 7.17. Vascular index against embryo transfer 
Error bars indicate SEM. 
 
 
 
 
Figure 7.18. Flow index against embryo transfer 
Error bars indicate SEM. 
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Figure 7.19. Vascular flow index against embryo transfer 
Error bars indicate SEM. 
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7.5.6. Follicular Growth 
The growth of the selected ovarian follicle was assessed by calculating the difference between the 
measurements at pre hCG scan with those at egg collection, thereby determining how to what degree the 
follicles increased in size following administration of hCG. Follicular growth was examined both in terms 
of mean diameter (figure 7.20) and volume (figure 7.21). Although it seemed that follicular growth from 
prehCG to egg collection was negatively correlated to oocyte retrieval and fertilisation, these relationships 
were not significant. 
 
 
Figure 7.20. Follicular mean diameter growth against oocyte retrieval, fertilisation and embryo transfer 
Error bars indicate SEM. 
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Figure 7.21. Follicular volume growth against oocyte retrieval, fertilisation and embryo transfer 
Error bars indicate SEM. 
 
 
The follicular volume was plotted against the mean follicular diameter for all follicles at prehCG and egg 
collection, to investigate the relationship between the two (figure 7.22). It was found that a third order 
polynomial relationship exists between the mean follicular diameter and the follicular volume. 
 
 
Figure 7.22. Mean follicular diameter against follicular volume 
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7.5.7. Patient Age 
The patient age was compared to the developmental stage achieved by the selected follicle (table 7.2 and 
figure 7.23). None of these relationships were found to be significant. 
 
Oocyte retrieved No oocyte Fertilisation No fertilisation Embryo transferred Embryo not transferred 
Mean age 34.6 ± 0.97 33.0 ± 4.00 34.6 ± 1.29 35.4 ± 1.93 35.0 ± 2.08 34.4 ± 1.73 
n 21 2 12 7 3 8 
Table 7.2. Mean patient age of oocyte retrieval, fertilisation and embryo transfer (±SEM). 
 
There was no significant correlation found between patient age and developmental stage. Developmental 
stage checkpoints are outlined in table 7.3 below.  
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Table 7.3. Summary of numbered developmental stages according to the final follicle outcome. Grey 
boxes indicate final endpoints as transferrable embryos and blastocyst. 
 
 181 
 
Figure 7.23. Patient age against oocyte development stage 
Red markers indicate embryos that were transferred. 
 
7.5.7.1. Follicular size and vascular indices 
The patient age was compared to the mean follicular diameter and volume measured on ultrasound. A 
line of best fit revealed a very slight positive trend in both cases, however these were not significant and 
the slope of the trendlines is almost flat, therefore these graphs are not shown. This would be an 
expected result as there should not be a correlation between age and follicular size due to the fact that 
hCG is administered only when a minimum of 3 follicles reach a target size of 18mm, regardless of 
patient age. 
Follicular mean diameter and volume growth from prehCG to egg collection was compared to patient age. 
Although the lines of best fit suggested a positive relationship to follicular mean diameter growth, this was 
not statistically significant (data not shown). 
 
Ultrasound measured vascular indices were compared to patient age, at both prehCG and egg collection 
scans (figure 7.29). Linear regression analysis revealed a significant negative relationship between 
vascular index at prehCG and patient age (figure 7.29a; P<0.05). The same relationship was observed for 
vascular flow index at prehCG scan (figure 7.29c; P<0.05) but not for flow index (figure 7.29b). 
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Figure 7.24. PrehCG vascular indices against patient age 
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The ultrasound vascular indices were also compared to patient age at egg collection and although 
negative trends were observed between VI and VFI and patient age were observed, these were not 
significant. As a result the graphs are not shown. 
 
7.5.7.2. Follicular Fluid Constituents 
Neither oestradiol, progesterone, AMH or BMP15 concentrations in the follicular fluid were significantly 
associated with patient age when grouped into ages 30 years and under (n=4), 31 to 35 (n=8), and 
greater than 35 years of age (n=9) (figure 7.25). GDF9 was unable to be measured in follicular fluid as 
concentrations were below detectable levels. 
 
Figure 7.25. Follicular fluid (a) oestradiol, (b) progesterone, (c) AMH and (d) BMP15 concentrations against 
grouped patient age 
Error bars indicate SEM. 
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7.5.8. Follicular Aspiration 
The number of aspirations (and flushes) required to retrieve an oocyte was compared with the 
developmental stage achieved by the resulting embryo, as outlined in table 7.3, in order to ascertain 
whether flushing of the follicle is detrimental to the oocyte within. There was no significant correlation 
between number of follicular aspirations and the development of the embryo (figure 7.26). 
 
Figure 7.26. Developmental stage outcome against number of aspirations required to obtain an oocyte 
Red squares indicate transferred embryos. 
 
7.5.9. Follicular Fluid Steroid Hormones 
Following measurement of oestradiol and progesterone in the follicular fluid by ELISA, the concentrations 
were compared to oocyte fertilisation and embryo transfer, follicular size and growth, and finally patient 
age. Comparison to oocyte retrieval could not be made because only one of the follicular fluid samples 
came from a patient from which an oocyte could not been collected. 
Figure 7.27 below shows the oestradiol and progesterone concentration in the follicular fluid against 
oocyte fertilisation. No significant relationship was observed between oestradiol and fertilisation, although 
oestradiol concentration was higher in the follicular fluid of oocytes that fertilised successfully. 
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Progesterone concentration in the follicular fluid was significantly higher in the follicles which yielded an 
oocyte that fertilised successfully (P<0.05). 
 
Figure 7.27. Follicular fluid (a) oestradiol and (b) progesterone against oocyte fertilisation 
*P<0.05. Error bars indicate SEM. 
 
Figure 7.28 shows the oestradiol and progesterone concentration in the follicular fluid against embryo 
transfer. Although the relationships observed were not significant probably due to small numbers, 
follicular oestradiol concentration was higher in the group of embryos that were transferred. 
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Figure 7.28. Follicular fluid (a) oestradiol and (b) progesterone against embryo transfer 
Error bars indicate SEM. 
 
Ratio of oestradiol to progesterone was compared to consequent oocyte fertilisation and embryo transfer, 
neither of which was found to be significant (figure 7.29). As concentrations of progesterone are 
approximately 1000 fold higher than those of oestradiol in the follicular fluid, the ratio of oestradiol in 
ng/ml to progesterone in !g/ml was used as described by Xia and Younglai (2000). 
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Figure 7.29. E2:P4 ratio against (a) oocyte fertilisation and (b) embryo transfer 
Error bars indicate SEM. 
 
The relationship between follicular fluid oestradiol and progesterone concentrations and follicular size 
parameters measured both at prehCG scan and egg collection was examined. Follicular oestradiol and 
follicular mean diameter at prehCG ultrasound scan were positively correlated according to a line of best 
fit second order polynomial regression (figure 7.30a). Follicular volume was also used as a proxy for 
follicular size, and the relationship to follicular fluid oestradiol was also examined (figure 7.30b). Linear 
regression analysis revealed that oestradiol was significantly positively correlated to follicular volume 
measured at prehCG (P<0.01). 
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Figure 7.30. Follicular fluid oestradiol against prehCG follicular (a) mean diameter and (b) volume 
 
The follicular mean diameter and volume was also measured at egg collection, and so the oestradiol 
concentration in the follicular fluid was also examined against these parameters. Again, oestradiol was 
found to positively correlate to follicular mean diameter and volume following the same trends observed at 
prehCG (data not shown). 
Follicular fluid oestradiol concentration was compared to the growth of the follicles between prehCG and 
egg collection scans. Figure 7.31 below shows that there is no significant relationship to mean diameter 
growth, but a significant positive relationship to volume growth as analysed by linear regression (P<0.05). 
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Figure 7.31. Follicular fluid oestradiol against (a) follicular mean diameter growth and (b) volume growth 
 
Follicular fluid oestradiol had no correlation to vascular indices measured at prehCG and egg collection 
and so the data is not shown. Correlation coefficients were less than 0.31 in all cases. 
 
Progesterone concentration in the follicular fluid was compared to follicular size and growth. There was 
found to be no significant correlation between progesterone and follicular size measured at prehCG and 
egg collection (correlation coefficients less than 0.14 in all cases), and no significant correlation to 
follicular growth (data not shown; correlation coefficients less than 0.21). Progesterone concentration also 
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had no correlation to vascular indices measured at prehCG and egg collection. Correlation coefficients to 
VI, FI and VFI were less than 0.45 in all cases. 
 
7.5.10. Follicular Fluid TGF!  members 
The TGF! superfamily members AMH, BMP15 and GDF9 were measured in the follicular fluids collected 
at egg collection by ELISA in order to compare their concentration against oocyte and embryo 
development, as well as follicular size and growth between prehCG scan and egg collection. 
 
 
7.5.10.1. AMH in Follicular Fluid 
Intrafollicular AMH concentration was not significantly different in follicles that had successfully fertilised, 
nor in the follicles from which a transferred embryo originated (figure 7.32). 
 
Figure 7.32. Follicular AMH against oocyte fertilisation and embryo transfer 
Error bars indicate SEM. 
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AMH in the follicular fluid was compared to follicular mean diameter and volume, measured at prehCG 
scan and at egg collection (figure 7.33). Linear regression analysis showed that intrafollicular AMH 
concentration had a significantly positive linear correlation to mean diameter and volume at prehCG 
(P<0.01 in both cases; volume data not shown).  
 
 
Figure 7.33. Follicular AMH against prehCG follicular mean diameter 
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Follicular fluid AMH concentration was compared to prehCG follicle size groups of <17mm, 17-18mm, 18-
19mm and >19mm (figure 7.34a). The larger follicle diameter groups were found to have significantly 
higher AMH levels than those of a smaller size. When comparing to follicular volume, intrafollicular AMH 
concentration was significantly different only between the lowest and highest prehCG follicle volume 
groups (<3cm" and >5cm"; figure 7.34b) (P<0.01). 
 
 
Figure 7.34. Follicular AMH against grouped prehCG (a) follicular mean diameter and (b) volume 
Different letters indicate statistically significant differences between grouped follicular mean diameters (a) P<0.05; (b) 
P<0.01. Error bars indicate SEM. 
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At egg collection, the differences in AMH concentration between the follicular diameter size groups were 
not significantly different (figure 7.35a), however AMH concentration was significantly lower in follicles 
with a volume of 4-6cm
3
 (figure 7.35b). 
 
 
Figure 7.35. Follicular AMH against grouped egg collection (a) follicular mean diameter and (b) volume 
Error bars indicate SEM. 
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There was no significant relationship observed between AMH concentration in the follicular fluid and 
follicular growth from prehCG to egg collection (data not shown). Correlation coefficients with mean 
diameter growth and volume were 0.20 and 0.51 respectively. 
 
In addition, there were no significant correlations to vascular indices measured at prehCG or egg 
collection. Correlation coefficients to VI, FI and VFI were less than 0.3 in all cases (data not shown). 
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7.5.10.2. BMP15 in Follicular Fluid 
BMP15 in the follicular fluid was found to have a significant positive relationship with the follicular mean 
diameter measured at prehCG scan following linear regression (P<0.05). Follicles with a mean diameter 
of less than 17mm had significantly lower intrafollicular BMP15 concentration than those larger than 
18mm (figure 7.36a). Following linear regression, follicular BMP15 did not have a significant correlation to 
follicular volume measured at prehCG scan, however as seen in figure 7.36b, follicles with a voume of 
less than 3cm" had significantly lower BMP15 concentrations than those in the larger follicle volume 
groups (P<0.05). 
 
Figure 7.36. Follicular BMP15 against grouped prehCG (a) follicular mean diameter and (b) volume 
Different letters indicate statistically significant difference between follicular mean diameter groups (P<0.05). Error 
bars indicate SEM. 
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BMP15 in the follicular fluid was also compared to follicular size measured at egg collection. No 
significant correlation to follicular mean diameter was observed, and there was no significant difference 
between the mean diameter groups (figure 7.37a). The same was found when intrafollicular BMP15 
concentration was examined against to follicular volume, although follicles with a volume of 4-6cm" did 
have slightly decreased BMP15 concentrations compared to the other groups (P<0.05) (figures 7.37b). 
 
 
Figure 7.37. Follicular BMP15 against grouped egg collection (a) follicular mean diameter and (b) volume 
Different letters indicate statistically significant difference between follicular volume groups (P<0.05). Error bars 
indicate SEM. 
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Follicular fluid BMP15 concentration did not correlate to vascular indices measured at prehCG or egg 
collection and so the data is not shown. Correlation coefficients were less than 0.19 in all cases. 
 
7.5.10.3. GDF9 in Follicular Fluid 
GDF9 was measured in the follicular fluid by ELISA. The concentrations present in the follicular fluid were 
found to be undetectable by this method. 
 
7.5.10.4. Intrafollicular hormone and growth factor interactions 
The steroid hormones and TGF! superfamily members measured in the follicular fluid were compared to 
each other to examine any relationships between their concentrations. Interestingly, AMH and BMP15 
concentrations were found to be significantly positively correlated following linear regression analysis 
(P<0.05) (figure 7.38). No other interactions between intrafollicular hormones and factors were observed. 
 
Figure 7.38. Follicular BMP15 against follicular AMH 
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7.5.11. Ovarian Stimulation Drugs 
There were found to be no significant correlations between ovarian stimulation drug and follicular vascular 
indices, follicular size or follicular fluid constituents. 
 
7.6. Discussion 
Clearly the primary major limitation of the clinical study was the small number of patients. Although a 
lower number of patients was recruited into the trial than initially hoped, the feasibility and the extensive 
potential of the project was clearly demonstrated, and it is likely that recruitment will recommence, and 
the trial continue in the future once adequate staffing in the unit has resumed. 
Many of the results observed were indicative trends, but were not statistically significant due to small 
sample sizes. This was particularly detrimental to the analysis when examining the embryo 
developmental relationships, as there were only one or two individuals that fell into each developmental 
stage. As a result the data was analysed in terms of the largest possible groupings; oocyte retrieval, 
fertilisation and embryo transfer (although again the sample size was just 3 in the transfer group). 
In addition, although granulosa and cumulus cells were collected from each patient, due to the nature of 
commencing the trial in a relatively busy IVF unit, unfortunately only one sample per patient could be 
obtained. As a result the mRNA array expression of angiogenic factors was unable to be performed due 
to the inherent variation of expression levels within individual patients. If this trial does proceed in the 
future, 2 samples per patient will be collected so that gene expression analysis can be performed by 
PCR. 
 
7.6.1. Follicular Size 
Overall, comparison of mean follicular diameter and volume to oocyte, retrieval, fertilisation and embryo 
transfer, measured at both prehCG and egg collection did not reveal a significant relationship. In addition, 
analysis of the follicular growth between these two scan timepoints did not yield any significant 
relationships. This is likely to be due to the nature of the study using infertility patient participants, as all of 
the follicles aspirated were relatively large as a result of the stimulation regime used in the IVF process. 
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Consequently, the follicle size range of 13 to 38mm diameter in this study would mean that all of the 
follicles studied were of pre-ovulatory size, and so there was unlikely to be a marked difference observed 
in terms of IVF outcome. 
A small number of studies have investigated a possible relationship between the size of the follicle and 
the success of IVF, although few have been able to examine implantation and pregnancy rates as 
individual follicle aspiration did was not performed. For example, Wittmaack et al. (1994) observed higher 
fertilisation and cleavage rates with oocytes from follicles more than 1ml in volume, however no difference 
in embryo quality was found, and so concluded that once fertilised, oocytes had the same implantation 
potential regardless of their follicular size. In clinical IVF, follicles of 1ml are considered to be relatively 
small, with a mean diameter of less than 15mm (as seen in figure 7.22). For example, in the clinic that 
this study was conducted, ovulation would not be induced until a minimum of 3 follicles had reached 
18mm in diameter. 
Dubey et al. (1995) found that follicles greater than 16mm had oocytes with higher fertilisation rates, but 
again, this is smaller than the minimum size required for ovulation induction in a clinical setting. Bergh et 
al. (1998) also observed a higher fertilisation rate in oocytes from larger follicles under the same criteria, 
however both of these studies made these observations based on a conventional IVF program, not ICSI. 
Bergh et al. also went on to discover that in the ICSI group of patients, there was no significant difference 
in fertilisation rates in the large and small follicle groups. 
Clearly, follicles of a very small size will possess much lower developmental potential (although ICSI can 
sometimes overcome this to some extent), however in the size cohort clinically relevant for ovulation 
induction and egg collection, there seems to be little evidence that a follicle 16mm in diameter would have 
a lower chance of fertilisation than a follicle of 18mm diameter. As a result, it is unlikely to serve as an 
adequate indicator of consequent embryo development, as found in this study. 
 
7.6.2. Vascular Indices 
Ultrasound measurement of vascular indices yielded some particularly interesting results in relation to 
oocyte fertilisation. At the prehCG scan, it was found that follicles containing an oocyte that failed to 
fertilise had significantly lower peri-follicular blood flow index (P<0.01) and vascular flow index (P<0.05) 
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than the group that fertilised successfully. Vascular index was also approaching significance (P<0.06) 
with the same relationship. These relationships were not found to be present at egg collection. 
From these results it seems that follicles with a larger local blood flow yield oocytes with a higher 
fertilisation capacity. These follicles would be provided with increased oxygen to the somatic cells, as well 
as vital nutrients needed for somatic cell growth and differentiation, and more importantly oocyte 
development (Van Blerkom et al., 1997), as well as circulatory and local endocrine signals that directly 
influence development. In addition, increased flow would result in an increased capacity for removal of 
carbon dioxide and waste metabolites that could be detrimental to the oocyte, especially in terms of 
chromosomal abnormalities (Gaulden, 1992; Van Blerkom et al., 1997). These factors could contribute to 
the development of the oocyte in a more favourable environment that would ultimately dictate the 
consequent outcomes of fertilisation, embryo development and implantation, as demonstrated by several 
studies over recent years (Chui et al., 1997; Van Blerkom, 1998; Borini et al., 2001; Merc, 2002; 
Shrestha et al., 2006).  
There is a distinct lack reports of ultrasound peri-follicular vascular indices measured at prehCG scan in 
relation to IVF outcome in the literature, however Nargund et al. (1996) did implicate measurement of 
follicular vascular indices as a strong candidate for predicting oocyte fertilisation and embryo quality in a 
study examining blood velocity. Various other studies measuring blood flow at egg collection have also 
concluded that blood flow to the follicle is especially important to follicular development with respect to 
oocyte developmental competence (Chui et al., 1997; Coulam et al., 1999; Huey et al., 1999). 
Vlaisavljevi$ et al. (2010) recently demonstrated that administration of hCG has a direct effect on peri-
follicular vascular dynamics as measured by software reconstruction of the vascular network from a 
power Doppler ultrasound scan. It was observed that before hCG, blood flow to the follicle is supplied 
through a dominant vessel, and that once hCG is administered, the vascular dynamics around the follicle 
change so that a more balanced flow is achieved, and so blood supply becomes more uniform around the 
follicular perimeter. As the volume of follicles increases following the administration of hCG, the response 
is an equivalent increase in perifollicular vascular activity to meet the demands of the peri-ovulatory 
follicle. Quantification of vascularity and flow may therefore not be the whole story in terms of follicular 
development, as the distribution of these vessels may also play an important part. As a result, it seems 
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that measurement of vascular indices at prehCG and egg collection could yield potentially divergent 
results and conclusions. 
 
The main drawback of the vast majority of the studies in the literature is that none have tracked individual 
oocytes from collection to embryo transfer, and as a result the conclusions that can be drawn in relation 
to oocyte and embryo quality are somewhat limited. In addition, power Doppler measurement of peri-
follicular blood flow has only been performed at the time of egg collection, and to date there have been no 
reportings of utilization of the technique at prehCG scan to predict oocyte quality and IVF outcome. From 
this standpoint, this makes the POEM study quite unique, and the potential to investigate a huge array of 
data is even more apparent. 
 
7.6.3. Patient Age 
Analysis of the data did not reveal a significant relationship between patient age and oocyte retrieval, 
fertilisation or embryo transfer, nor was there a significant correlation to the embryo developmental 
timepoints. This was primarily as a result of the lack of numbers in each group. 
However, this study was able to demonstrate that the vascular indices measured by 3D power Doppler at 
prehCG decrease significantly with increasing patient age, and although these relationships were not 
significant at egg collection, there was again a negative trend associated with age. This finding supports 
the results of a number of other studies that have also concluded that as the patient age increases, the 
vascular supply to the ovarian stroma as well as individual follicles becomes impaired (Kupesic et al., 
2003; Ng et al., 2004; Costello et al., 2006). 
Previous studies have indicated that oocyte quality decreases with age, which is normally as a result of 
increased prevalence of chromosomal abnormalities (Costello et al., 2006). One of the possible causes of 
these defects could be associated with decreased perifollicular blood flow, resulting in reduced available 
oxygen to the somatic cells surrounding the oocyte, that are then unable to provide pyruvate needed for 
oocyte metabolism (Van Blerkom et al., 1997). It is likely, however, that vascularity of the individual follicle 
is directly affected by the oocyte itself by means of a signalling cascade ultimately resulting in the 
secretion of locally acting angiogenic factors (Fraser, 2006). Alternatively it is also possible that oocyte 
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quality could be purely dependant on follicular vascularity, driven by factors external to the follicle. 
Consequently the negative relationship between peri-follicular vascularity and advancing age could either 
be as a result of decreased oocyte quality or because of impaired angiogenic function within the ovary, 
which is unclear at this time. 
 
7.6.4. Follicular Fluid Steroid Hormones 
Steroid hormone measurement in the follicular fluids revealed correlations between oestradiol and oocyte 
fertilisation and embryo transfer, as well as follicular size and growth. Oestradiol concentration was higher 
in follicles which yielded an oocyte that successfully fertilised, as well as those from which an embryo was 
transferred, and although this was not statistically significant, trends were observed. Progesterone in the 
follicular fluid was also higher in follicles yielding an oocyte that consequently fertilized, and this was 
found to be significant (P<0.05). Therefore it seems that the microenvironment in which the oocyte 
resides could be highly influential to its later development, especially the ability to fertilise. The granulosa 
and theca cells, that produce oestradiol and progesterone respectively, must have a local effect on the 
oocyte contained within the follicle. 
Relatively few studies have examined the concentration of steroid hormones in relation to oocyte 
development, and those that have been performed have frequently contradicted each other. Some have 
shown oestradiol and progesterone to correlate to oocyte fertilisation and embryo cleavage (Wramsby et 
al., 1981; Botero-Ruiz et al., 1984; Kreiner  et al., 1987; Kobayashi et al., 1991; Mendoza et al., 1999; 
Ilkhanizadeh et al., 2010; Lamb et al., 2010), whereas others have found no relationship (Franchimont et 
al., 1989; Rosenbusch et al., 1992; Tavmergen et al., 1992; Fujiwara et al., 2000;  Asimakopoulos et al., 
2008). It does, however, seem logical that healthy granulosa cells from healthy ovarian follicles, would 
have increased steroidogenic capacity and therefore higher steroid hormone concentrations would be 
found in the follicular fluid. In addition, oestradiol and progesterone are thought to play a part in the 
angiogenic development of the follicle (Morales et al., 1995; Shimizu and Miyamoto, 2007), and so 
follicles with higher concentrations in the follicular fluid may have increased vasculature and hence 
superior development, although no significant relationships between steroid hormones and ultrasound 
vascular indices were found in this study. 
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The difficulty with standardizing follicular fluid constituents as predictors of embryo development, is that 
there is a plethora of factors that will ultimately influence the results of any study. For example, 
gonadotrophin stimulation has been shown to affect follicular fluid composition, due to the FSH effect on 
somatic cell steroidogenesis, which in turn has a direct effect on the oocyte within (Mendoza et al., 2002). 
As a result, the treatment regime that the patient receives will affect follicular fluid composition, and 
therefore when attempting to identify follicular fluid predictors of embryo development, it is vital that the 
study subjects receive identical stimulation protocols. In this study the patient ovarian stimulation regime 
was not dictated or indeed affected by the trial itself, and consequently patients received human 
menopausal gonadotrophin, recombinant FSH, or recombinant FSH with recombinant LH. Although 
statistical analysis revealed no relationships between stimulation drug administered and follicular fluid 
constituents, vascular indices and follicle size, the fact that the patients did not all receive identical 
stimulation treatment regimes could be considered to be one limitation to the study, though this would be 
very difficult to achieve given that drug type and dosages differ between individuals. 
In addition to the stimulation drugs administered to the patients, the infertility treatment method itself will 
have an effect of the outcome of the study; unless ICSI is used to fertilise the oocytes, the maturity of the 
oocyte is uncertain as this can only be assessed indirectly by examining the morphology of the cumulus 
oophorus and corona radiata (Mendoza et al., 1999). Consequently, immature oocytes would 
undoubtedly have been included in a number of the previously mentioned follicular fluid studies, which 
could have biased the results; another potential reason for discrepancy in the literature. 
Another side to the argument is that the follicular fluid is simply a waste product reservoir of the oocyte 
and somatic cells that may not reflect the health status of the oocyte at all, and that measuring its 
constituents would indicate nothing more than the viability oocyte and somatic cells. However, even if this 
is the case, it is unlikely that there is not a single indicator of oocyte quality within the follicular fluid in 
which the oocyte develops. 
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7.6.5. Follicular Fluid TGF-! Factors 
7.6.5.1. AMH in Follicular Fluid 
This study did not find a significant correlation between AMH concentration measured in the follicular fluid 
and oocyte fertilization and embryo transfer. Previous studies published to date provide conflicting 
evidence regarding this relationship. In an IVF patient study, Takahashi et al. (2008) observed that 
oocytes from follicles with higher follicular AMH concentrations had higher fertilisation rates and Fanchin 
et al. (2007) even found high AMH to directly reflect increased embryo implantation rates. However, other 
studies found no correlation to any outcome parameters (Jancar et al., 2008), and even that AMH may be 
negatively correlated to oocyte quality (Cupisti et al., 2007). It has been demonstrated previously that 
atretic follicles do not express or secrete AMH in rats, sheep or humans (Baarends et al., 1995; Bezard et 
al., 1987; Weenen et al., 2004), indicating that at the very least that if no AMH is present in the follicular 
fluid, the follicle is likely to be atretic and hence the oocyte within of compromised health. These 
conflicting studies warrant further research into the relationships between AMH and oocyte quality and 
developmental competence. 
 
In this study, follicular fluid AMH concentration was observed to positively correlate to follicle size, 
although this relationship was only significant between the smallest and largest follicles. This was an 
unexpected result and requires greater numbers to confirm, as there were relatively low numbers in each 
size group. Currently data is very limited regarding the relationship between follicular size and 
intrafollicular AMH with regard to large peri-ovulatory follicles in IVF treatment cycles. In normal 
unstimulated human cycles, AMH is expressed by granulosa cells in a specific window of follicular 
development from the early stages, up until the late antral stage, when expression becomes low or 
absent altogether (Baarends et al., 1995; Fanchin et al., 2007; Seifer and MacLaughlin, 2007). However, 
the effects of ovarian stimulation regimes on AMH secretion have not yet been explored, and it possible 
that gonadtrophin stimulation and hCG may have an effect on the follicular developmental characteristics 
at these late stages of development, and so further research is required in this area. 
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AMH did not significantly correlate to steroid hormone levels in the follicular fluid in this study. This result 
is supported by the work recently published by Gr¿ndahl et al. (2011), who measured AMH expression in 
granulosa and cumulus cells collected from patients in ART treatment cycles. AMH and aromatase 
expression were not correlated in these large antral follicles, which suggests that at this final stage of 
development, AMH and oestradiol production are independent of each other. It is thought that in small 
antral follicles at least, AMH suppresses steroidogenesis by inhibiting aromatase expression, however 
Gr¿ndahl et al. (2011) found that in larger antral follicles in stimulated cycles this result was not observed, 
possibly because in these follicles there is decreased AMH expression, which in turn may have a 
decreased effect on aromatase. Therefore it seems that in larger follicles, as studied in this trial, 
aromatase expression, and hence oestradiol production, occurs independently of AMH expression and 
secretion. 
 
BMP15 and AMH concentrations in the follicular fluid displayed a significant positive correlation, which 
could be a function of follicular size rather than a direct relationship, as both of these factors increased in 
concentration along with follicular mean diameter and volume. However, it seems more likely that oocyte-
secreted factors could affect the surrounding cumulus cells by preventing cellular differentiation and 
increase AMH production, as shown by AMH immunohistochemistry performed on ovarian sections 
(Campbell, unpublished results), the staining of which is localized only to the cumulus cells (Weenan et 
al., 2004). Also Gr¿ndahl et al. (2011) observed that cumulus cell AMH expression was maintained 
though the later stages of development, while granulosa cell expression was depressed. This provides 
further evidence that suggests a local effect of the oocyte on AMH production by somatic cells, although 
the relationship between follicular AMH and oocyte development is clearly quite complex and requires 
further research.  
 
7.6.5.2. BMP15 and GDF9 in Follicular Fluid 
BMP15 measured in the follicular fluid was positively correlated to follicular size, both in terms of mean 
diameter and volume, which linear regression revealed to be significant. This effect was most prominent 
with the prehCG scan measurements. Smaller follicles had significantly lower BMP15 concentrations than 
 206 
the larger size groups. Although this relationship was observed overall, if the largest follicle is removed 
from the analysis, this was no longer found to be significant compared to the egg collection scan 
measurements, indicating that overall BMP15 did not strongly correlate to follicular size at this timepoint. 
The reason for this could be due to the administration of hCG causing follicle maturation, and so at this 
point the role of the oocyte in preventing premature luteinization through production of oocyte-secreted 
factors is no longer in effect. 
There have been no reported studies measuring BMP15 or GDF9 concentrations in the follicular fluid of 
ovarian follicles to date, and so it is not known at what concentrations these two factors are normally 
present in the follicular environment. Two previous studies have used Western blotting to measure the 
oocyte-secreted factors in follicular fluid, however this technique does not allow fully quantitative 
measurement of concentrations in the fluid (Wu et al., 2007; Gode et al., 2011), and can only be used as 
a relative measure between samples. Wu et al. (2007) found that BMP15 protein levels were higher in the 
follicular fluids from follicles containing oocytes that fertilised successfully, as well as embryos that 
cleaved and developed successfully. Follicular oestradiol was found to positively correlate to BMP15, and 
progesterone negatively so, further indicating a role for BMP15 as an anti-luteolytic factor produced by 
the oocyte (Shimasaki et al., 2004).  Conversely, Gode et al. (2011) recently observed no relationship 
between BMP15 protein in the follicular fluid and IVF outcome, and so the potential for this factor as a 
predictor of embryo development needs further research. However this latter study did find GDF9 to 
positively correlate to oocyte maturation and embryo quality, and so this could serve as a more 
appropriate factor to measure.  
Our study was unable to detect GDF9 levels in the follicular fluid, as concentrations were below the 
threshold 0.156ng/ml of the ELISA, which is probably as a result of hCG administration decreasing GDF9 
levels to undetectable levels. The study was unable to determine at what concentrations GDF9 is present 
in human follicular fluid, however if levels are too low to be detected by ELISA, it suggests that it is 
unlikely GDF9 concentrations would be predictive of embryo development anyway, as there would be 
such small differences between samples. Much like BMP15, it is likely that hCG-induced follicular 
maturation causes the oocyte to cease production of these factors, the role of which is to prevent 
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premature luteinization, and so intrafollicular concentration of GDF9 at egg collection is at a negligible 
level at this point. 
 
In conclusion, our study was unable to demonstrate a relationship between the TGF% superfamily 
members AMH, BMP15 and GDF9 concentrations and oocyte/embryo developmental parameters, and 
therefore it seems that measurement of concentrations in the follicular fluid could not be used in a clinical 
setting to predict oocyte developmental competence. However, the study has shown that AMH and 
BMP15 may interact in the pre-ovulatory follicle 
 
7.7. Conclusion 
In conclusion, this clinical trial has identified several targets for future research into potential predictors of 
oocyte and embryo development that have not yet been explored in detail. There is currently insufficient 
data to provide definitive links, but there is some indication that follicular vascularity and follicular steroid 
hormones may be related to oocyte developmental competence. While peri-follicular blood flow appears 
to have strong links to the development of the oocyte within, this requires further research. Measurement 
of oocyte secreted factors in the follicular fluid at egg collection seems to be fairly limited in terms of the 
relationship to oocyte developmental capacity due to the administration of hCG decreasing these factors 
in the follicular fluid significantly.   
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Chapter 8 Ð General Discussion 
It has been reported that around 10% of couples fail to conceive within a year of attempting to become 
pregnant naturally (Fauser et al., 2005). In the developed world the tendency to postpone having children 
has increased the incidence of ovarian ageing, which considerably affects fertility (Lambalk et al., 2004). 
As a result of this change in lifestyle to delay having children, the field of infertility treatment in 
reproductive medicine has now become commonplace not just in the developed world, but also across 
the globe. In fact, it is thought that between 1 and 3% of all children born in the Western world are from 
IVF (Fauser and Edwards, 2005). 
There is now awareness of the contribution of infertility treatment to multiple gestations and births, which 
are associated with increased perinatal morbidity and mortality, in addition to considerable financial 
implications to the National Health Service in the UK, as a result of increased need for surgical and 
medical procedures for both mother and child. The costs of infertility treatment are far outweighed by the 
direct perinatal costs of multiple births following IVF treatment (Collins, 2002), and as a result the shift 
toward single embryo transfer has now taken place. However, as a consequence of IVF clinics implanting 
a single embryo, where before 2 were transferred, success rates in these clinics dropped considerably in 
many cases, and although research in the field was taking place before this change, there has been a 
copious increase in order to ensure that success rates are brought back up to where they were 
previously, and beyond. 
One of the most challenging aspects of IVF, and arguably one of the areas that has attracted the most 
attention in terms of research, is selection of the embryo with the best possible chance of developing and 
implanting to lead to a pregnancy. In order to do this, research has focused on what makes a Ôgood or 
badÕ oocyte and embryo, as current clinical practice is to examine the oocyte and embryo under the 
microscope, and formulate an assessment of its quality. However, this morphological examination is 
subjective, and weakly correlated with pregnancy (Guerif et al., 2007), and as a result there is a 
desperate need to find that Ôgolden markerÕ of embryo quality that will enable embryologists and clinicians 
to make the crucial decision of which embryo to transfer to the patient. 
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Some argue that improving embryo selection methods may be becoming a dead-end in terms of reaching 
the final goal of optimising IVF success, and that improving cryopreservation may serve as a more 
promising avenue of research (Mastenbroek et al., 2011). However, this is a fairly single minded way of 
looking at the problem, and although improving crypreservation may well provide a helpful way of storing 
oocytes and embryos, if the quality of the embryo is not known the value of this is very limited. 
Of course, laboratory research, which underpins the ability to assess the developmental capacity of an 
oocyte or embryo in the clinic, is absolutely crucial. This work described in this thesis has demonstrated 
this, from targeting oocyte-secreted factors affecting granulosa cells in culture, to how blood moves 
around the mammalian ovary, scaled up to a clinical trial examining these factors and ovarian blood flow 
in vivo, in the species which the research is ultimately aiming to benefit. 
 
 
8.1. Summary of research findings 
There are still gaps in the jigsaw of knowledge that forms the complex molecular mechanism of oocyte 
development; in particular, the oocyte and its microenvironment. 
The research described in this thesis has focused on the interactions between the oocyte and its 
surrounding somatic cells, specifically concerning the role of oocyte-secreted factors in regulating 
follicular development in terms of both avascular granulosa cell function and follicular vascularity and 
hypoxia, both in vitro and in vivo. 
 
In the experiments described in Chapter 4, granulosa cell cultures provided further evidence for a role of 
a combination of BMP15 and GDF9, as well as BMP6, in the prevention of luteinization by increasing 
oestradiol and suppressing progesterone production. Furthermore, co-culture results indicated a further 
role for the COC in promoting somatic cell proliferation, suggesting the COC can directly affect the fate of 
its own development by producing factors that have a positive effect on its surrounding cells, and in turn, 
the individual microenvironment in which it resides. The in vivo infusion study supported the in vitro 
evidence suggesting that oestradiol synthesis is regulated by these factors in combination, as the passive 
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immunization against the combination of BMP15 and GDF9 had a negative effect on steroidogenesis in 
some of the animals, however more experimentation is required to confirm this effect.  
 
Further cell cultures described in Chapter 4 explored the effects of hypoxia in the ovarian follicle induced 
by increased media depth, high seeding density and treatment with chemical agents, which in all cases 
were found to have a considerable detrimental effect on granulosa cell steroidogenesis. During hypoxic 
conditions the follicle reacts by producing angiogenic factors in order to increase follicular vasculature and 
hence overcome these conditions so that normal development can resume under optimal conditions. 
 
Although the development of clinical ultrasound technology has come a long way since its advent over 50 
years ago, and has facilitated the prediction of ovarian response to stimulation in the IVF clinic, as yet 
there have been no concrete links between ultrasound parameters and oocyte quality. Even though highly 
sensitive power Doppler is able to detect diminutive blood flow in capillaries well below the surface of the 
skin, there has been no concensus reached to ascertain the use of the technology in a clinical setting to 
relate to follicular blood flow and oocyte quality.  
Measurement of follicular vascularity and blood flow could be considered to be an indirect indication of 
the hypoxic state of the follicle, although this has not yet been demonstrated in the clinical trial described 
in Chapter 7. It seems relatively clear that the follicle requires a significant degree of blood flow in order to 
provide it with the endocrine and molecular signals needed for adequate development, however the 
mechanisms by which the vascular network is formed and regulated in vivo are not yet clear. 
 
Overall this thesis has elucidated some of the interactions involved in follicular development with regard 
to the relationship between the oocyte and somatic cells, however considerable research will be required 
in the future to investigate the complex system that exists in the ovary, as summarized in figure 8.1. Of 
course, these factors not only interact with each other, but are also affected, and affect, additional 
external endocrine and molecular stimuli, such as gonadotrophins, which are not included in the diagram 
for simplicity. 
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Figure 8.1. Oocyte interactions with intrafollicular and extrafollicular factors 
 
8.2. Limitations of the research 
In both the in vitro and in vivo experiments, one of the major limitations was that the oocyte secreted 
factors of ovine origin proved extremely hard to obtain. This meant that mouse GDF9 and human BMP15 
had to be used in the in vitro cultures, which differ structurally to those of the sheep. McNatty et al. 
(2005a) found that mouse and ovine GDF9 had different effects on both bovine and ovine granulosa cell 
cultures in vitro, indicating that the oocyte-secreted factor species of origin has an affects its mechanism 
of action in culture. This group also observed these divergent effects of factors originating from different 
species when culturing rat granulosa cells (McNatty et al., 2005b). Consequently, it is not possible to 
make a concrete statement from our in vitro work that the cooperative activity of hBMP15 and mGDF9 
observed in these ovine granulosa cell cultures is physiologically representative, and so further 
experimentation is required. 
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The primary limitation in the clinical trial was partly the amount of time required to obtain ethics approval, 
as the trial was able to run for just a few months as opposed to a full year as planned. In addition, the 
restricted number of aspirations performed per patient limited the number of replicates considerably, as it 
was originally planned to aspirate two follicles per patient. However, due to the experimental nature of the 
techniques employed, such as single embryo culture, it was decided that in order to avoid a potentially 
severely detrimental effect on IVF success rates in the unit it was necessary to commence the trial 
aspirating one follicle per patient. Because of this, the planned molecular analyses were not possible until 
two aspirations per patient could be performed. 
Another limitation of the clinical trial methodology is that in IVF, the oocytes, which are collected at MII, 
have considerably reduced oocyte-secreted factor production at this stage, and so the value of 
measurement of these factors in the follicular fluid at aspiration may be somewhat limited. Ideally these 
oocytes would be collected at GV stage, however for obvious reasons in an IVF setting this would not be 
possible. 
 
The primary focus of the research described in this thesis has been on embryo quality and development, 
but what has not been explored is the maternal side of establishment of pregnancy.  
Favourable uterine conditions, more specifically good endometrial receptivity, are needed for the embryo 
to implant, and is a whole different field of research that is ongoing not just in our IVF clinic, but in 
research facilities around the world. Even the highest possible quality embryo will not be able to implant in 
a uterus that does not offer favourable conditions for development, and this is thought to be one of the 
causes of the relatively common problem of recurrent miscarriage.  
Study of endometrial receptivity is relatively limited in the IVF setting, but the work that has been carried 
out has concentrated on the non-invasive ultrasound assessment of the uterus. The measurement of 
blood flow, using the technology described in this thesis, has in particular been linked to uterine 
receptivity, as well as numerous other factors including thickness, shape and general condition of the 
uterine lining (Dechaud et al., 2008). 
 
 
 213 
8.3. Future work 
Doubtlessly research into how the oocyte interacts with its follicular environment, as well as how its 
environment affects its development, will continue to be a key area of study in the future. There is 
presently a huge number of questions to be answered in this field, the answers to which will lead to 
significantly better understanding of not just oocyte development and ovarian physiology as a whole, but 
also potentially huge developments in clinical assisted reproduction. 
The work described in this thesis has provided some of these answers, but there are of course new 
avenues of research to explore and ideas to investigate, leading on from this. 
 
8.3.1. In vitro culture 
The culture method used in the granulosa cell cultures has been designed to replicate as closely as 
possible the physiological environment of the follicular compartment, and has performed exceptionally 
well in almost every experiment performed. This further confirms the potential and value of this culture 
system, developed by Campbell et al., capacity to explore the molecular aspects of follicular somatic cell 
growth and differentiation has only been touched upon in this research. To further investigate the effect of 
oocyte-secreted factors on the granulosa cells, it would seem logical as a next step to examine SMAD 
phosphorylation by GDF9, BMP15, and the two in combination. This was, in fact, attempted but due to 
time constraints it was not possible to complete this particular experiment. Reader et al. (2011) recently 
reported the results of in vitro rat granulosa cell cultures in which the GDF9/BMP15 combination 
signalling pathway was investigated. This study showed differing signalling cascades of GDF9 and 
BMP15 from different species, and overall the results suggested that the molecular complexes formed by 
these two factors are likely to act not just through the SMAD 2/3 pathway, but also via non-SMAD 
signaling pathways. A similar result was also observed by Mottershead et al. (2011), although both of 
these studies concluded that more research was needed to further investigate these findings. 
Oocyte culture was not performed to any great degree in the in vitro work, and there is potentially a 
wealth of information to be gained from co-culturing the somatic cells with oocytes and COCs. Following 
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on from the granulosa cell cultures, it would be interesting to see what factors affect the synthesis and 
secretion of oocyte-secreted factors, particularly in relation to endocrine signaling. 
Furthermore, the effect of hypoxia on the oocyte itself could be explored in vitro using a similar 
methodology to the granulosa cell cultures, perhaps by examining the effect on oocyte-secreted factor 
production serving as an indicator of oocyte health. This would be extremely valuable as there has not yet 
been a direct link shown between oxygen availability and oocyte-secreted factor production. 
 
8.3.2. In vivo experiments 
The infusion experiment was almost as much about researching and optimizing the surgical procedure of 
ovarian cannulation as it was investigating the effect of blocking the effects of GDF9 and BMP15, as this 
technique is still fairly novel. However, overall the work was a success, and the results from the infusion 
study itself are encouraging.  
Due to the small number of animals involved in the experiment, and not all of them responding to the 
infusion, the next step experiment would be focused on repeating the procedure with more animals, to 
obtain further results to support the hypothesis that the GDF9/BMP15 combination antiserum does indeed 
inhibit steroidogenesis. Leading on from this, the effect on the reproductive cycle could be explored, as a 
number of published studies have indicated a role for these factors in the regulation of ovulation, however 
none have investigated the effects of the two factors in combination. 
Conversely, it would be very interesting to examine the effect of infusing recombinant oocyte-secreted 
factors into the ovarian vasculature, although availability of these factors at a significantly lower cost 
would be a prerequisite for this to take place! It is possible that in the distant future administering oocyte-
secreted factors could have a role in ovarian stimulation, but there is a long way to go before any such 
work could become commonplace. 
 
8.3.3. Clinical research 
Following the promising results of the clinical trial, the study is set to continue in the future, following a 
similar format to the original, in order to further investigate the observed relationships between follicular 
 215 
fluid factors and oocyte developmental competence. In addition to the endocrine and growth factor 
profiling of the follicular fluid, the methodology is expected to change to allow the collection of two sets of 
follicular aspirates, and therefore enable the quantitive analysis of gene expression by the oocyte somatic 
cells, which this preliminary trial was not able to do. 
The potential of the trial to reveal new information about oocyte developmental competence and 
ultimately optimization of IVF, is considerable. Single embryo culture, tracking the oocyte from the 
moment it is aspirated from the follicle, through fertilisation, culture, and transfer is a feat in itself, but the 
POEM study has shown that it is possible. In fact, this study was the first to track a human pregnancy 
from pre-hCG right through to live birth. In addition, and perhaps more importantly, the clinical trial has 
shown that single culture is not only feasible, but enables the study of any somatic cell marker, follicular 
fluid constituent, ultrasound parameter, and a number of other measures, to be compared to oocyte 
quality and embryo development, which will undoubtedly prove invaluable for future research in the unit. 
 
 
8.4. Conclusion 
In summary, this thesis has explored some of the complex interactions that exist within the mammalian 
ovary, from a cellular to a whole organism level, which ultimately lead to the creation of life. Although 
some of the results of the research have elucidated some of these interactions, in these have lead to yet 
more questions; however this is arguably the finding of any credible research. 
This research has provided further evidence that the oocyte plays a key part in the development of the 
follicle, by optimizing its microenvironment to ensure the most ideal conditions for its own requirements. It 
seems that the potent oocyte-secreted factors secreted for this purpose have a considerable effect on the 
somatic cells that surround the oocyte itself, and potentially the vascular network that surrounds the 
follicle, through this interaction. 
 
As more is discovered every day in this fast-paced area of work, it is exciting to look to the future with 
anticipation of what research will reveal about ovarian physiology, as well as how this will translate into a 
developments in the IVF clinic. 
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Appendix 
1. Cell Culture Media 
Dissection medium 
500ml Medium 199 (Sigma M7528) or DMEM (Sigma D5671) 
2.5ml Penicillin/Streptomycin (Sigma P0906) 
5ml Fungizone (Sigma) 
10ml HEPES (if not already in media) (Sigma H0887, 1M) 
 
Granulosa medium 
500ml McCoys 5A with sodium bicarbonate (Sigma M8403) 
0.5g BSA (Sigma A9056) 
5ml Pen/Strep 
7.5ml L-Glutamine (Sigma G2150, 200mM) 
10ml HEPES 
250!l Transferrin (10mg/ml) 
100!l Selenium (20!g/ml) 
143!l Testosterone or androstenedione (1mg/ml) 
50!l IGF-I LR3 (100!g/ml) 
50!l Insulin (100!g/ml) 
50!l FSH (10!g/ml) 
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2. Assay Buffers 
Radioimmunoassay PGel buffer (0.05M) 
Per litre distilled water: 
2.3g Sodium di-hydrogen orthophosphate 
6.3g Disodium hydrogen orthophosphate 
9.0g Sodium chloride 
1.0g Sodium azide 
1.0g Gelatin 
 
ELISA Coating buffer (0.05M carbonate buffer) 
 2.1g sodium bicarbonate 
2.65g sodium carbonate 
500ml distilled water 
 
ELISA Assay buffer (PBS/0.1%BSA) 
10 PBS tablets in 1 litre distilled water 
0.5g BSA 
 
ELISA Wash buffer (PBS/0.05% Tween) 
1 PBS tablet in 1 litre distilled water 
0.5mls Tween 20 
 
Blocking solution (PBS/3% BSA) 
5 PBS tablets in 500mls distilled water 
15g BSA 
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3. Tissue Processing 
Bouins Fixative 
Picric acid  75ml 
Formaldehyde  25ml 
Glacial acetic acid 5ml 
 
Tissue processing method 
75% ethanol  1 hour 
90% ethanol  1 hour 
95% ethanol  1 hour 
3 x 100% ethanol 1 hour each 
3 x Xylene  45 minutes each 
3 x Parafin wax  45 minutes each 
 
Haematoxylin & eosin staining method 
2 x Xylene   3 minutes 
2 x Ethanol   3 minutes 
70% ethanol   3 minutes 
Distilled water   3 minutes 
Harris haematoxylin  10 minutes 
Running tap water  5 minutes 
1%  HCl in 70% Ethanol  2 dips 
Scotts tap water  2 dips 
Running tap water  5 minutes 
1% eosin   2 minutes 
Running tap water  90 seconds 
2 x ethanol   2 minutes 
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Xylene    2 minutes 
Xylene    3 minutes 
Allowed to air dry then mounted in DPX 
 
Aromatase immunohistochemistry BOND-MAXª automated protocol 
Peroxide block 
Wash 
Marker (primary antibody) 1 hour 
Wash 
Post primary IgG 
Wash 
Polymer (secondary antibody Ðpoly HRP) 
Wash 
DAB 
Water 
Hematoxylin counterstain 
Water 
Wash 
Water 
 
